Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytokine receptor activity (GO:0004896),0.6285166299123894,1.9305519481717277,0.0,0.0680401838923889,0.063,24/83,10.90%,CD74;CCR2;CD44;IFNLR1;FLT3;IL27RA;IFNGR1;IL18RAP;XCR1;CCR1;IL10RA;ACKR2;CCR9;IL6R;IL2RG;IL17RA;CCRL2;CSF2RB;IFNAR1;IL6ST;IL1R2;IL1RAPL2;IL31RA;IL17RB
prerank,C-C chemokine binding (GO:0019957),0.7580751626612124,1.8644822771276326,0.0,0.12946534990635108,0.213,6/22,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,C-C chemokine receptor activity (GO:0016493),0.7618008914108156,1.8442874851189894,0.001557632398753894,0.12505533798739996,0.29,6/21,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,chemokine binding (GO:0019956),0.6976997667830998,1.8237410811619112,0.0,0.13206410693001872,0.379,7/30,6.59%,CCR2;ITGA4;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,microtubule minus-end binding (GO:0051011),-0.7280887176711659,-1.7806221978737522,0.005012531328320802,0.8599656357388317,0.507,9/13,20.30%,CAMSAP1;NUMA1;TUBGCP5;CAMSAP2;MACF1;TUBGCP6;HAUS4;CEP290;TUBGCP2
prerank,chemokine receptor activity (GO:0004950),0.7175546296280123,1.7765132008035214,0.0,0.2177285884556445,0.64,7/24,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;GPR35;CCRL2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.8318713719168713,1.7623835325107298,0.0018018018018018018,0.2258556104205687,0.71,7/11,14.57%,MAP3K15;MAP3K5;MAP3K1;MAP3K4;MAP3K7;MAP3K20;MAP3K13
prerank,thioesterase binding (GO:0031996),0.8313401696040956,1.757608360242553,0.0035149384885764497,0.20871056408260563,0.736,6/11,8.19%,TRAF1;CDC42;TRAF4;ADRA2A;TRAF3;RAC1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5657312504071489,-1.7567036961540947,0.0,0.5813144329896908,0.615,14/29,18.60%,GRIA4;GRIA2;GABRG3;GABRG2;GRID2;GRIK4;GLRA3;GABRB1;GRIK1;GLRA2;GABRA4;GABRB3;GABRA2;GABRA5
prerank,MHC protein binding (GO:0042287),0.721199658175474,1.7492966552490636,0.006211180124223602,0.20683743402009194,0.782,4/20,6.29%,CD74;LILRB1;PILRA;TAP1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6631086670759233,1.7452549863838966,0.002881844380403458,0.19404052443384984,0.795,10/35,7.19%,FGR;HCK;LYN;FYN;SYK;SLA;ZAP70;STYK1;PTK2B;DYRK1A
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.7635254450395359,1.7447569434721453,0.00333889816360601,0.175770475055338,0.795,6/15,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,endodeoxyribonuclease activity (GO:0004520),0.7023434839555844,1.717322149329269,0.0124804992199688,0.22602742906676163,0.876,11/20,19.99%,DNA2;RBBP8;MRE11;FEN1;MBD4;RPS3;EXOG;ERCC4;ENDOV;SETMAR;APEX1
prerank,MHC class II protein complex binding (GO:0023026),0.8071767774832485,1.7161273042032146,0.003430531732418525,0.2108930699812702,0.879,1/11,0.02%,CD74
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.7765255010503646,1.7145068964906447,0.013333333333333334,0.1989593838819107,0.881,7/14,13.43%,KMO;CYBB;NOX1;CYB5R4;NCF2;AIFM1;NCF1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7882344020804338,1.7102835304701798,0.01680672268907563,0.19352302303519742,0.895,2/11,3.31%,KCNE3;KCNQ1
prerank,N-methyltransferase activity (GO:0008170),-0.6100188148971156,-1.7066394465934918,0.013812154696132596,0.6392038946162657,0.763,7/20,9.11%,METTL15;TRMT1;ZCCHC4;SETD3;HNMT;TRMT1L;DIMT1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7094041754383382,1.6908929444155574,0.011345218800648298,0.22610761110165162,0.946,7/18,13.46%,PDLIM5;STXBP6;ANXA2;PDLIM1;ANXA1;S100A11;TMOD3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6676794469596758,-1.6642055976497068,0.005076142131979695,0.7304123711340206,0.891,7/13,18.60%,GABRG3;GABRG2;GLRA3;GLRA2;GABRA4;GABRA2;GABRA5
prerank,FAD binding (GO:0071949),0.6676370217719063,1.654118154495799,0.013513513513513514,0.31722554486633747,0.98,8/24,11.17%,KMO;AGPS;CRY1;CRY2;NQO2;MTRR;CYB5R1;AIFM1
prerank,protein serine/threonine kinase activity (GO:0004674),0.4901987673199626,1.6521008894315925,0.0,0.30379052693783115,0.981,102/334,14.85%,GRK3;LRRK2;GRK5;STK10;MAP4K1;MAP3K15;ALPK1;SGK3;PRKCE;SIK1;STK24;CDK13;VRK1;DAPK1;SLK;CAMK1D;CASK;MAP3K5;LMTK2;AKT3;MAP3K8;MAPKAPK3;SYK;PIM1;PKN1;PAK1;STK17B;STKLD1;MAP3K14;ERN1;PRKCH;RPS6KA3;BMPR2;CSNK1G1;MAPKAPK2;STK38;SBK3;EIF2AK2;BCR;IKBKB;VRK2;TAOK3;SIK3;HIPK2;MAPK14;IRAK4;RPS6KA5;CDK14;MAP3K1;HIPK1;STK4;PRKAB2;PTK2B;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;MAPK12;SIK2;RIOK1;ACVR2A;STK38L;MINK1;CSNK1G3;LATS1;PIKFYVE;OXSR1;NEK8;CSNK2A2;CSNK2A1;MAP3K4;BRAF;TLK2;GRK6;RIPK1;DMPK;NLK;LATS2;MAP4K3;PRKAA1;RPS6KA1;MAP3K7;PIK3R4;SMG1;CDK12;MAP3K20;EIF2AK3;MAPK8;AKT1;PDK3;LIMK2;MARK3;STK39;PRKAA2;ROCK1;TLK1;RPS6KA2;MOK;MAP3K13;AURKB;BRSK1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.576675076527996,1.6509391020545914,0.006443298969072165,0.2903782848061751,0.981,14/53,11.77%,KMO;CYBB;GSR;AGPS;CRY1;ACOX3;CRY2;NQO2;LDHD;DLD;MTRR;CYB5R1;AIFM1;FOXRED2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.6142012574470888,-1.645623251832049,0.01832460732984293,0.5755441008018327,0.933,9/16,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.6142012574470888,-1.645623251832049,0.01832460732984293,0.5755441008018327,0.933,9/16,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,sialyltransferase activity (GO:0008373),0.6863095962672039,1.6452968588112622,0.01579778830963665,0.2919063152517766,0.989,5/20,3.54%,ST3GAL1;ST8SIA4;ST3GAL4;ST8SIA1;ST8SIA6
prerank,nucleotidyltransferase activity (GO:0016779),0.6906227983440307,1.6332097697511787,0.019345238095238096,0.31222884386174016,0.993,9/19,14.80%,DNTT;PAPSS1;TUT1;PAPSS2;TENT2;MTPAP;TUT7;PNPT1;TENT4B
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6274217861503707,-1.6313798067818757,0.024657534246575342,0.5601742758959254,0.956,10/15,26.40%,HS3ST5;HS3ST4;HS6ST3;NDST1;HS3ST3B1;HS6ST1;HS6ST2;HS3ST2;HS3ST1;HS3ST3A1
prerank,glutamate receptor activity (GO:0008066),-0.584496379984905,-1.6305437600029922,0.024861878453038673,0.4925257731958763,0.958,7/19,10.34%,GRIA4;GRIA2;GRIA1;GRID2;GRIK4;GRIK1;GRM5
prerank,growth factor receptor binding (GO:0070851),0.5333053049953301,1.6272260442187596,0.0011806375442739079,0.31612585439420104,0.994,21/95,9.47%,IL1B;IL27RA;FYN;FGF5;FGF22;PLSCR1;JAK2;KL;ERN1;CCDC88A;IL6R;VEGFC;SNX1;GLMN;ARF4;GRB2;ADAM17;IL6ST;IL6;HIP1;PGF
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5810682691908953,-1.6245101014861039,0.024691358024691357,0.46113020236731583,0.966,8/19,18.60%,GABRG3;GABRG2;GRID2;GRIK4;GRIK1;GABRA4;GABRA2;GABRA5
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7761611198186349,1.618785969338221,0.029038112522686024,0.32873202482856834,0.996,3/10,5.83%,DPP4;PRCP;FAP
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5823079869769306,1.6105723074301193,0.012113055181695828,0.3400776582592409,0.998,11/42,7.08%,FGR;HCK;PLCG2;STAP1;SYK;CRK;PTPN6;ZAP70;FBXW7;GRB2;SAMSN1
prerank,lysophospholipase activity (GO:0004622),-0.5830382289896474,-1.6071137134597377,0.03773584905660377,0.48493127147766324,0.973,8/20,13.25%,ABHD12;PNPLA7;MGLL;GDE1;ENPP2;PLA2G4A;ABHD4;LYPLAL1
prerank,calcium channel inhibitor activity (GO:0019855),0.7537364559995677,1.6038804954620305,0.03577512776831346,0.3460678103184062,0.998,4/11,11.63%,ITPR1;MCUB;SLC30A1;FKBP1B
prerank,WW domain binding (GO:0050699),0.6287081182728431,1.6033995992447059,0.025954198473282442,0.33354810148135533,0.998,8/26,15.39%,NFE2;RAPGEF2;TRAF4;TCEAL3;TCEAL6;PMEPA1;ENAH;WBP11
prerank,hexosaminidase activity (GO:0015929),-0.6574062191851661,-1.603084007162961,0.02506265664160401,0.4572945954389253,0.975,5/12,20.22%,HEXB;HEXD;HEXA;CEMIP;HYAL1
prerank,phosphotyrosine residue binding (GO:0001784),0.5905873612493033,1.594537383189498,0.016551724137931035,0.34801536365898705,0.999,10/37,7.08%,FGR;HCK;PLCG2;STAP1;SYK;CRK;PTPN6;ZAP70;GRB2;SAMSN1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.6090990929508001,1.586124557781784,0.023494860499265784,0.36137597669182886,0.999,10/29,14.36%,ACE;DUSP16;MAPKAPK3;MAPKAPK2;MAPK14;DUSP6;DIRAS1;DUSP1;PPM1D;PTPRJ
prerank,MAP kinase kinase activity (GO:0004708),0.713111046092107,1.5843571927302575,0.03789126853377265,0.3540047067694778,0.999,8/15,18.98%,LRRK2;MAPKAPK3;MAPK14;MAP2K5;MAP2K3;MAP3K9;MAP2K4;MAP2K1
prerank,nuclease activity (GO:0004518),0.5591717698050448,1.5787396161830287,0.014647137150466045,0.3593942471978722,0.999,15/52,13.63%,DNA2;SAMHD1;STK31;PLSCR1;SND1;MRE11;FEN1;XRN2;WRN;RNASE1;RNASE6;DFFB;EXOG;RNASEH2A;RNASEH1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.5397387262463447,1.5781218802665056,0.017591339648173207,0.34908394347011745,0.999,20/60,17.53%,LRRK2;CDC14A;LRRC2;PPP3CA;PTEN;MTMR3;SSU72;PPTC7;PHLPP1;CTDSPL2;PDP2;DUSP1;PGAM5;PPP1CB;PPM1D;TIMM50;ILKAP;PPM1G;LRRK1;TAB1
prerank,heme binding (GO:0020037),0.5359944814928022,1.5761963376168395,0.011138613861386138,0.34346270247112265,0.999,12/65,8.76%,CYBB;JAK2;RSAD1;PTGIS;EIF2AK1;CYB5B;DGCR8;CYP27A1;CYB5R4;PTGES2;PXDN;BACH1
prerank,ligand-gated cation channel activity (GO:0099094),-0.4157286111448907,-1.5745957410005453,0.0,0.5219358533791524,0.987,17/75,13.32%,GRIA4;KCNJ2;GRIA2;GRIA1;P2RX7;P2RX4;GRIK4;GRIK1;KCNN2;MCOLN1;CHRNA7;KCNJ6;KCNK6;SHROOM2;KCNN3;TRPM2;KCNJ9
prerank,histone acetyltransferase activity (GO:0004402),0.6058022235627111,1.569040830765905,0.03012912482065997,0.3528698599523242,0.999,14/30,15.44%,BAZ1A;NCOA3;TAF9;KAT7;ATF2;TADA3;CLOCK;KAT6A;EPC2;TADA2A;SRCAP;KAT2B;CREBBP;TAF1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4229022274793131,-1.5676578169417665,0.004608294930875576,0.5102233676975946,0.991,12/60,6.65%,MERTK;CSF1R;TGFBR2;ERBB4;FLT1;NTRK2;EPHA6;NTRK3;EPHA5;ACVR1;FGFR2;RYK
prerank,deoxyribonuclease activity (GO:0004536),0.7095376484490504,1.5676284504509144,0.04433497536945813,0.3461572991966317,0.999,7/14,19.99%,MRE11;MBD4;RPS3;DFFB;ERCC4;DNASE1L1;APEX1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.6231245450983491,1.5642133557147322,0.030973451327433628,0.34617667090674176,0.999,15/28,18.98%,LRRK2;MAPKAPK3;MAPK14;RPS6KA1;MAP2K5;MAP2K3;AKT1;PRKAA2;RPS6KA2;AURKB;RPS6KB1;MAP3K9;MAP2K4;PRKCG;MAP2K1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.43124553602709403,-1.5616469520625407,0.004761904761904762,0.4965942562592047,0.993,12/60,6.65%,MERTK;CSF1R;ERBB4;NRP1;FLT1;NTRK2;EPHA6;NTRK3;NRP2;EPHA5;FGFR2;RYK
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5624151624676287,1.551863960192488,0.020435967302452316,0.3721150057162317,0.999,11/42,13.46%,CD47;PDLIM5;EMB;STXBP6;ANXA2;PDLIM1;NPTN;IGSF9;ANXA1;S100A11;TMOD3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.6434306719540129,-1.5517272883215376,0.03944315545243619,0.49959908361970223,0.997,4/11,15.37%,SLC25A20;SLC22A5;SLC22A4;SLC25A47
prerank,lipoprotein particle receptor binding (GO:0070325),-0.5046910351906757,-1.549823440987296,0.024024024024024024,0.47423754295532644,0.997,10/27,16.91%,APOE;SYT1;LRP1;AP2A1;HSP90B1;CLU;AP2M1;SNX17;APBB1;APBB3
prerank,fibroblast growth factor receptor binding (GO:0005104),0.6416758121803401,1.5393573111704515,0.03592814371257485,0.4009435836313071,1.0,4/21,3.56%,FGF5;FGF22;KL;NPTN
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5827973191205734,1.531192875846266,0.027220630372492838,0.41725693853226636,1.0,8/34,8.46%,MYO1G;IQGAP2;IQGAP1;DAPP1;RACGAP1;ARAP1;GBF1;CYTH3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7192670278902376,1.5256462318230881,0.0546448087431694,0.42457970014428204,1.0,5/10,11.04%,PRKAG2;PKIB;CXCL10;PRKAR2A;PRKAG1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5995400488790166,1.5209707122432408,0.03880597014925373,0.4287646203617598,1.0,8/27,10.27%,ITPR1;SLC23A1;ATP2B1;ATP2A3;MMGT1;SLC4A8;ZDHHC13;MAGT1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7177536660163656,1.5199222471569511,0.05660377358490566,0.42154201430274135,1.0,2/11,2.23%,SLC23A2;SLC23A1
prerank,retinoic acid binding (GO:0001972),0.7136873121371343,1.5159271095654159,0.0625,0.4227388254641954,1.0,1/12,0.51%,RARA
prerank,CCR chemokine receptor binding (GO:0048020),0.5973717950167682,1.515677888123658,0.0463768115942029,0.41359611782734546,1.0,3/28,10.16%,CCR2;CCRL2;CNIH4
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.5780445028823573,-1.5150804279960393,0.05793450881612091,0.5764200525571054,0.999,5/15,11.23%,P2RY12;GPR34;P2RX7;P2RX4;P2RY13
prerank,protein phosphatase 1 binding (GO:0008157),0.6335173424971471,1.514936256381321,0.047244094488188976,0.4064609822641256,1.0,6/21,8.84%,LILRB1;KCNQ1;AKAP11;PPP1R9B;SHOC2;PPP1R15A
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6657318704084864,1.5139063178509238,0.06493506493506493,0.4002085816448152,1.0,2/14,3.31%,KCNE3;KCNQ1
prerank,SH3 domain binding (GO:0017124),0.5198626943564852,1.5120457623700234,0.02069857697283312,0.3969430728191157,1.0,22/62,15.27%,WIPF1;PTPN22;PLSCR1;WASF2;CRK;GPX1;REPS1;CBLB;ABI1;CBL;CD2AP;PTPN12;GRB2;AFAP1L2;SYNJ1;CABYR;VASP;AFAP1;NCF1;ENAH;ADAM9;ELMO1
prerank,anion transmembrane transporter activity (GO:0008509),-0.6156182051078786,-1.5099188273694024,0.04807692307692308,0.5652443680794197,0.999,5/12,22.48%,SLCO2B1;ABCG2;SLC26A11;ABCC5;SLC4A2
prerank,filamin binding (GO:0031005),-0.6242664067144011,-1.494492730561415,0.06791569086651054,0.5937466087900163,0.999,5/11,18.86%,NEBL;FBLIM1;DPYSL3;CRMP1;SYNPO2
prerank,pyrophosphatase activity (GO:0016462),-0.42248522244103875,-1.4878999493804266,0.03278688524590164,0.5895790378006873,0.999,28/50,35.40%,ENTPD1;ENPP1;DHX29;PLPP1;PRUNE2;ENTPD5;TRPM2;DHX9;NUDT6;ITPA;DDX3X;ATCAY;PPA2;NUDT3;PLPP4;NUDT16L1;NUDT16;FITM2;PLPP5;ENTPD7;NUDT1;DOLPP1;ENPP3;ENTPD3;ENTPD6;NUDT14;NUDT4;NUDT11
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.5012782558444044,-1.4866470706643522,0.04054054054054054,0.5657052855506464,0.999,9/22,16.91%,APOE;SYT1;AP2A1;HSP90B1;CLU;AP2M1;SNX17;APBB1;APBB3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6976284401382682,1.4862666167971408,0.07872696817420435,0.46658473930070554,1.0,4/12,7.45%,TRAF1;TRAF4;STAT1;TRAF3
prerank,chemorepellent activity (GO:0045499),0.5963060246829344,1.4856132434986709,0.04962406015037594,0.4588490060898957,1.0,2/25,2.16%,DPP4;SEMA4A
prerank,nuclear export signal receptor activity (GO:0005049),0.7126144371385241,1.4832901072211337,0.0456140350877193,0.4571449855269879,1.0,4/11,5.77%,XPO1;XPO5;XPO6;XPO4
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7178596589257714,1.4748519290137103,0.070298769771529,0.4736777087814523,1.0,5/10,17.78%,CYBB;NOX1;NCF2;NCF1;CYBA
prerank,amyloid-beta binding (GO:0001540),0.4908163654641205,1.4722562151566034,0.02395964691046658,0.47274697769453433,1.0,15/79,6.88%,CD74;LILRB1;LILRB3;NGFR;LDLR;APBA1;CACNA1A;CD36;SORL1;APBA3;PICALM;ITGB2;HSPG2;PRNP;GSAP
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6462612679042836,-1.4703812351358463,0.05665024630541872,0.6023820681037176,1.0,5/10,18.60%,GABRG3;GABRG2;GABRA4;GABRA2;GABRA5
prerank,BMP binding (GO:0036122),0.7040209562628535,1.470115109602671,0.07093425605536333,0.47016656483809255,1.0,2/11,8.15%,BMPR2;ENG
prerank,CXCR chemokine receptor binding (GO:0045236),0.6944273819449298,1.468533075434511,0.06397306397306397,0.4661043366645274,1.0,2/11,3.60%,ITCH;CXCL10
prerank,exopeptidase activity (GO:0008238),0.5201042312559053,1.467590642285816,0.03978779840848806,0.46014492288020975,1.0,7/50,5.83%,DPP4;ACE;LNPEP;ACE2;DPEP1;PRCP;FAP
prerank,inward rectifier potassium channel activity (GO:0005242),-0.4874410644738354,-1.463723370335418,0.06790123456790123,0.5993538024802032,1.0,15/24,40.68%,KCNJ2;KCNN2;KCNJ6;KCNK6;KCNN3;KCNJ9;KCNK1;ABCC9;KCNJ3;KCNJ13;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6819493747081748,1.4586771690066875,0.07394366197183098,0.48025379798323775,1.0,4/11,17.80%,PADI1;ARG2;DDAH1;PADI2
prerank,small GTPase binding (GO:0031267),0.4491139535712404,1.4564270268747752,0.011917659804983749,0.4779135643855549,1.0,54/169,16.38%,LRRK2;IQGAP2;IQGAP1;CYRIB;SRGAP2;RIN3;EPS8;NGFR;PKN1;PAK1;MYO1C;RCC2;SORL1;USP6NL;OCRL;UNC13D;PICALM;XPO5;FGD4;AFDN;ARHGDIB;MYO5B;RABGAP1L;RAB34;FLNA;CIB1;MYCBP2;PAK2;GCC2;RABGAP1;NOX1;RHOBTB3;FGD1;FGD3;BRAF;KIF3B;AP1G1;DVL3;SH3BP4;DNM1L;PEX5L;ANKFY1;STRN3;SGSM1;EVI5;MAPKAP1;TRIOBP;RAB29;EHD1;KCTD13;RNF41;EXOC2;HACE1;DAPK3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6420576587479883,1.4553737009083403,0.07861635220125786,0.47261940234973615,1.0,6/16,8.66%,MTMR14;INPP5F;PTEN;MTMR3;MTMR4;SYNJ1
prerank,ligand-gated ion channel activity (GO:0015276),-0.45866099744652916,-1.452909622611438,0.04220779220779221,0.6134700744558992,1.0,7/30,6.91%,GRIA4;GRIA2;GRIA1;GRID2;GRIK4;GABRB1;GRIK1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6235232086665837,1.451631673113333,0.07332293291731669,0.47535286368483787,1.0,3/16,4.94%,HGD;ETHE1;HAAO
prerank,calcium channel regulator activity (GO:0005246),0.537067661467916,1.4510415840599447,0.06172839506172839,0.46885161199410513,1.0,5/37,8.42%,ITPR1;SGK3;MCUB;STIM2;SLC30A1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6842311817261291,1.4510369311840612,0.09302325581395349,0.46092099149512133,1.0,2/11,3.72%,ITPR1;RASA3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6983708057020295,1.4507156287822787,0.09803921568627451,0.44673833854845596,1.0,3/10,11.47%,DUSP16;DUSP6;DUSP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6983708057020295,1.4507156287822787,0.09803921568627451,0.44673833854845596,1.0,3/10,11.47%,DUSP16;DUSP6;DUSP1
prerank,ligand-gated channel activity (GO:0022834),-0.45866531801099125,-1.448872811566114,0.04126984126984127,0.6028247422680412,1.0,7/29,6.91%,GRIA4;GRIA2;GRIA1;GRID2;GRIK4;GABRB1;GRIK1
prerank,MAP kinase phosphatase activity (GO:0033549),0.6707534929180362,1.4476848053699771,0.09090909090909091,0.44814459829839126,1.0,3/12,11.47%,DUSP16;DUSP6;DUSP1
prerank,transcription cis-regulatory region binding (GO:0000976),0.4257355052138828,1.446901216601661,0.0010152284263959391,0.44305619744918234,1.0,65/406,12.30%,CIITA;TRPS1;NFE2;ZBTB46;FOXP1;RARA;SP3;RUNX3;GLI1;KLF4;PPARG;ETV6;LONP1;NFKB1;FOSL2;STAT3;FOXJ1;FOS;ZBTB20;TAF9;SPI1;SCX;TBL1XR1;ATF6;ATF2;IRF2;RFX3;DEAF1;XRN2;BBX;RFX5;TIPARP;KLF10;CDC5L;SETX;AHR;CREBRF;ARID4A;CREM;NFE2L2;PURB;THRA;CRY2;ZFP3;ZBED4;E2F2;GABPB1;GABPB2;CTCF;NFYC;RBAK;E4F1;SNAPC3;SMAD4;RPS3;BNC2;NR3C1;PBX1;FOXO3;IKZF5;TAF7;REST;ATF6B;NFYA;TFAM
prerank,voltage-gated ion channel activity (GO:0005244),-0.5651334067469065,-1.445704787568307,0.07556675062972293,0.592139175257732,1.0,6/14,16.18%,KCND2;PKD2;HCN1;VDAC1;GPR89B;GPR89A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5455641749308685,1.4430625974794806,0.06862745098039216,0.4473996466882343,1.0,5/32,5.68%,KCNE3;KCNG4;KCNA6;KCNQ1;KCNH1
prerank,CARD domain binding (GO:0050700),0.6394913768800417,1.4353902619977001,0.08263069139966273,0.46302217448820554,1.0,3/14,13.47%,CARD11;CARD16;CARD19
prerank,phosphoric ester hydrolase activity (GO:0042578),0.5058614113522524,1.428825282360433,0.059379217273954114,0.47480651053356654,1.0,13/49,15.09%,PTPN22;SAMHD1;DUSP16;PTPRO;ARMT1;SMPDL3B;SMPDL3A;PXYLP1;DUSP12;PGAM5;PPP1CB;PTPRJ;DUSP28
prerank,tropomyosin binding (GO:0005523),-0.5272548202362138,-1.4260817514831123,0.08549222797927461,0.6457808323787705,1.0,5/16,18.62%,NEBL;CALD1;PYCARD;TMOD1;TMOD2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.574280489205298,-1.4259838122410151,0.07046070460704607,0.6229166666666667,1.0,9/12,38.45%,ENTPD1;ENTPD5;SLC25A42;ENTPD7;ENTPD3;ENTPD6;CANT1;NUDT18;ENTPD2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6697938851510186,1.4256791529232307,0.07979626485568761,0.4776494252727508,1.0,7/12,15.47%,TENT5A;TUT1;TENT2;PAPOLG;MTPAP;TENT4B;PAPOLA
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.47970566417996285,1.4244620555044831,0.038314176245210725,0.4738492953796537,1.0,6/73,2.72%,CRHR2;CYSLTR2;FPR1;LTB4R;FPR3;RXFP2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5214701240035282,-1.4223105773841234,0.08290155440414508,0.6147233084488684,1.0,5/17,6.91%,GRIA4;GRIA2;GRIA1;GRIK4;GRIK1
prerank,cytokine receptor binding (GO:0005126),0.4736721092705701,1.421366646666803,0.03694874851013111,0.4758019381250972,1.0,19/83,16.19%,IL1B;IL27RA;SYK;JAK2;IL6R;VEGFC;CCRL2;ADAM17;PXDN;IL6ST;IL6;USP15;PGF;LIFR;TYK2;TIMM50;IL18;SPRED1;CD300LF
prerank,ligand-gated calcium channel activity (GO:0099604),0.6039461832911582,1.4173924864030687,0.09149277688603531,0.48092529979810755,1.0,2/19,3.72%,ITPR1;RASA3
prerank,GTPase binding (GO:0051020),0.4322120421505823,1.4173472226545982,0.01810436634717785,0.47421825350194136,1.0,56/194,16.38%,LRRK2;IQGAP2;IQGAP1;CYRIB;SRGAP2;LCP1;RIN3;EPS8;NGFR;PKN1;PAK1;MYO1C;RCC2;SORL1;USP6NL;OCRL;UNC13D;PICALM;XPO5;FGD4;AFDN;ARHGDIB;MYO5B;RABGAP1L;RAB34;FLNA;CIB1;MYCBP2;PAK2;GCC2;RABGAP1;NOX1;RHOBTB3;FGD1;GNB1;FGD3;BRAF;KIF3B;AP1G1;DVL3;SH3BP4;DNM1L;PEX5L;ANKFY1;STRN3;SGSM1;EVI5;MAPKAP1;TRIOBP;RAB29;EHD1;KCTD13;RNF41;EXOC2;HACE1;DAPK3
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.6127681218286634,-1.4170165741257816,0.08571428571428572,0.6122880870561284,1.0,5/10,16.24%,ECHS1;ECHDC1;HADHB;HADHA;ECI1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5776839963239513,-1.413792086483695,0.08495145631067962,0.6025884048331671,1.0,6/12,19.33%,IGF1;IRS1;PIK3R1;SOCS2;GNAS;YWHAH
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5659863777740983,1.4129923187490745,0.09696969696969697,0.4808356745558771,1.0,4/25,10.44%,KMO;CYP27A1;MSMO1;MTRR
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.47075186506414507,-1.4115662203440325,0.07507507507507508,0.5912612757731959,1.0,10/22,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP2A2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,ribosomal large subunit binding (GO:0043023),-0.5912788945307459,-1.410887892594208,0.0967741935483871,0.5759163802978235,1.0,6/11,12.76%,CPEB2;MRRF;LTN1;CPSF6;RBM3;NPM1
prerank,lipase activity (GO:0016298),0.5166348059741768,1.4106885728440866,0.07927677329624479,0.4805143808792967,1.0,2/43,0.54%,PLBD1;PLA1A
prerank,GTPase activator activity (GO:0005096),0.41493044306291527,1.4078467125449885,0.008247422680412371,0.48237272262898007,1.0,61/313,9.82%,ARHGAP15;LRRK2;VAV3;RIN2;RAP1GAP2;DOCK5;IQGAP2;IQGAP1;TIAM1;ARHGEF18;SRGAP2;RASGRP4;TBC1D1;RIN3;RAP1A;DOCK2;DENND3;TBC1D8;RACGAP1;DOCK10;SIPA1L3;TBC1D9;CCDC88C;ARHGAP18;RASGRP2;ARHGEF10L;ARHGAP30;DENND1A;RAPGEF2;RGS2;ARHGAP26;RGS3;USP6NL;TBC1D10C;CCDC88A;TBC1D2B;DOCK11;OCRL;BCR;RP2;TAGAP;DLC1;ARAP1;FGD4;TBC1D8B;DENND1B;RABGAP1L;CCZ1;NUCB2;MYCBP2;RABGAP1;PLCB1;FGD1;CYTH3;SOS1;FGD3;CYTH2;DEPDC5;TBC1D5;ARHGEF6;ARFGEF1
prerank,sodium channel activity (GO:0005272),-0.41789826496457827,-1.4074774389045315,0.06,0.569751869820093,1.0,9/37,12.13%,SCN1A;PKD2;SCN3A;GRIK4;GRIK1;HCN1;HCN2;SHROOM2;SCN1B
prerank,cGMP binding (GO:0030553),0.6592846014283362,1.4063290855897526,0.11475409836065574,0.4804896986208071,1.0,2/11,7.49%,RAPGEF2;PDE2A
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5517611188028324,1.4052660983482685,0.08357348703170028,0.47740036921863654,1.0,14/28,23.70%,TRAF1;TRAF4;STAT1;TRAF3;SIVA1;PIDD1;RIPK1;MYD88;TRAF2;FEM1B;BID;TNF;MADD;CASP8AP2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.43130606706652863,1.4003066040092844,0.03587443946188341,0.4858294948708707,1.0,30/147,9.82%,VAV3;RIN2;DOCK5;TIAM1;ARHGEF18;RASGRP4;RIN3;RAP1A;DOCK2;DENND3;DOCK10;CCDC88C;RASGRP2;DENND1A;RAPGEF2;CCDC88A;DOCK11;BCR;FGD4;DENND1B;CCZ1;NUCB2;MYCBP2;FGD1;CYTH3;SOS1;FGD3;CYTH2;ARHGEF6;ARFGEF1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5660570347602877,1.3949603146371476,0.10380116959064327,0.4947451833029902,1.0,7/25,9.67%,ZC3HAV1;PARP8;PARP4;TIPARP;PARP14;TNKS;PARP9
prerank,semaphorin receptor activity (GO:0017154),-0.5884614662167614,-1.3946902552096963,0.10952380952380952,0.5936156111929307,1.0,5/11,6.67%,PLXNA4;NRP1;NRP2;PLXNB2;PLXNA2
prerank,intracellular chloride channel activity (GO:0061778),-0.5247913579776724,-1.3916526027216554,0.09424083769633508,0.5716100120739297,1.0,3/16,5.90%,TTYH3;ANO10;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5247913579776724,-1.3916526027216554,0.09424083769633508,0.5716100120739297,1.0,3/16,5.90%,TTYH3;ANO10;TTYH2
prerank,ligand-gated anion channel activity (GO:0099095),-0.5116112438792102,-1.3896966254987957,0.08376963350785341,0.5630923313438234,1.0,9/17,18.60%,GABRG3;GABRG2;GLRA3;GABRB1;GLRA2;GABRA4;GABRB3;GABRA2;GABRA5
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6343850624910922,1.387172940972592,0.11400651465798045,0.5112344196893315,1.0,6/13,13.08%,PIP4K2A;PIK3C2A;PIKFYVE;PIP4K2B;PIK3CA;PIP5K1A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5430313690585796,1.386501705471457,0.1083086053412463,0.5066985569555593,1.0,6/24,7.11%,DAPK1;CAMK1D;MAPKAPK3;MAPKAPK2;PTK2B;MKNK2
prerank,adenylyltransferase activity (GO:0070566),0.5707972753018636,1.3828444010583014,0.09767441860465116,0.5109430475938224,1.0,9/21,15.47%,OAS2;OASL;TUT1;TENT2;PAPOLG;MTPAP;NMNAT3;TENT4B;PAPOLA
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.6234190766952101,1.3827839777934736,0.1348314606741573,0.5048618522963708,1.0,2/13,4.13%,DNA2;FEN1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5263168971199376,1.3802186202816065,0.12066574202496533,0.5060204037672912,1.0,12/30,15.36%,RPS6KA3;BIRC6;DPEP1;BIRC3;CAST;SERPINB9;TNFAIP8;CARD16;UBE2Z;RPS6KA1;XIAP;PRDX5
prerank,protein kinase C activity (GO:0004697),0.608712851944826,1.3744560659652163,0.13355048859934854,0.5160838948213373,1.0,3/14,2.88%,PRKCE;PKN1;PRKCH
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.6167606349846505,1.3744289248044992,0.11993517017828201,0.5100790256507848,1.0,5/14,8.66%,MTMR14;PTEN;MTMR3;MTMR4;SYNJ1
prerank,calcium activated cation channel activity (GO:0005227),-0.5224061007870863,-1.3743053818742774,0.08376963350785341,0.5972794959908363,1.0,5/17,8.19%,KCNMA1;ANO10;KCNN2;TMEM63B;KCNMB2
prerank,carbohydrate kinase activity (GO:0019200),-0.5808492724168814,-1.3722522011718228,0.10199004975124377,0.5884901202749141,1.0,4/11,3.49%,FGGY;HK3;NAGK;HK1
prerank,magnesium ion binding (GO:0000287),0.4276556398891568,1.371534409197752,0.037037037037037035,0.5121803958992472,1.0,41/135,17.17%,LRRK2;SIK1;MAP3K5;PLSCR1;ERN1;STK38;FEN1;RP2;SIK3;STK4;GSS;IMPA1;WRN;PDE2A;MAPK12;SIK2;STK38L;MSH6;IDH1;PGM1;LATS1;OXSR1;NLRC4;TDG;MTPAP;NLK;RHEB;GNAI1;EXD2;XXYLT1;MAP3K20;NT5C3A;BRSK1;PAPOLA;SRR;ENDOV;IRAK3;DYRK2;MVK;ABL2;PI4K2A
prerank,cholesterol transfer activity (GO:0120020),-0.5102932610753138,-1.3690014187721358,0.09571788413098237,0.5848420082138965,1.0,4/16,16.71%,ABCA1;GRAMD1A;MTTP;STARD5
prerank,transcription coregulator binding (GO:0001221),-0.38754149328662624,-1.3689592934020913,0.04780876494023904,0.5709969726722305,1.0,32/50,30.82%,VGLL4;LMO2;NEK6;EED;CTNNB1;THRB;CTBP1;PGR;MTF2;SMAD3;MED25;PER1;PHF1;PER3;ESR1;ZBTB49;AR;PER2;EHMT2;HDAC6;CDK9;HDGF;THAP7;CHD6;ZBTB17;CIT;RORA;PPARD;USP11;UBE2I;ZBTB7A;SUZ12
prerank,chloride channel inhibitor activity (GO:0019869),-0.5890251237560558,-1.368197823202273,0.13082039911308205,0.5598477583313354,1.0,7/10,21.63%,WNK1;WNK2;VTI1B;STX1A;VAMP8;STX8;WNK3
prerank,voltage-gated calcium channel activity (GO:0005245),-0.40831048293583655,-1.3653436447436236,0.08125,0.5559063573883162,1.0,8/37,7.14%,CACNA1D;CACNB2;CACNA2D3;CACNA2D1;PKD2;CACNA1C;CACHD1;TPCN2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4136836611323739,1.3647853685169107,0.03128371089536138,0.5255191789427949,1.0,53/181,18.17%,KLF4;CREB1;PPARG;DTX3L;STAT3;FOS;MAD2L2;RBBP8;NCOA3;SPI1;NFKBIA;CRY1;MTA3;ATF2;RBPJ;STAT1;HIPK2;MAPK14;FAF1;ANXA4;BUD31;TADA3;NFE2L2;CPNE1;BCAS3;ID2;WWP2;NCOA2;SMARCE1;PARP9;NCOA1;SPEN;BAZ2A;TACC1;NRIP1;CHD4;HCLS1;HDAC3;DUSP26;CREBBP;RELA;MIER1;TAF1;BHLHE40;MED1;RBL2;RB1;PROX1;SIRT1;BBS10;SMARCD3;HDAC1;NCOA7
prerank,actinin binding (GO:0042805),0.5632602313933378,1.36416965247549,0.10954616588419405,0.5212548178877142,1.0,4/21,2.11%,RARA;PDLIM5;PPARG;NFKB1
prerank,carboxypeptidase activity (GO:0004180),-0.41426285142137964,-1.3631099791318029,0.07936507936507936,0.5505269186712486,1.0,17/35,29.41%,CTSA;FOLH1;NAALAD2;MINDY2;CTSZ;BLMH;MINDY1;AEBP1;AGBL1;AGBL4;CPA6;CPE;SCPEP1;PEPD;AGBL3;VASH2;CPD
prerank,monocarboxylic acid binding (GO:0033293),0.5799239574228556,1.3540561621531817,0.14653784219001612,0.5460415881476266,1.0,2/18,7.59%,RARA;PSAP
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5391347006335184,1.3520608523814333,0.12558869701726844,0.5456234746580396,1.0,8/25,14.35%,MYO1G;DAPP1;SESTD1;PLEKHA2;HIP1;AKT1;NCF1;MAPKAP1
prerank,retinoid binding (GO:0005501),0.5593656789361113,1.3514004921775653,0.13374805598755832,0.5414968481203796,1.0,1/22,0.51%,RARA
prerank,serine-type endopeptidase activity (GO:0004252),0.4574670353754152,1.349974915378631,0.08202653799758745,0.5396478172032663,1.0,12/80,13.35%,DPP4;PRSS53;HP;HPR;FAP;PARL;C1RL;HGF;RHBDL2;MBTPS1;CORIN;PCSK5
prerank,phosphatidylinositol binding (GO:0035091),0.4409252144106454,1.3460692821383933,0.07255139056831923,0.5454595387310985,1.0,26/91,13.71%,ITPR1;FRMPD2;PLEKHF1;MYO1E;DENND1A;CCDC88A;PICALM;DPEP1;MITD1;ESYT3;SCARB1;SNX1;DENND1B;ESYT1;SESTD1;PITPNB;ZFYVE9;PHF12;BCAS3;PITPNM1;HIP1;SNX9;ING2;ESYT2;NCF1;ANKFY1
prerank,protein kinase binding (GO:0019901),0.39109322725707557,1.345218303230981,0.0020222446916076846,0.541969017972619,1.0,116/479,15.93%,FGR;PTPRC;RND3;NEDD9;GRK5;RARA;IQGAP1;CD226;PDLIM5;SIK1;PLCG2;ACE;VRK1;MARVELD3;STAP1;DUSP16;MAPKAPK3;UTRN;PKN1;PPP1R12A;MSN;RACGAP1;PRKAG2;JAK2;STAT3;CRK;BMPR2;MAD2L2;KCNQ1;KIF20A;RCC2;MAPKAPK2;STK38;PTPN6;CCDC88A;RAC2;BCL2L14;IKBKB;VRK2;SLC12A7;CDC42;AXIN1;IBTK;ATF2;CCND3;ADRA2A;BCAR1;ITGB2;CAV2;PRKRIP1;IRAK4;FAF1;TIRAP;TEX14;CDKN2C;AP2A2;MAP3K1;CCND1;PRKAB2;GRB2;NBEAL2;PAK2;RHOBTB3;EZR;RAC1;CACUL1;HDAC9;DUSP6;PPP1R15A;RHOA;LATS1;RNF13;DIRAS1;OXSR1;SPRED3;GSKIP;RPS3;DAXX;IL31RA;NR3C1;CYLD;PTPN1;CEP250;TRIM14;PRKAR2A;YWHAZ;PRKAG1;FOXO3;DUSP1;PPP1CB;MAP2K3;CASS4;PPM1D;CCND2;MVP;CSK;RNF138;HCLS1;DNAJC3;KAT2B;MAPKAP1;PTPRJ;USP37;MAP3K13;ADAM9;RB1CC1;GSTP1;FBXO7;RHOG;RELA;SPRED1;MAML1;IRAK3;DUSP22;APC;EXOC2
prerank,DNA replication origin binding (GO:0003688),0.5460543903690599,1.3434244799474586,0.1259600614439324,0.5413571473379515,1.0,9/23,17.74%,CDC45;KAT7;ORC5;MCM6;ORC4;MCM2;MCM9;HSPD1;ORC2
prerank,ephrin receptor binding (GO:0046875),0.5521143390565443,1.3433375024027405,0.11703703703703704,0.5358853545887962,1.0,7/21,10.51%,LYN;FYN;CRK;CBL;GRB2;EFNA2;PTPN1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.45164408602570844,-1.3402521804278555,0.11560693641618497,0.6090411624084865,1.0,10/22,22.05%,IKBKE;ZRANB1;MINDY2;RNF169;OPTN;OTUD7A;OTUD7B;SQSTM1;SPRTN;WDR81
prerank,alpha-actinin binding (GO:0051393),0.540740612347494,1.3398476802780475,0.13403614457831325,0.540473264862265,1.0,4/24,2.28%,RARA;PDLIM5;PPARG;PDLIM1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.611203666916463,1.3393903742749682,0.1605960264900662,0.5361925205975461,1.0,6/12,20.95%,PNLDC1;CNOT6;CNOT2;CNOT8;CNOT6L;PARN
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.5160880781065912,1.3369335240923417,0.13352272727272727,0.5379355447889417,1.0,15/31,21.00%,BIRC6;UBE2E1;UBE2QL1;UBE2D3;UBE2N;UBE2W;UBE2Z;UBE2S;UBE2G1;UBE2J2;TAF1;UBE2Q2;AKTIP;UBE2E3;CDC34
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5493696311275584,1.3315072417407778,0.15233785822021115,0.5476573301549463,1.0,2/20,1.57%,CARD11;CASK
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4065519427573995,1.3298118339017047,0.03544575725026853,0.5468009332859047,1.0,33/188,12.30%,CIITA;GLI1;KLF4;PPARG;NFKB1;STAT3;FOXJ1;FOS;ZBTB20;TAF9;SPI1;TBL1XR1;ATF6;RFX3;AHR;ARID4A;NFE2L2;THRA;CRY2;ZBED4;GABPB1;GABPB2;CTCF;NFYC;SMAD4;BNC2;PBX1;FOXO3;TAF7;REST;ATF6B;NFYA;TFAM
prerank,G protein-coupled receptor activity (GO:0004930),0.3968510172811301,1.3269878032744957,0.03205128205128205,0.5500007511943991,1.0,22/239,11.26%,GPR141;FFAR4;CRHR2;CYSLTR2;FPR1;ADGRG5;LTB4R;FPR3;ADGRG6;ADGRE5;RXFP2;LPAR3;GPR35;ADRA2A;P2RY14;CYSLTR1;OPRM1;HRH1;S1PR5;TAPT1;GPR88;GLP2R
prerank,transcription corepressor binding (GO:0001222),-0.4303451575840709,-1.3263004560539133,0.0851063829787234,0.6398058784821233,1.0,13/27,20.87%,NEK6;EED;CTBP1;MTF2;PER1;PHF1;PER3;ESR1;PER2;EHMT2;HDAC6;HDGF;THAP7
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.488054093595063,1.3232216296337578,0.13623188405797101,0.5556156278774514,1.0,13/35,18.05%,FOXP1;FOS;H3-3A;STAT1;KLF10;GTF2A1;SNAPC3;NR3C1;BAZ2A;RELA;TAF1;TAF1C;HDAC1
prerank,SUMO transferase activity (GO:0019789),-0.49889142176679235,-1.322693711083232,0.1345646437994723,0.6377613115693013,1.0,8/16,30.08%,RANBP2;PIAS2;PIAS4;MDM2;HDAC4;EGR2;CBX4;UBE2I
prerank,titin binding (GO:0031432),-0.5273007641030638,-1.3225829103437687,0.12432432432432433,0.6250648713093484,1.0,4/13,18.90%,CAPN3;CALM1;ACTN2;MYBPC1
prerank,mannosyltransferase activity (GO:0000030),-0.4589865464863852,-1.3203697056097332,0.12285714285714286,0.6197783505154639,1.0,13/21,30.54%,DPY19L4;ALG8;PIGB;ALG2;ALG9;POMT1;PIGV;ALG1;DPY19L3;TMTC1;ALG3;POMT2;DPM1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.41950287742557146,-1.3160177516305809,0.11464968152866242,0.620108146351324,1.0,9/28,18.60%,GABRG3;GABRG2;GRID2;GRIK4;GRIK1;GABRA4;CHRNA7;GABRA2;GABRA5
prerank,ADP binding (GO:0043531),0.5244214824178284,1.3142373274455617,0.14771048744460857,0.5761789610865893,1.0,11/25,14.76%,LONP1;PRKAG2;ERN1;MYH9;TAP1;COQ8A;MSH6;GLUD1;PRKAG1;ABCD1;ABCG1
prerank,actin monomer binding (GO:0003785),0.5375158486419637,1.3114644693273614,0.16323529411764706,0.5789715647880129,1.0,4/22,4.97%,PRKCE;CORO1A;MYL4;TMSB10
prerank,GTPase regulator activity (GO:0030695),0.3928716659253936,1.306889597851366,0.04893617021276596,0.586561302281949,1.0,40/212,9.82%,ARHGAP15;LRRK2;VAV3;RIN2;RAP1GAP2;IQGAP2;IQGAP1;SRGAP2;TBC1D1;TBC1D8;RACGAP1;SIPA1L3;TBC1D9;ARHGAP18;ARHGEF10L;ARHGAP30;RAPGEF2;RGS2;ARHGAP26;RGS3;USP6NL;TBC1D10C;CCDC88A;TBC1D2B;OCRL;BCR;RP2;TAGAP;DLC1;ARAP1;TBC1D8B;RABGAP1L;RABGAP1;PLCB1;SOS1;RGS12;DEPDC5;TBC1D5;ARHGEF6;ARFGEF1
prerank,microtubule plus-end binding (GO:0051010),-0.46487591266423534,-1.30609280711935,0.1388888888888889,0.6393685567010309,1.0,5/20,6.89%,DST;NUMA1;CLIP1;CLASP2;CLIP2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.6199397276935421,1.3040429102168303,0.17677642980935876,0.5895049577426239,1.0,1/11,0.07%,ITPR1
prerank,phospholipase inhibitor activity (GO:0004859),0.6235454415334951,1.3031666824369341,0.19861830742659758,0.5863390847002289,1.0,4/10,15.05%,ANXA2;ANXA4;ANXA1;ANGPTL3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4202979503641981,1.2995754833417992,0.10129564193168433,0.5918056820436237,1.0,22/100,14.35%,MYO1G;IQGAP2;IQGAP1;DAPP1;RACGAP1;PLEKHF1;DENND1A;GOLPH3L;ARAP1;KCNH1;DENND1B;SESTD1;GBF1;CYTH3;SNX20;HIP1;WIPI2;SNX3;BTK;AKT1;ANKFY1;MAPKAP1
prerank,actin binding (GO:0003779),0.39854721229145873,1.2992781093378556,0.07166482910694598,0.587456542265839,1.0,22/170,7.99%,LRRK2;FXYD5;IQGAP2;PHACTR2;PRKCE;LCP1;PDLIM5;EPS8;UTRN;PDLIM1;MSRB1;HPCA;CORO1A;MYL4;CCDC88A;FHL3;MYH9;TMSB10;FLNB;CAPZB;PAWR;EZR
prerank,chemokine receptor binding (GO:0042379),0.4903026959513722,1.295345881122087,0.1627260083449235,0.5936914694364038,1.0,5/35,6.59%,ITCH;CXCL10;CKLF;CXCL16;CCRL2
prerank,sterol transfer activity (GO:0120015),-0.47915428747067335,-1.2944396094829755,0.1358974358974359,0.6637813654930947,1.0,4/17,16.71%,ABCA1;GRAMD1A;MTTP;STARD5
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4341584486456078,1.292832221958916,0.1259351620947631,0.5951912961251248,1.0,25/71,18.42%,PTPRC;CDC14A;PTPN22;PTPRE;PTPRU;PTPRO;PTPN6;PTPN7;PTPN12;TNS2;PTEN;MTMR3;PTPN1;PTP4A2;PTPDC1;DUSP1;TIMM50;PTPRJ;PTPRG;DUSP26;DUSP22;EYA3;PTPN4;PTPRA;PTP4A3
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5099959327912481,-1.287746190487978,0.16094986807387862,0.6733088328878706,1.0,4/14,20.76%,FHIT;ENPP1;NUDT6;NUDT3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.5280400285832665,-1.2876195791728862,0.18577981651376146,0.6615542018119338,1.0,5/11,31.14%,AKR1A1;AKR1B1;RDH13;DHRS13;RDH11
prerank,cation:chloride symporter activity (GO:0015377),0.6074454523579422,1.2871057779493995,0.17777777777777778,0.6058637171155233,1.0,3/10,11.21%,SLC12A7;SLC12A6;SLC12A9
prerank,cadherin binding (GO:0045296),0.37712588952728954,1.2852704020598358,0.0412796697626419,0.6061113749809567,1.0,74/315,14.84%,FXYD5;IQGAP1;AHNAK;ZC3HAV1;PDLIM5;STK24;SLK;STXBP6;CNN2;ANXA2;PTPRO;PDLIM1;SHTN1;WASF2;HSPA1A;ARHGAP18;EPS15;BMPR2;PRDX6;STK38;SND1;CTNNA1;KIF5B;ABI1;MRE11;CBL;MYH9;PICALM;LRRFIP1;CHMP4B;CD2AP;RPL6;STAT1;SNX1;FLNB;AFDN;CAST;CAPZB;FLNA;PKN2;PAK2;GIGYF2;PHLDB2;TRIM25;F11R;EZR;STX5;CAPZA1;IDH1;EPS15L1;EEF1G;RTN4;ANXA1;PTPN1;SNX9;VASP;YWHAZ;BZW2;TBC1D2;CDH9;S100A11;RPL34;TLN1;ESYT2;PACSIN2;LRRC59;SWAP70;TMOD3;KTN1;RPS2;PTPRJ;TAGLN2;EIF3E;EHD1
prerank,GTPase inhibitor activity (GO:0005095),0.5768932873914531,1.2852227479214107,0.19343696027633853,0.6009805373152007,1.0,2/13,0.55%,IQGAP2;IQGAP1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5920332496467763,1.2843352737094385,0.18932874354561102,0.5981947632943276,1.0,7/12,18.05%,FOS;H3-3A;STAT1;GTF2A1;RELA;TAF1;HDAC1
prerank,DNA-binding transcription factor binding (GO:0140297),0.3860926658373631,1.2835193929727746,0.06774193548387097,0.5952062240500858,1.0,47/189,18.05%,CIITA;SIK1;KLF4;CREB1;PPARG;STAT3;FOS;MAD2L2;RBBP8;TAF9;SPI1;SCX;MTA3;ATF2;RBPJ;STAT1;HIPK2;CGGBP1;CREM;NFE2L2;PURB;HDAC9;ID2;WWP2;PSMD9;SPEN;YWHAZ;TXLNG;NLRP3;CHD4;TLE1;HCLS1;CRTC3;DUSP26;CREBBP;RELA;MIER1;TAF1;BHLHE40;RBL2;RB1;DAPK3;CHCHD2;SIRT1;BBS10;HDAC7;HDAC1
prerank,hyaluronic acid binding (GO:0005540),0.6189298265124378,1.2805883759558343,0.20350877192982456,0.5987151774711621,1.0,1/10,0.26%,CD44
prerank,ATP hydrolysis activity (GO:0140603),0.46079614448316975,1.2796672227928607,0.15489130434782608,0.5963124940083304,1.0,8/41,7.90%,DNA2;HSPA1A;MYO1E;ATP2B1;ABCA3;RNF213;SMCHD1;RHOBTB3
prerank,cAMP response element binding (GO:0035497),0.6184082733954529,1.2790604011000595,0.18579234972677597,0.5931151030137919,1.0,3/10,9.33%,CREB1;ATF2;E4F1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.508324564937612,-1.2788370731129097,0.1683673469387755,0.6769038414334806,1.0,11/14,34.16%,POP1;RPP30;TSEN2;RPP14;TSEN34;ELAC2;RPP40;POP4;POP5;RPP21;POP7
prerank,sterol binding (GO:0032934),-0.3491746562480287,-1.2787327422874746,0.07981220657276995,0.665420208597094,1.0,26/56,32.81%,ABCA1;OSBPL11;OSBPL8;GRAMD1A;APOD;OSBPL1A;ERLIN2;STARD3;VDAC1;SIDT1;NPC1;GPR183;STARD5;OSBPL6;PTCH1;OSBPL7;SOAT2;OSBP;OSBPL5;RORA;NR1H3;CAV1;PROM1;OSBPL2;STARD4;STAR
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5404367454197218,-1.2778114944833292,0.20681818181818182,0.6566817750918356,1.0,4/11,12.80%,KCNMA1;KCNN2;KCNMB2;KCNN3
prerank,histone demethylase activity (GO:0032452),0.5047835706702147,1.2762993282158972,0.17298937784522003,0.595703056289252,1.0,4/27,7.20%,JARID2;KDM6A;KDM7A;KDM3B
prerank,1-phosphatidylinositol binding (GO:0005545),0.5592239458817955,1.2709297119508431,0.19633943427620631,0.6060022525980242,1.0,6/15,10.56%,FRMPD2;PICALM;SCARB1;SESTD1;ZFYVE9;SNX9
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.3680457417092769,-1.2697756047187354,0.11147540983606558,0.6696298561360592,1.0,16/40,22.25%,DNMT3A;COMT;SETD3;HNMT;DPH5;METTL2B;METTL2A;AS3MT;METTL8;PCMT1;SUV39H1;THUMPD2;LCMT1;METTL9;PCMTD2;N6AMT1
prerank,double-stranded RNA binding (GO:0003725),0.4238133450645767,1.26351310210946,0.14901477832512317,0.6230870498727122,1.0,13/70,8.52%,MBNL1;OAS2;MSN;VIM;DHX58;EIF2AK2;LRRFIP1;DGCR8;RC3H1;IFIH1;PRKRIP1;OASL;TLR3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.49771431195243676,-1.262461506190728,0.1957547169811321,0.6806013745704468,1.0,7/13,24.61%,TRMT1;TRMT1L;METTL1;THUMPD2;TRMT10A;WDR4;TRMT5
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.5353218468953803,-1.2602272375270283,0.20047732696897375,0.6766210354346234,1.0,5/11,19.07%,CTC1;NABP2;TERF2IP;TERF1;HNRNPA2B1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4247863530264021,1.2596706467484873,0.15384615384615385,0.6288534737975316,1.0,11/72,9.45%,MYO1G;SVIL;STXBP6;ANXA2;KCNQ1;PICALM;SESTD1;TIRAP;PLCB1;SNX20;HIP1
prerank,protein tyrosine kinase activity (GO:0004713),0.4052474559752632,1.2582491616381797,0.1325581395348837,0.6276253362846926,1.0,16/108,7.19%,FGR;HCK;LYN;FLT3;FYN;RET;LMTK2;SYK;JAK2;SLA;ZAP70;HIPK2;STYK1;HIPK1;PTK2B;DYRK1A
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5894666377505383,1.2555323119995916,0.22022838499184338,0.6306317044100119,1.0,4/12,16.94%,NAPSA;SPPL2A;BACE2;PSEN1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5264209196487004,1.2543644188589973,0.2032,0.6289178021400483,1.0,5/18,17.80%,HSD17B14;HSD17B7;DHRS9;RDH5;HSD17B2
prerank,androgen receptor binding (GO:0050681),0.5110498212179247,1.2528346541641684,0.19703703703703704,0.628397167120722,1.0,5/25,13.24%,FOXP1;PKN1;PRPF6;DAXX;NSD1
prerank,potassium channel regulator activity (GO:0015459),0.43838499609628206,1.2527855267237966,0.16551724137931034,0.6236211040670946,1.0,6/49,6.97%,KCNE3;SGK3;NEDD4L;SUMO1;KCNIP3;FLNA
prerank,death receptor binding (GO:0005123),0.5508510531204778,1.2524075745752712,0.22308892355694226,0.6199362139648195,1.0,9/15,24.83%,NGF;PIDD1;RIPK1;MYD88;FEM1B;BID;MADD;CASP8AP2;BDNF
prerank,protein phosphatase regulator activity (GO:0019888),0.43881025814495594,1.252204308203004,0.16754617414248021,0.6157376946902828,1.0,19/53,16.22%,LMTK2;PPP2R5A;EIF2AK2;PPP1R9B;SHOC2;PPP2R2A;PPP4R2;PPP1R15A;PPP1R2;ANKLE2;PPP4R1;DMPK;PPP2R3A;PPP1R15B;LGALS3;PPP6R2;PPP2R5C;PPP2R5E;PPP1R7
prerank,protein kinase C binding (GO:0005080),0.44798673868548566,1.2507908581043914,0.1712707182320442,0.6151608671423927,1.0,6/43,8.51%,GRK5;PDLIM5;PKN1;CCDC88A;TIRAP;HDAC9
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5250250849359326,1.2507605993152682,0.22720247295208656,0.610606650288244,1.0,8/18,15.36%,RPS6KA3;DPEP1;BIRC3;SERPINB9;TNFAIP8;RPS6KA1;XIAP;PRDX5
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6019303118086683,1.2497004966458538,0.22719449225473323,0.6091387731866802,1.0,3/10,13.96%,HEXIM1;CDKN2C;KAT2B
prerank,vitamin D receptor binding (GO:0042809),0.5548902537525954,1.2485700129881463,0.20777027027027026,0.6079236430368731,1.0,6/14,15.78%,MED30;MED13;MED12;TAF7;MED14;MED1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5477769259577995,1.248262284300888,0.22185970636215335,0.6042457507436825,1.0,6/16,11.49%,SLC25A13;SLC25A30;SLC1A5;SLC25A12;SLC1A4;SLC25A18
prerank,serine-type peptidase activity (GO:0008236),0.4103426896114641,1.2475700520455473,0.14736842105263157,0.6014492897721977,1.0,10/96,10.46%,DPP4;PRSS53;HP;HPR;FAP;PARL;C1RL;HGF;RHBDL2;MBTPS1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5877513929124474,1.2473208382376952,0.2306368330464716,0.5977894417340964,1.0,7/10,20.53%,NSD3;SETD5;ASH1L;SETD2;NSD1;SETMAR;PRDM9
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5347253558544712,-1.2466747360172659,0.24145785876993167,0.7060761002106197,1.0,3/10,3.50%,CACNA1D;CACNB2;CACNA1C
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5156325742412927,1.2418422692852402,0.21630094043887146,0.6084320760656926,1.0,5/22,11.47%,DUSP16;MTMR3;DUSP6;DUSP12;DUSP1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5364305796194591,1.2410342338832543,0.235202492211838,0.602167691310034,1.0,5/16,3.76%,PTPRC;PTPRE;PTPRU;PTPRO;PTPN6
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5364305796194591,1.2410342338832543,0.235202492211838,0.602167691310034,1.0,5/16,3.76%,PTPRC;PTPRE;PTPRU;PTPRO;PTPN6
prerank,nuclear receptor binding (GO:0016922),0.3922080283064388,1.2409744151569848,0.11977401129943503,0.5980268979790543,1.0,33/111,18.17%,FOXP1;PKN1;NCOA3;STAT5B;CRY1;MED30;PRPF6;MED13;STAT1;BUD31;TADA3;OASL;BCAS3;LATS1;NCOA2;SMARCE1;NCOA1;DAXX;MED12;TAF7;BAZ2A;MED14;TACC1;NRIP1;NSD1;TAF1;MED1;PROX1;SIRT1;NR4A1;PADI2;SMARCD3;NCOA7
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3660843428475891,1.2384100438274808,0.06510681586978637,0.6007771132324171,1.0,95/346,18.60%,TRAF1;NEURL1B;NEURL3;DTL;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CUL5;RSPRY1;BIRC6;CBLB;UBE2E1;MALT1;RNF38;TRIM7;CBL;ANKIB1;CDC42;RNF146;CBLL1;TRIM62;PEX12;BIRC3;ARIH1;TRAF3IP2;RNF213;RNF20;PELI1;RC3H1;UBE2QL1;UBE2D3;FBXW11;UBE2N;RNF217;UBR5;HLTF;FBXW2;HECTD1;MYCBP2;TRAF3;TRIM25;FBXO4;UBR2;COP1;ARIH2;RNF130;RNF141;WWP2;RNF13;TRIM71;UBE2W;KCMF1;UBE2Z;FANCL;TRIM14;RNF31;UBE2S;MEX3C;RCHY1;TRIM17;UBE2G1;SH3RF1;AREL1;RNF138;UBE2J2;RNF150;UHRF2;FBXO7;KCTD13;RMND5B;XIAP;RNF166;RNF122;TAF1;TRIM35;RNF41;HACE1;TRIM36;UBR3;MAEA;MSL2;RNF144A;UBE2Q2;TRAF2;TSPAN17;RNF19B;NEURL4;SMURF2;ANAPC11;FBXO3;FBXL14;ANAPC4
prerank,MAP-kinase scaffold activity (GO:0005078),0.5947744962137187,1.2321046773394737,0.2168458781362007,0.6138841591463761,1.0,1/11,0.55%,IQGAP1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5107090843773028,-1.2312492703344513,0.22,0.7435307914689357,1.0,4/12,12.68%,SLC36A4;SLC36A1;SLC7A8;SLC3A2
prerank,voltage-gated anion channel activity (GO:0008308),-0.4635775027050064,-1.2286206448847774,0.22762148337595908,0.7401149054982817,1.0,7/15,21.10%,CLCN6;CLCN4;VDAC1;CLCN3;GPR89B;GPR89A;CLCN2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3575977372184861,1.227988749938889,0.02914572864321608,0.6210426440108738,1.0,72/597,12.30%,CIITA;NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;GLI1;KLF4;CREB1;PPARG;BCL6;NFKB1;PITX3;STAT3;FOXJ1;ELF4;RFX7;FOS;ZBTB20;CDC45;TAF9;SPI1;TBL1XR1;KAT7;ATF6;ATF2;IRF2;RFX3;ORC5;HIVEP1;KLF5;MCM6;IRF4;BBX;RFX5;KLF13;KLF10;AHR;ARID4A;MBD4;CREM;NFE2L2;THRA;CRY2;ORC4;CLOCK;ZBED4;RARG;E2F2;GABPB1;GABPB2;CTCF;NFYC;ELF1;PKNOX1;IRF7;MEF2B;SMAD4;BNC2;NR3C1;GMEB2;PBX1;FOXO3;TAF7;ETS2;REST;MBD2;ATF6B;NFYA;TFAM
prerank,5'-3' exonuclease activity (GO:0008409),0.5474218579626262,1.2273793533886912,0.24086378737541528,0.6185883156959291,1.0,6/14,15.38%,MRE11;FEN1;XRN2;DCP2;EXOG;CPSF3
prerank,syntaxin-1 binding (GO:0017075),0.49236366664171477,1.2268093756965042,0.22015503875968992,0.616006664882878,1.0,2/22,1.36%,LRRK2;DAPK1
prerank,Toll-like receptor binding (GO:0035325),0.5644104778816461,1.2255972573553275,0.2465986394557823,0.6150178784266985,1.0,6/11,22.33%,CD36;TIRAP;TLR2;MYD88;TLR1;UNC93B1
prerank,kinesin binding (GO:0019894),-0.4018595852839197,-1.2251841383164355,0.17647058823529413,0.740446735395189,1.0,11/27,26.50%,PLEKHM2;NEK6;KIF1B;AP1AR;TOR1B;CROCC;NEFH;ATCAY;KLC2;PRC1;SPTBN5
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4659371313250022,1.22490434854992,0.21954674220963172,0.6128183005609792,1.0,15/34,21.00%,BIRC6;UBE2E1;UBE2QL1;UBE2D3;UBE2N;UBE2W;UBE2Z;UBE2S;UBE2G1;UBE2J2;TAF1;UBE2Q2;AKTIP;UBE2E3;CDC34
prerank,acetylcholine receptor activity (GO:0015464),-0.42308157667800894,-1.2206836855809016,0.2056338028169014,0.7440344163282306,1.0,4/22,9.50%,CHRM3;CHRM2;CHRFAM7A;CHRNA7
prerank,vinculin binding (GO:0017166),0.5696369749808557,1.2193285504733815,0.24338624338624337,0.6240544866337476,1.0,4/11,12.50%,UTRN;CTNNA1;PXN;TLN1
prerank,ribonuclease P RNA binding (GO:0033204),-0.5325795715731686,-1.2167258616467458,0.2345679012345679,0.7453980099502487,1.0,8/10,34.16%,POP1;RPP30;RPP14;RPP40;POP4;POP5;RPP21;POP7
prerank,retinoid X receptor binding (GO:0046965),0.5902803346220359,1.214716738958575,0.24783362218370883,0.6324007158136403,1.0,5/11,13.24%,PPARG;RARG;TACC1;NRIP1;NSD1
prerank,muscle alpha-actinin binding (GO:0051371),0.5426801416774675,1.2143003123507232,0.24489795918367346,0.6292908784177368,1.0,2/15,2.28%,PDLIM5;PDLIM1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.45615002080123124,-1.2136903908774344,0.22311827956989247,0.7441757630887407,1.0,5/15,27.32%,ALDH9A1;ALDH7A1;ALDH3B1;ALDH1L1;ALDH1A2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.442464212884366,-1.2135814570524441,0.20224719101123595,0.7336981423377658,1.0,5/18,13.75%,TGFBR2;TGFBR1;SMAD7;SMAD3;TGFB2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4467622751736914,1.212751276476113,0.2163265306122449,0.6293840539791603,1.0,12/42,14.75%,CCNJL;CCND3;HEXIM1;CDKN2C;CCND1;CCNH;CCNT2;CCNT1;CCNL1;CCND2;KAT2B;CDK5R2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.47360591118469964,1.2122238521410873,0.22693997071742314,0.6268066940721462,1.0,8/29,15.32%,PRKAG2;PKIB;HEXIM1;CDKN2C;CIB1;PRKAR2A;KAT2B;SPRED1
prerank,aspartic-type peptidase activity (GO:0070001),0.5891300011610499,1.2120509628736376,0.2516891891891892,0.623220039217194,1.0,1/10,0.17%,NAPSA
prerank,kinase binding (GO:0019900),0.35371585511939135,1.2116173386451206,0.06161616161616162,0.620406292158378,1.0,100/434,15.93%,FGR;PTPRC;RND3;SP100;IQGAP1;TIAM1;CD226;PTPN22;SIK1;PLCG2;VRK1;STAP1;PPP2R5A;UTRN;PPP1R12A;MSN;RACGAP1;PRKAG2;JAK2;STAT3;CRK;KIF20A;RCC2;PTPN6;RAC2;BCL2L14;IKBKB;VRK2;SLC12A7;CDC42;AXIN1;IBTK;ATF2;CCND3;BTG1;ADRA2A;BCAR1;ITGB2;CAV2;TNS2;PRKRIP1;IRAK4;FAF1;TEX14;CDKN2C;AP2A2;MAP3K1;CCND1;PRKAB2;GRB2;FLNA;NBEAL2;PAK2;MOB1B;RHOBTB3;CARD16;RAC1;CACUL1;PPP1R15A;RHOA;LATS1;OXSR1;SPRED3;GSKIP;RPS3;DAXX;IL31RA;NR3C1;CYLD;PTPN1;CEP250;TRIM14;YWHAZ;PRKAG1;FOXO3;HTT;PPP1CB;MAP2K3;EIF4ENIF1;CCND2;PIP5K1A;MVP;RNF138;HCLS1;DNAJC3;KAT2B;MAPKAP1;PTPRJ;USP37;MAP3K13;AURKB;RB1CC1;FBXO7;RHOG;RELA;SPRED1;MAML1;IRAK3;APC;EXOC2
prerank,ATP binding (GO:0005524),0.3597048200340014,1.2084487800650843,0.11041009463722397,0.6246948412306778,1.0,75/266,18.86%,MAP4K1;RUNX3;SIK1;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;ERN1;STK38;MYH9;ZAP70;SIK3;MCM6;RPS6KA5;SMARCA5;DARS2;STK4;TAP1;GSS;MKNK2;ATP7A;RHOBTB3;SIK2;STK38L;MINK1;MSH6;SMC4;LATS1;OXSR1;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;PRKAG1;DMPK;NLK;LATS2;MAP4K3;CAD;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TLK1;HASPIN;MYO1F;ABCG1;BRSK1;PAPOLA;SRR;IRAK3;DYRK2;INSR;DAPK3;MVK;GCK;PI4K2A;PRPS2;ABCB8;HSPA5;PTPA;PYGL;MTHFD1L;STK3;PINK1;ABCE1
prerank,MHC class I protein binding (GO:0042288),0.5536929995276778,1.2075736456719561,0.2413793103448276,0.6229959242790974,1.0,3/13,6.29%,LILRB1;PILRA;TAP1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.513374618935313,1.2072919438431415,0.2665639445300462,0.619820637455063,1.0,6/17,16.31%,ACOT11;ACOT2;ACAA2;ABCD1;PLA2G6;PPT1
prerank,endonuclease activity (GO:0004519),0.4247571369851581,1.2061069862363503,0.2192513368983957,0.6189471415801124,1.0,15/49,18.77%,ZC3H12D;ERN1;SND1;MRE11;FEN1;MBD4;KHNYN;RPS3;INTS11;EXOG;ERCC4;CPSF3;SMG6;NYNRIN;SETMAR
prerank,calcium channel activity (GO:0005262),-0.3052320259614895,-1.2057434371114146,0.11483253588516747,0.7473085419734904,1.0,21/84,15.00%,CACNA1D;SLC24A3;CACNB2;CACNA2D3;CACNA2D1;TRPV2;PKD2;CACNA1C;TRPC4;P2RX4;CACHD1;TPCN2;TRPC1;MCOLN1;CHRNA7;CACNG2;TRPC7;TRPM2;TRPV4;TRPC3;NCS1
prerank,acylglycerol lipase activity (GO:0047372),-0.5087910385137675,-1.2041308409575022,0.24776785714285715,0.7416594066114903,1.0,3/11,10.36%,ABHD12;MGLL;ABHD3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.39270068559209603,1.2032359054534378,0.19879518072289157,0.6229386401396855,1.0,13/91,9.45%,MYO1G;SVIL;STXBP6;ANXA2;KCNQ1;PICALM;KCNH1;SESTD1;TIRAP;PLCB1;GBF1;SNX20;HIP1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4889704604018181,-1.2023908748766459,0.22695035460992907,0.7364308896525392,1.0,7/12,18.60%,GABRG3;GABRG2;GABRB1;GABRA4;GABRB3;GABRA2;GABRA5
prerank,metal ion binding (GO:0046872),0.34969928373183984,1.1990137188146133,0.08484848484848485,0.6302875368131625,1.0,80/477,12.87%,ITPR1;LRRK2;IQGAP1;LCP1;PADI1;SIK1;RET;MAP3K5;ACER3;TNNC1;ANXA2;EFCAB9;TPM4;PLSCR1;TRIM26;HPCA;C2CD5;ERN1;RASGRP2;RAPGEF2;SELL;MCTP2;DYSF;STK38;CLGN;FEN1;RP2;ESYT3;PPP3CA;SIK3;SLC25A13;S100A4;STIM2;ESYT1;STK4;PRNP;GSS;IMPA1;ANXA4;ATP2A1;WRN;NUCB2;CIB1;S100A10;PDE2A;MAPK12;SIK2;STK38L;CABYR;RPE;MSH6;IDH1;PGM1;CPNE1;LATS1;PITPNM1;OXSR1;BRAF;FBN1;CAMKK2;NLRC4;PAPOLG;ANXA1;SLC25A12;TDG;MTPAP;CALB2;LETM1;NLK;TPD52;RHEB;EFCAB11;CDH9;S100A11;GNAI1;EXD2;ESYT2;XXYLT1;MAP3K20;MICU3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5675774071852113,1.1980603325804766,0.2743055555555556,0.6289948594953092,1.0,1/10,1.14%,GDA
prerank,PDZ domain binding (GO:0030165),-0.3199426213531652,-1.1939355776683453,0.1446280991735537,0.7517852939791931,1.0,17/61,14.76%,PRKN;CADM1;DOCK4;NLGN1;DLG4;GRIA1;ATP2B2;GRID2;TBC1D10A;SLC22A5;GNG12;ATP2B3;CLCN3;ADRB1;CXADR;SLC22A4;ERC1
prerank,solute:proton symporter activity (GO:0015295),-0.4397462432346422,-1.1937946257192165,0.2481012658227848,0.7420033435497353,1.0,5/16,12.90%,SLC11A2;SLC36A1;SLC25A3;SLC2A9;SLC15A2
prerank,glucose transmembrane transporter activity (GO:0005355),-0.4377369188241781,-1.1936867800824411,0.20822622107969152,0.7323928980526919,1.0,5/17,25.89%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC5A11
prerank,adenyl ribonucleotide binding (GO:0032559),0.35397044801909455,1.1930152030264631,0.1189245087900724,0.6387122445419925,1.0,80/291,18.86%,MAP4K1;RUNX3;SIK1;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;ERN1;RAPGEF2;STK38;MYH9;ZAP70;SIK3;MCM6;RPS6KA5;SMARCA5;DARS2;STK4;TAP1;GSS;MKNK2;PDE2A;ATP7A;RHOBTB3;SIK2;COQ8A;STK38L;MINK1;MSH6;SMC4;LATS1;OXSR1;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;GLUD1;PRKAG1;DMPK;NLK;LATS2;MAP4K3;CAD;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TLK1;HASPIN;MYO1F;ABCG1;BRSK1;PAPOLA;SRR;IRAK3;DYRK2;INSR;DAPK3;MVK;GCK;PI4K2A;PRPS2;ABCB8;HSPA5;PTPA;PYGL;PDE4B;MTHFD1L;STK3;PINK1;ABCE1
prerank,kinase activity (GO:0016301),0.38751816457792976,1.1927947178957437,0.20138089758342922,0.6354827175208582,1.0,24/109,16.97%,LRRK2;LYN;DGKG;CERKL;NADK;ITPKC;PIK3C2A;IP6K3;PANK1;PANK4;PKN2;PAPSS1;COQ8A;PAPSS2;CSNK2A1;PIK3CA;PGM2L1;AKT1;STK39;TAF1;IPMK;SEPHS1;MVK;GK
prerank,cholesterol binding (GO:0015485),-0.3362587435272498,-1.1915381418611246,0.1673469387755102,0.7298245614035087,1.0,22/47,32.81%,ABCA1;OSBPL8;GRAMD1A;APOD;OSBPL1A;ERLIN2;STARD3;VDAC1;SIDT1;NPC1;STARD5;OSBPL6;PTCH1;OSBPL7;SOAT2;OSBPL5;NR1H3;CAV1;PROM1;OSBPL2;STARD4;STAR
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3477920501810579,1.189160641614617,0.08850457782299084,0.6413265525921155,1.0,102/431,17.19%,LRRK2;RND3;MAP4K1;RUNX3;SIK1;RAP1A;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;RABL3;ERN1;NOA1;STK38;RAC2;MYH9;ZAP70;CDC42;SIK3;RAB7A;MCM6;RPS6KA5;SMARCA5;DARS2;ARF4;RAB6A;STK4;TAP1;GSS;RAB39A;GNL1;MKNK2;ARF1;ATP7A;RHOBTB3;RAC1;SIK2;STK38L;MINK1;RALB;MSH6;RHOA;SMC4;LATS1;DIRAS1;OXSR1;ATL3;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;GLUD1;PRKAG1;DMPK;NLK;RHEB;LATS2;MAP4K3;CAD;GNAI1;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TUBD1;ARL8B;GBP5;MMAA;TLK1;HASPIN;RRAD;MYO1F;RAB29;GBP2;ABCG1;BRSK1;ATL1;GBP3;RHOG;DRG2;PAPOLA;SRR;IRAK3;SEPHS1;DYRK2;TUBA1B;INSR;DAPK3;RAB35;MVK;GCK;PI4K2A;PRPS2
prerank,single-stranded DNA helicase activity (GO:0017116),0.4986960619651334,1.188609771237323,0.27217125382262997,0.6389179244099915,1.0,4/19,12.94%,DNA2;MCM6;CHTF18;MCM2
prerank,calcium-release channel activity (GO:0015278),0.5167237017100348,1.1876281986126462,0.28317152103559873,0.637786723747902,1.0,2/17,3.72%,ITPR1;RASA3
prerank,low-density lipoprotein particle binding (GO:0030169),0.5152596179343485,1.1855984697207609,0.25199362041467305,0.6391460469483757,1.0,4/16,5.03%,LDLR;CD36;SORL1;SCARB1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5023560293836538,-1.1827246868077546,0.24170616113744076,0.7477306198955684,1.0,4/10,14.69%,DLG4;SQSTM1;GNAS;IGSF11
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.35183659692732355,1.1826217776055468,0.14256198347107438,0.6432354443565269,1.0,76/269,17.98%,TRAF1;PTPN22;RPL5;NGFR;CD40;ITCH;DTX3L;HSPA1A;CUL3;CUL5;LAPTM5;PRDX6;NFKBIA;FBXW7;SUMO1;AXIN1;TRAF4;ARIH1;STAT1;RNF20;SPOP;FAF1;GLMN;UBE2N;HLTF;TSG101;NEDD8;WFS1;ELOB;TRAF3;UBXN7;ATXN3;RALB;WRAP53;PARP9;TANK;UBE2W;CAMLG;RTN4;FANCL;DAXX;SUMO2;SNX9;RIPK1;PRKAR2A;YWHAZ;STAM;RNF31;GPI;NLK;NDUFS2;SLC25A5;UBE2G1;DNM1L;RPL11;HSPA9;STAT2;TNFRSF1B;VCP;UBE2J2;TRIOBP;USP7;FBXO7;RELA;TCP1;APC;TUBA1B;RB1;CCDC50;SMAD5;AMBRA1;TRAF2;HSPD1;SMC6;BECN1;HSPA5
prerank,sodium channel regulator activity (GO:0017080),0.43598196313711673,1.1817961991702823,0.24890829694323144,0.6416291025537623,1.0,3/37,2.59%,FXYD5;SGK3;NEDD4L
prerank,phosphatidylinositol kinase activity (GO:0052742),0.5264562820025728,1.1810124059096745,0.2625607779578606,0.6398985899207648,1.0,4/15,10.64%,PIK3C2A;PI4K2B;PIKFYVE;PIK3CA
prerank,cell adhesion mediator activity (GO:0098631),0.4745093017044637,1.1803543839073343,0.2650957290132548,0.6378111746810375,1.0,4/24,6.69%,CD47;EMB;NPTN;IGSF9
prerank,hexose transmembrane transporter activity (GO:0015149),-0.46741717296121277,-1.1795829168596441,0.26036866359447003,0.7471076746849943,1.0,4/12,21.80%,SLC2A3;MFSD4A;SLC2A5;SLC2A8
prerank,ion channel activity (GO:0005216),-0.30430735357113536,-1.1780818419302561,0.17647058823529413,0.742245204228109,1.0,15/80,9.50%,GRIA4;TRPV2;TRPM3;PKD2;GRIA2;GRIA1;UNC80;GRID2;GRIK4;GABRB1;GRIK1;TMEM63B;TRPC1;MCOLN1;CHRNA7
prerank,ion channel inhibitor activity (GO:0008200),0.4377395867985311,1.1777526217880303,0.2532561505065123,0.641037594603005,1.0,6/35,11.63%,ITPR1;NEDD4L;MCUB;SLC30A1;STX7;FKBP1B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.48179832336610073,1.1775321932124174,0.24962178517397882,0.6378281238597941,1.0,4/23,7.82%,PLCG2;CCR1;PLCB1;PLCD4
prerank,neuropeptide binding (GO:0042923),0.5048666891836296,1.1755373422699436,0.2638888888888889,0.639310335820318,1.0,2/18,9.06%,SORL1;OPRM1
prerank,lipoprotein particle binding (GO:0071813),0.4905883187559975,1.1731298738619351,0.27001569858712715,0.6419290230788988,1.0,4/20,5.03%,LDLR;CD36;SORL1;SCARB1
prerank,transferrin receptor binding (GO:1990459),0.5702889530748652,1.1706474824782103,0.297153024911032,0.6449376981310395,1.0,2/10,5.33%,IKBKB;SNX1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3991490678818895,1.1682121164596733,0.24185463659147868,0.6476857449154212,1.0,11/69,10.06%,CERS6;HHAT;NAA16;CERS1;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC17;KAT6A;NAA15;MOGAT3
prerank,phospholipase activator activity (GO:0016004),0.5749468305688521,1.1677720299633934,0.30220713073005095,0.6451794937283614,1.0,4/10,16.87%,FYN;PDPK1;BTK;ARHGAP6
prerank,single-stranded RNA binding (GO:0003727),-0.334216911892173,-1.1631249180514625,0.21285140562248997,0.7782130584192439,1.0,20/43,22.21%,AGO3;AGO1;ADARB2;JMJD6;CNBP;FXR1;STRBP;PTBP1;DHX9;LACTB2;HNRNPF;EIF4H;ZFR2;SNRPC;TLR7;DDX3X;EXOSC10;DDX11;SRA1;HNRNPU
prerank,tau-protein kinase activity (GO:0050321),0.48990875833904607,1.160010035729397,0.2987987987987988,0.6613451575850907,1.0,7/20,14.85%,FYN;SIK3;DYRK1A;PRKAA1;MARK3;ROCK1;BRSK1
prerank,tau protein binding (GO:0048156),-0.3493074618237513,-1.155696592748731,0.23293172690763053,0.7912318102753384,1.0,9/40,12.13%,LGMN;BIN1;APOE;MAP2;MARK1;STUB1;MAP1A;CDK5;CLU
prerank,receptor ligand activity (GO:0048018),0.3482651268804385,1.1538447670365657,0.19874476987447698,0.6742229760704135,1.0,18/245,9.47%,DPP4;IL1B;NGF;TNFSF13B;METRNL;SEMA4A;FGF5;FGF22;CXCL10;GDF1;GDNF;VEGFC;IL33;OSGIN2;BMP3;HGF;IL6;PGF
prerank,histone methyltransferase binding (GO:1990226),-0.48200219115847226,-1.153677065675294,0.33573141486810554,0.7876707736149526,1.0,5/11,25.85%,CTNNB1;CBX1;PHF1;HSP90AB1;NOP56
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3404684573232529,-1.1534377926286918,0.2,0.7789612056473315,1.0,9/46,13.71%,HEXB;LARGE1;B3GALNT1;MGAT5;PIGP;MGAT4C;HEXA;MGAT4A;PIGA
prerank,ion gated channel activity (GO:0022839),-0.38739527994459316,-1.1525733343144624,0.25360230547550433,0.7720544918998528,1.0,6/24,18.03%,TTYH3;ANO10;TTYH2;TMEM63B;KCNT2;ANO8
prerank,aminopeptidase activity (GO:0004177),-0.38532937098776604,-1.1518287838590908,0.26153846153846155,0.7652577319587629,1.0,7/26,9.28%,METAP1D;MMP16;LTA4H;METAP2;MMP14;BLMH;TRHDE
prerank,translation elongation factor activity (GO:0003746),-0.45732300135979254,-1.151108893883844,0.26854219948849106,0.7586709821785343,1.0,6/14,25.76%,GFM2;EEF1A1;EIF5A;EIF5AL1;GTPBP2;EEF1B2
prerank,lipase activator activity (GO:0060229),0.5589076604876618,1.150795052056389,0.3178694158075601,0.6784705222287043,1.0,4/10,16.87%,FYN;PDPK1;BTK;ARHGAP6
prerank,exoribonuclease activity (GO:0004532),-0.47046092026159914,-1.1500163658838487,0.3185011709601874,0.7530829087174625,1.0,6/12,22.71%,EXOSC1;EXOSC9;EXOSC5;EXOSC10;EXOSC3;CNOT7
prerank,thyroid hormone receptor binding (GO:0046966),0.44778285113439115,1.1486214451503938,0.2878120411160059,0.6806586330961882,1.0,9/28,15.78%,NCOA3;MED30;MED13;OASL;MED12;TAF7;TACC1;NSD1;MED1
prerank,CoA hydrolase activity (GO:0016289),0.500689514725758,1.1478650348202635,0.31129032258064515,0.6790073216414098,1.0,5/16,14.44%,ACOT11;ACOT2;ACAA2;ABCD1;HIBCH
prerank,pentosyltransferase activity (GO:0016763),0.4245834521665962,1.14715407223155,0.28900949796472186,0.6771451365736036,1.0,7/36,9.67%,ZC3HAV1;PARP8;PARP4;TIPARP;PARP14;TNKS;PARP9
prerank,voltage-gated cation channel activity (GO:0022843),-0.2866844754729374,-1.1465043199077676,0.16560509554140126,0.7550082005623244,1.0,16/97,10.51%,CACNA1D;KCNMA1;KCNQ5;CACNB2;CACNA2D3;KCND2;CACNA2D1;KCNQ3;PKD2;CACNA1C;CACHD1;TPCN2;KCNA2;HCN1;CACNG2;HCN2
prerank,protein kinase regulator activity (GO:0019887),0.376555692645171,1.1458924681173788,0.26481257557436516,0.6768997706353101,1.0,24/95,13.93%,PRKAG2;GPRC5C;CXCL10;CCNJL;GMFG;CCND3;TAOK3;HEXIM1;PRKRIP1;FAF1;CCND1;CCNH;MBIP;GSKIP;DAXX;PRKAR2A;PRKAG1;CCNT2;CCNT1;SH3BP5;CCNL1;CCND2;KIDINS220;DNAJC3
prerank,chloride channel activity (GO:0005254),-0.30690411234000403,-1.1445195500862044,0.18781725888324874,0.7519585698289509,1.0,11/59,9.21%,TTYH3;CLCN6;GABRG3;GABRG2;CLCN4;TTYH2;CLCN7;GLRA3;GABRB1;GLRA2;GABRA4
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.2921043941551483,-1.1444851761731407,0.18072289156626506,0.7436655211912944,1.0,15/85,13.25%,ABHD12;PON3;PNPLA7;MGLL;PLA2G15;GDE1;ENPP2;LIPA;PLA2G4A;DDHD2;ABHD3;CA2;ABHD4;PTRH2;LYPLAL1
prerank,double-stranded DNA binding (GO:0003690),0.3336927522578144,1.1429235105598163,0.12890231621349446,0.6812211762446971,1.0,55/531,10.94%,NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;KLF4;CREB1;PPARG;BCL6;POLR3F;PITX3;ELF4;RFX7;FOS;RBBP8;ZBTB20;MRE11;FEN1;CRY1;MBD1;CAMTA2;ATF6;ATF2;IRF2;RFX3;HIVEP1;STAT1;KLF5;RBMS1;IRF4;BBX;RFX5;KLF13;KLF10;AHR;CGGBP1;CREM;MECP2;MSH3;CLOCK;RARG;E2F2;ELF1;MSH6;PKNOX1;IRF7;MEF2B;RPS3;NR3C1;MAU2;TDG;GMEB2;PBX1
prerank,protein homodimerization activity (GO:0042803),0.3331093825155755,1.1421362909758026,0.119358074222668,0.6796218368157753,1.0,90/589,11.61%,DPP4;JAML;LRRK2;STK10;SRGAP2;EXT1;KYNU;PECAM1;LILRB1;SLK;PIP4K2A;MAP3K5;MCL1;NECTIN1;TNNC1;PTPRO;TPM4;STAT3;RABL3;ERN1;UPB1;RBPMS;ABCB7;CORO1A;GLIPR2;SLC8B1;CCDC88A;EIF2AK1;INPP5F;IL6R;MYH9;IKBKB;PANK1;LRRFIP1;CHMP4A;CHMP4B;AXIN1;GDNF;DGCR8;ADRA2A;STAT1;SNX1;CAV2;EXD1;SMCHD1;FAP;PRMT8;DARS2;STK4;TAP1;TSG101;GSS;AHR;IMPA1;FLNA;ATP2A1;WRN;IKZF3;S100A10;CPQ;PDE2A;F11R;MSH3;PSAP;FBXO4;PAPSS1;TOX3;PDCD6IP;RPE;MSH6;SPPL2A;SNF8;IDH1;HIP1;NQO2;SMAD4;NLRC4;KYAT1;PIP4K2B;SNX9;NUDT21;RIPK1;TDG;B2M;TRIM14;MTPAP;SCARB2;TPD52;TPST1;S100A11
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5299697291694216,1.1409018194968807,0.32338308457711445,0.6793971519979926,1.0,4/12,15.45%,PIK3C2A;PIK3R6;PIK3CA;IPMK
prerank,ubiquitin protein ligase activity (GO:0061630),0.34538373658836763,1.1406504798292698,0.22526315789473683,0.6763497075533345,1.0,59/228,18.24%,NEURL1B;NEURL3;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CBLB;RNF38;TRIM7;CBL;ANKIB1;CDC42;CBLL1;TRIM62;BIRC3;ARIH1;TRAF3IP2;PELI1;RC3H1;UBE2D3;RNF217;UBR5;HLTF;HECTD1;MYCBP2;TRIM25;UBR2;COP1;ARIH2;RNF130;WWP2;RNF13;TRIM71;KCMF1;FANCL;TRIM14;MEX3C;RCHY1;TRIM17;SH3RF1;AREL1;RNF138;RNF150;UHRF2;XIAP;RNF166;RNF122;TRIM35;RNF41;HACE1;UBR3;MSL2;RNF144A;RNF19B;NEURL4;SMURF2;ANAPC11
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4103834618142739,1.1405379432658553,0.28777923784494086,0.6730829910182189,1.0,21/44,21.35%,NSD3;KMT2C;SETD7;SETDB2;DOT1L;SETD5;ASH1L;SETD2;KMT5B;NSD1;EZH2;KMT2E;KMT2A;ASH2L;SETMAR;EHMT1;WDR5;TTLL12;PRDM9;SMYD5;RBBP5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.46542863556826797,-1.13705616116061,0.2881773399014778,0.7565783014236623,1.0,5/11,26.10%,SLC25A25;LRRC8A;SLC17A9;SLC35B2;SLC25A42
prerank,peptidase activator activity (GO:0016504),0.4609399966897566,1.1361158158148088,0.30153846153846153,0.6814007017271452,1.0,8/22,18.80%,PSME3;PSME2;PSME4;TANK;NLRC4;VCP;MAL;PINK1
prerank,guanyl ribonucleotide binding (GO:0032561),0.3463751115760153,1.13581450787275,0.2209051724137931,0.6787261642919459,1.0,41/196,16.79%,LRRK2;RND3;RAP1A;RABL3;NOA1;RAPGEF2;RAC2;CDC42;RAB7A;ARF4;RAB6A;RAB39A;GNL1;ARF1;PDE2A;RHOBTB3;RAC1;RALB;RHOA;DIRAS1;ATL3;PIP4K2B;GLUD1;RHEB;GNAI1;TUBD1;ARL8B;GBP5;MMAA;RRAD;RAB29;GBP2;ATL1;GBP3;RHOG;DRG2;SEPHS1;TUBA1B;INSR;RAB35;RAB9B
prerank,GTP binding (GO:0005525),0.3481462248881348,1.1346453166967239,0.23917748917748918,0.6782356022999646,1.0,38/172,16.57%,LRRK2;RND3;RAP1A;RABL3;NOA1;RAC2;CDC42;RAB7A;ARF4;RAB6A;RAB39A;GNL1;ARF1;RHOBTB3;RAC1;RALB;RHOA;DIRAS1;ATL3;PIP4K2B;GLUD1;RHEB;GNAI1;TUBD1;ARL8B;GBP5;MMAA;RRAD;RAB29;GBP2;ATL1;GBP3;RHOG;DRG2;SEPHS1;TUBA1B;INSR;RAB35
prerank,phosphatase activity (GO:0016791),0.3784379209461605,1.1343938074837956,0.26774595267745954,0.6754309326318643,1.0,16/73,17.28%,PTPN22;DUSP16;PTPRO;ARMT1;OCRL;PXYLP1;DUSP12;PGAM5;HDDC2;ACP5;PPP1CB;PTPRJ;DUSP28;DUSP26;LHPP;PLPPR2
prerank,tRNA methyltransferase activity (GO:0008175),-0.42360439823733337,-1.1341888940628668,0.30213903743315507,0.7569008665770207,1.0,10/16,25.13%,ALKBH8;METTL2B;METTL2A;THUMPD2;TRMT44;TRMT12;LCMT2;TRMT9B;TRMT5;BCDIN3D
prerank,FMN binding (GO:0010181),-0.4669220417930262,-1.1330533354286203,0.32019704433497537,0.7518604737094927,1.0,2/11,7.08%,PPCDC;DUS2
prerank,DNA binding (GO:0003677),0.3294225301012501,1.1327191405553987,0.11723446893787576,0.6765114984602166,1.0,127/694,15.72%,CIITA;NFE2;HIVEP2;DNA2;GLI1;SAMHD1;MLH1;PPARG;BCL6;LONP1;POLR3F;STAT3;EHF;FOXJ1;TRIM26;RBBP8;POLL;CRLF3;CDC45;TAF9;MRE11;MYRF;SLPI;FEN1;CRY1;SCX;FAM111A;ZEB2;MBD1;CAMTA2;ATF6;LRRFIP1;RYBP;PARP4;IRF2;RFX3;RPL6;RBPJ;STAT1;NUFIP1;MCM6;RBMS1;IRF4;RFX5;SMARCA5;TSHZ1;TRIM16;CDC5L;SMC1B;TSG101;SETX;AHR;PHF19;CGGBP1;ARID4A;MBD4;CBFB;CREM;WRN;IKZF3;NFE2L2;OASL;PURB;MECP2;MSH3;NABP1;CRY2;CLOCK;RARG;GTF2A1;E2F2;CTCF;NFYC;BRIP1;MSH6;KAT6A;EZH1;SNAPC3;ZNF496;IRF7;CHTF18;SMAD4;RPS3;CSRNP1;MAU2;TDG;PBX1;ING2;SRRT;AIFM1;FOXO3;DEDD2;NLRP3;ETS2;RPA3;GTF3C6;APP;CCNT1;BCLAF3;NFYA;XRCC4;LIN9;TFAM;PQBP1;MSL3;TEAD1;MCM2;ERCC3;ERCC4;CHD4;JUNB;RNF138;CHRAC1;RPL7;SLTM;MAFK;SP4;CENPC;CREBBP;RELA;WBP11;STN1;TAF1;INO80;ENDOV;MCM9;ZNF148
prerank,clathrin adaptor activity (GO:0035615),0.477627624220245,1.1285352587808855,0.3160453808752026,0.6839813940529078,1.0,7/15,17.19%,AP2A2;HIP1;AP1G1;AP2B1;STON1;AP2S1;AP1M1
prerank,calcium ion binding (GO:0005509),0.33401325404895343,1.1272392188314686,0.22381930184804927,0.6836404908930829,1.0,45/323,11.61%,ITPR1;IQGAP1;LCP1;PADI1;RET;ACER3;TNNC1;ANXA2;EFCAB9;TPM4;PLSCR1;HPCA;C2CD5;RASGRP2;RAPGEF2;SELL;MCTP2;DYSF;CLGN;ESYT3;PPP3CA;SLC25A13;S100A4;STIM2;ESYT1;PRNP;ANXA4;ATP2A1;NUCB2;CIB1;S100A10;CABYR;CPNE1;PITPNM1;BRAF;FBN1;CAMKK2;ANXA1;SLC25A12;CALB2;LETM1;TPD52;EFCAB11;CDH9;S100A11
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3394217259042357,1.1264702478006545,0.25104166666666666,0.6823012940575515,1.0,59/232,18.24%,NEURL1B;NEURL3;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CBLB;RNF38;TRIM7;CBL;ANKIB1;CDC42;CBLL1;TRIM62;BIRC3;ARIH1;TRAF3IP2;PELI1;RC3H1;UBE2D3;RNF217;UBR5;HLTF;HECTD1;MYCBP2;TRIM25;UBR2;COP1;ARIH2;RNF130;WWP2;RNF13;TRIM71;KCMF1;FANCL;TRIM14;MEX3C;RCHY1;TRIM17;SH3RF1;AREL1;RNF138;RNF150;UHRF2;XIAP;RNF166;RNF122;TRIM35;RNF41;HACE1;UBR3;MSL2;RNF144A;RNF19B;NEURL4;SMURF2;ANAPC11
prerank,glycerophospholipid flippase activity (GO:0140333),-0.4641434471102759,-1.1261934055258553,0.31786542923433875,0.7633353440081889,1.0,4/11,7.06%,ATP8A2;ABCB4;ATP8A1;ATP8B1
prerank,protease binding (GO:0002020),0.360397500208379,1.1257639978102003,0.2688679245283019,0.6806933322490222,1.0,15/99,10.32%,DPP4;LDLR;ANXA2;SELL;CD177;SUMO1;FAP;PTEN;PRNP;SERPINB9;PSAP;CARD16;SPATA2;NLRC4;FN1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.44384980741349533,-1.1232753876800035,0.3170103092783505,0.7635530837402785,1.0,5/13,27.32%,ALDH9A1;ALDH7A1;ADH5;ALDH1L1;ALDH1A2
prerank,nucleosomal DNA binding (GO:0031492),0.45467257677797834,1.1230015114430063,0.315541601255887,0.6844906123508656,1.0,10/21,20.26%,GATAD2B;H3-3A;RBBP4;SMARCE1;MBD2;CHD4;SMARCC2;HDAC1;ACTB;HNRNPC
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.32507893032696633,1.1225512981091343,0.11911911911911911,0.682254602552048,1.0,85/831,9.96%,BCL11A;TRPS1;NFE2;ZBTB46;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;ETV6;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;SCX;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;ZNF319;RBPJ;KCNIP3;HIVEP1;DEAF1;STAT1;KLF5;IRF4;BBX;RFX5;KLF13;KLF10;CDC5L;CREBRF;CREM;IKZF3;NFE2L2;PURB;THRA;CLOCK;ZFP3;RARG;GTF2A1;E2F2;CTCF;NFYC;ELF1;ZBTB11;BACH1;NFE2L1;ZNF182;RBAK;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;RPS3
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3131856479137186,-1.1199113543667298,0.23282442748091603,0.7647086197021764,1.0,12/53,12.68%,SLC38A6;SLC1A3;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SLC17A6;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,phosphatidylglycerol binding (GO:1901611),-0.4441964237413445,-1.1186055748634867,0.327455919395466,0.760509441315053,1.0,3/13,14.79%,PITPNC1;PLEKHN1;STOML2
prerank,ubiquitin protein ligase binding (GO:0031625),0.3343859033640883,1.1177335211622141,0.2533889468196038,0.6914870894722609,1.0,70/254,17.98%,TRAF1;PTPN22;RPL5;NGFR;CD40;HSPA1A;CUL3;CUL5;LAPTM5;PRDX6;NFKBIA;FBXW7;SUMO1;AXIN1;TRAF4;ARIH1;RNF20;SPOP;FAF1;GLMN;UBE2N;HLTF;TSG101;NEDD8;WFS1;ELOB;TRAF3;UBXN7;ATXN3;RALB;WRAP53;TANK;UBE2W;CAMLG;RTN4;FANCL;DAXX;SUMO2;SNX9;RIPK1;PRKAR2A;YWHAZ;RNF31;GPI;NLK;NDUFS2;SLC25A5;UBE2G1;DNM1L;RPL11;HSPA9;TNFRSF1B;VCP;UBE2J2;TRIOBP;USP7;FBXO7;RELA;TCP1;APC;TUBA1B;RB1;CCDC50;SMAD5;AMBRA1;TRAF2;HSPD1;SMC6;BECN1;HSPA5
prerank,cysteine-type peptidase activity (GO:0008234),-0.2947500354037725,-1.1167210066738038,0.19796954314720813,0.7577977067115506,1.0,20/73,11.74%,LGMN;CTSB;USP35;CAPN3;USP46;USP2;USP29;USP12;CTSZ;USP28;USP20;CASP4;BLMH;CTSF;OTUD7B;OTULIN;ATG4A;USP16;USP21;CASP3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4406114559613163,-1.1138658307841967,0.3251231527093596,0.7578031170814676,1.0,7/14,30.13%,BLVRB;QDPR;DHFR;ALDH1L1;MTHFD1;PYCR3;NOXRED1
prerank,cardiolipin binding (GO:1901612),-0.4791322752402142,-1.112060293641685,0.3491686460807601,0.7556194158075602,1.0,7/10,46.74%,PLEKHN1;STOML2;UQCC3;GSDME;OPA1;NME4;MME
prerank,cation channel activity (GO:0005261),-0.273307800806562,-1.1118527638179565,0.2222222222222222,0.7487130414072335,1.0,19/94,14.98%,CACNA1D;SLC24A3;CACNB2;TRPV2;TRPM3;PKD2;UNC80;ANO10;TMEM63B;TRPC1;MCOLN1;KCNA2;CHRNA7;HCN1;TMEM38A;TRPM2;TRPV4;TRPC3;KCNA1
prerank,beta-tubulin binding (GO:0048487),0.42768223541680384,1.1107762410004292,0.33236574746008707,0.7057509562155045,1.0,9/31,13.62%,UXT;RACGAP1;PEX14;BCAS3;SPAST;HTT;ARL8B;EML4;TBCD
prerank,phosphatase activator activity (GO:0019211),0.5061165102320104,1.1092418168554345,0.360062893081761,0.706343535250174,1.0,5/14,15.68%,PPP2R5A;PPP1R15A;PPP2R5C;FRS2;PPP2R5E
prerank,nucleoside-triphosphatase activity (GO:0017111),0.33023683147684496,1.1084121828785463,0.26260504201680673,0.7050906013024477,1.0,46/248,15.04%,LRRK2;RND3;GNA14;DNA2;RAP1A;RAB19;HSPA1A;RABL3;MYO1E;RAC2;MYH9;ATP2B1;ABCA3;CDC42;RAB7A;RNF213;SMCHD1;ARHGDIB;RAB6A;GNL1;RHOBTB3;RAC1;GNG10;GNB1;RALB;RHOA;DIRAS1;ATL3;GPR88;RHEB;GNAI1;DNM1L;ABCD1;ARL8B;GBP5;MMAA;GNAI2;VCP;RAB29;KIF5A;GBP2;GNA11;ATL1;GBP3;RHOG;DRG2
prerank,P-type ion transporter activity (GO:0015662),0.5126225915910552,1.1077034154873961,0.3824503311258278,0.7035680313429121,1.0,4/12,7.73%,ATP2B1;ATP2A3;ATP2A1;ATP7A
prerank,RNA cap binding (GO:0000339),-0.4282275267582425,-1.1070451270355668,0.33815028901734107,0.7546214877703659,1.0,2/16,1.51%,LARP1;EIF4A1
prerank,DNA secondary structure binding (GO:0000217),-0.34919293740387386,-1.1058374038546632,0.29473684210526313,0.750613051746572,1.0,17/31,27.82%,MEF2C;RAD51B;HMGB1;BLM;MSH2;HMGB2;FANCM;RAD51C;HMGA2;CLSPN;XPC;NEIL3;GEN1;MEN1;RAD51AP1;ABL1;RAD51D
prerank,mechanosensitive ion channel activity (GO:0008381),0.5123341681741758,1.1053666592053268,0.3651877133105802,0.7063961914755466,1.0,6/12,22.02%,TMC8;PIEZO1;TMC6;TMC4;PIEZO2;TMEM63A
prerank,protein phosphatase binding (GO:0019903),0.34639016495252295,1.1045602576658802,0.297423887587822,0.7051924059254214,1.0,27/117,15.47%,IQGAP1;LILRB1;MAP3K5;STAT3;KCNQ1;AKAP11;PPP1R9B;MAPK14;STX17;MTMR3;SHOC2;STRN4;TRAF3;MTMR4;KCNN4;PXN;PPP1R15A;ANKLE2;SNX3;LGALS3;EIF2AK3;MVP;GRIN3A;STRN3;VCP;ANAPC7;TBK1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.31698872382783316,-1.1041265695491445,0.2748091603053435,0.7482710481099657,1.0,10/47,14.59%,SLC38A6;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SLC7A2;SLC7A8;SLC3A2;SLC22A4
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.37039987868424246,-1.1039696953848404,0.2894736842105263,0.7415807560137456,1.0,6/23,8.77%,PDE3B;PDE1B;PDE8B;PDE1A;PDE1C;PDE4A
prerank,chemokine activity (GO:0008009),0.4239913772609464,1.103102504210583,0.33426573426573425,0.7054376885788688,1.0,3/31,6.24%,CXCL10;CKLF;CXCL16
prerank,transaminase activity (GO:0008483),-0.4564948387735811,-1.1027739009227135,0.3660287081339713,0.7377245023665954,1.0,2/11,7.13%,GOT1;PSAT1
prerank,epidermal growth factor receptor binding (GO:0005154),0.4432605925674,1.1021644102835877,0.33285094066570187,0.7044815738155743,1.0,6/25,9.45%,PLSCR1;CCDC88A;SNX1;ARF4;GRB2;HIP1
prerank,motor activity (GO:0003774),0.37576051122412407,1.1019266733876394,0.33208020050125314,0.7018485166061925,1.0,12/60,10.96%,DNAH2;DNAH8;MYO1E;KIF20A;KIF5B;KIF6;MYH9;KIF23;KIF24;KIFC3;KIF3B;GPR88
prerank,microtubule binding (GO:0008017),-0.24449999160862868,-1.1013686492477472,0.17543859649122806,0.7346500947425892,1.0,71/222,20.81%,DST;NAV3;KIF13B;CAMSAP1;STARD9;FMN1;GAS2L3;NUMA1;TUBGCP5;MTUS2;IRAG2;MAP2;MAP1B;FGF13;CLIP1;RMDN1;MAST2;CEP57;KIF1B;CLASP2;KIF1A;CKAP5;CCDC66;GOLGA2;CLIP2;DCX;KIF5C;CEP57L1;MAP1A;MTUS1;MTCL1;DNM1;CDK5;EML2;SNPH;MAP1LC3B;MAPRE1;CAMSAP2;CHP1;EML3;TRPV4;HOOK1;CCDC88B;REEP1;MACF1;TUBGCP6;TPPP;CETN3;CCDC181;HAUS4;WHAMM;MAP6D1;CENPE;NEFH;TERF1;KIF15;RAB11A;HDAC6;VAPB;FAM161A;KIF3A;ARL3;MAST1;KIF21B;KIF18A;NDEL1;MAP9;CEP290;TUBGCP2;NEFM;SUN2
prerank,poly-purine tract binding (GO:0070717),-0.3684073784524718,-1.0990212007238929,0.3249211356466877,0.7343419880361461,1.0,13/27,24.03%,ATXN1;RBMS3;ZC3H14;HNRNPDL;TIA1;PATL1;ELAVL4;KHDRBS2;PPIE;DDX3X;DAZAP1;HNRNPU;MCRS1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.443333680645401,-1.098864318647231,0.34532374100719426,0.7279942621141903,1.0,4/13,10.43%,SLC7A6;SLC7A1;SLC7A7;SLC7A2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.519385272104079,1.0982727972433788,0.39317773788150806,0.7077583380940181,1.0,1/11,3.56%,CHRNA4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.34025293556756275,-1.098214080455452,0.3054662379421222,0.7228990940331147,1.0,11/32,11.84%,PHYHD1;KDM2A;EGLN3;ALKBH5;KDM2B;TYW5;EGLN2;KDM4A;TET1;PHF8;TET3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.38188250615494185,-1.096989530117814,0.31486880466472306,0.7199281755982787,1.0,6/21,8.77%,PDE3B;PDE1B;PDE8B;PDE1A;PDE1C;PDE4A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.33710504922943896,1.0952472636598578,0.2878787878787879,0.7122945762832672,1.0,30/173,15.72%,BCL11A;TRPS1;FOXP1;PPARG;ETV6;BCL6;NFKB1;ZBTB20;ZEB2;LRRFIP1;KLF8;KCNIP3;DEAF1;CREM;CTCF;BACH1;E4F1;NR3C1;FOXO3;IKZF5;ETS2;REST;SREBF2;NFIL3;ZNF436;MAFK;RELA;ZBTB25;BHLHE40;ZNF148
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.44867133487645156,-1.0947003588441269,0.35142118863049093,0.7196727724594992,1.0,3/12,6.12%,TGFBR2;TGFBR1;ACVR1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.2792728277374544,-1.094530558172091,0.2676767676767677,0.7138772313961622,1.0,18/78,11.74%,LGMN;CTSB;USP35;CAPN3;CFLAR;USP46;USP2;USP29;USP12;CTSZ;USP28;USP20;CAPNS1;CASP4;PYCARD;CTSF;USP16;CASP3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.48515007479572314,1.0944566904545077,0.3550488599348534,0.710917546398774,1.0,5/15,11.49%,SLC25A13;SLC1A5;SLC25A12;SLC1A4;SLC25A18
prerank,palmitoyltransferase activity (GO:0016409),0.4258102289606198,1.094229283389109,0.3439767779390421,0.708233688338652,1.0,6/28,9.01%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3166201488881888,1.094132087725383,0.2092092092092092,0.7051799792863314,1.0,91/732,13.24%,BCL11A;NFE2;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;ZNF319;RBPJ;KCNIP3;HIVEP1;STAT1;KLF5;IRF4;RFX5;KLF13;TIPARP;KLF10;AHR;CREM;IKZF3;NFE2L2;THRA;CLOCK;RARG;E2F2;CTCF;NFYC;ELF1;ZBTB11;BACH1;NFE2L1;ZNF182;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;NR3C1;GMEB2;PBX1;FOXO3;IKZF5;ZNF260;ETS2;REST;ZNF418;ATF6B;NFYA;TEAD1;KLF9;MYB;NRIP1;STAT2;NSD1
prerank,growth factor activity (GO:0008083),0.3714342998181663,1.0939764799373508,0.33250927070457353,0.7023526516750674,1.0,9/74,9.47%,NGF;FGF5;FGF22;GDNF;VEGFC;OSGIN2;HGF;IL6;PGF
prerank,phosphatidate phosphatase activity (GO:0008195),-0.42897649037423813,-1.0927791254520738,0.33665835411471323,0.7121510821727859,1.0,7/13,31.26%,PLPP3;PLPP1;PLPPR1;PLPPR4;PLPP4;PLPP5;PLPP2
prerank,four-way junction DNA binding (GO:0000400),-0.40192243843900166,-1.0923876023403731,0.325,0.7071724189451666,1.0,11/17,27.82%,RAD51B;HMGB1;BLM;MSH2;HMGB2;FANCM;RAD51C;GEN1;MEN1;ABL1;RAD51D
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.31607770498616133,1.0923626233757209,0.2072072072072072,0.7032966735290931,1.0,91/731,13.24%,BCL11A;NFE2;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;SCX;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;ZNF319;RBPJ;KCNIP3;HIVEP1;STAT1;KLF5;IRF4;RFX5;KLF13;KLF10;AHR;CREM;IKZF3;NFE2L2;THRA;CLOCK;RARG;E2F2;CTCF;NFYC;ELF1;ZBTB11;BACH1;NFE2L1;ZNF182;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;NR3C1;GMEB2;PBX1;FOXO3;IKZF5;ZNF260;ETS2;REST;ZNF418;ATF6B;NFYA;TEAD1;KLF9;MYB;NRIP1;STAT2;NSD1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.37347427040070086,-1.0900583141967952,0.32608695652173914,0.7073246237705889,1.0,4/21,10.34%,GRIA1;CHRFAM7A;CHRNA7;GRM5
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3915915831738057,-1.0872501157036087,0.3464788732394366,0.708466972126766,1.0,6/18,17.01%,TGFBR2;TGFBR1;ACVR1;ACVR2B;BMPR1B;ACVR1B
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5083688667242475,1.0860692756816241,0.38394415357766143,0.7158757809532541,1.0,3/12,5.52%,SULF2;ARSI;ARSJ
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.33697161538385517,-1.0851323951744705,0.32228915662650603,0.7080756013745705,1.0,7/32,12.68%,SLC38A6;MFSD12;SLC36A4;SLC36A1;SFXN1;SLC7A8;SLC3A2
prerank,hydro-lyase activity (GO:0016836),-0.3207418032629757,-1.0849544094689776,0.3035019455252918,0.7026415720927547,1.0,13/41,21.84%,ECHS1;HACD2;ECHDC1;ENO2;TGDS;HADHB;CA2;HADHA;TBXAS1;ECI1;PCBD2;ENO3;NAXD
prerank,poly-pyrimidine tract binding (GO:0008187),-0.3731314522207674,-1.0842617047686798,0.3323943661971831,0.6986197021764032,1.0,7/23,14.33%,ATXN1;RBMS3;HNRNPH1;PATL1;SSB;PTBP1;DIS3L2
prerank,endopeptidase activity (GO:0004175),0.3266511089387054,1.0838440936215037,0.3124346917450366,0.7182359952324195,1.0,48/257,16.04%,DPP4;NAPSA;ACE;PRSS53;ACE2;MALT1;MMP1;PSMB7;HP;HPR;FAP;PARL;USP49;ADAM17;C1RL;ADAMTS6;HGF;USP48;CPNE1;RHBDL2;USP15;PIDD1;PSMB8;ADAM19;PSMA5;MBTPS1;CASP2;USP42;PSMB3;USP40;THSD4;TPP2;PSMB1;CAPN7;BACE2;CORIN;CASP7;PCSK5;ADAMTS12;USP37;ADAM9;USP7;CASP6;USP9X;MIPEP;ADAMTS19;PROC;USP47
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.33182585904724393,-1.0824899367953313,0.33217993079584773,0.697248729090341,1.0,21/35,32.32%,DUS2;QTRT1;DTWD2;PTRH2;GATB;GATC;DUS3L;TARS2;DUS1L;TRMT12;LCMT2;ELAC2;TRMT9B;TRMT5;BCDIN3D;DTWD1;QRSL1;QTRT2;FTSJ1;ALKBH1;AARS2
prerank,nuclear receptor coactivator activity (GO:0030374),0.3779593341124007,1.0816700777299373,0.3598937583001328,0.7205030011170676,1.0,16/52,18.17%,PKN1;NCOA3;MED30;MED13;HELZ2;BUD31;CNOT6;NCOA2;NCOA1;MED12;MED14;TACC1;ZMIZ2;MED1;SS18;NCOA7
prerank,phospholipase activity (GO:0004620),0.36241863184895406,1.0812199594859269,0.35118306351183065,0.7183622540196055,1.0,4/67,5.04%,PLBD1;PLD4;PRDX6;SMPDL3A
prerank,voltage-gated sodium channel activity (GO:0005248),-0.3734745522407586,-1.0811574327811277,0.32303370786516855,0.6951129513830206,1.0,6/22,12.13%,SCN1A;PKD2;SCN3A;HCN1;HCN2;SCN1B
prerank,tubulin binding (GO:0015631),-0.22919732936628592,-1.0775983053569005,0.25,0.6985143743190009,1.0,87/295,20.81%,DST;NAV3;PRKN;DIP2B;KIF13B;CAMSAP1;STARD9;FMN1;GAS2L3;NUMA1;TUBGCP5;MTUS2;IRAG2;MAP2;MAP1B;FGF13;CLIP1;RMDN1;RAB11FIP5;MAST2;CEP57;IFT74;KIF1B;DIXDC1;CLASP2;KIF1A;CKAP5;CCDC66;GOLGA2;CLIP2;TTLL11;TRAPPC14;DCX;CDK5R1;KIF5C;CEP57L1;MAP1A;MTUS1;MTCL1;DNM1;WASHC1;CDK5;EML2;SNPH;MAP1LC3B;TTLL5;CHP1;GJA1;EML3;TRPV4;HOOK1;NCALD;CCDC88B;REEP1;TUBGCP6;TPPP;CETN3;CCDC181;TPR;WHAMM;TBCA;MAP6D1;CENPE;NEFH;TERF1;KIF15;BRCA1;RAB11A;PDCD5;HDAC6;VAPB;DDX3X;ARL4C;AGBL1;FAM161A;KIF3A;ARL3;MAST1;AGBL4;KIF21B;ATF5;KIF18A;NDEL1;MAP9;TUBGCP2;NEFM;SUN2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.37331338429283084,1.076202409260045,0.3612565445026178,0.7281349679323457,1.0,6/55,6.98%,ITPR1;ANXA2;CUL5;ATP2B1;ATP2A3;ATP2A1
prerank,ubiquitin binding (GO:0043130),-0.2772543186478465,-1.07431832386083,0.27932960893854747,0.701635766544729,1.0,31/73,27.10%,PRKN;BIRC2;MVB12B;BUB3;VPS36;PLAA;NBR1;UCHL3;GGA3;AUP1;NPLOC4;DNAJB2;SMAD3;ASCC2;TOM1L1;USP16;UCHL1;SQSTM1;OTUB1;TRIM32;SPRTN;SHARPIN;USP5;RAD23A;UBE2L6;CKS2;MDM2;VPS28;UBXN2A;WDR48;USP33
prerank,phospholipase C activity (GO:0004629),0.4304852469457856,1.071587198663015,0.37961595273264404,0.7368009294069605,1.0,4/25,7.82%,PLCG2;CCR1;PLCB1;PLCD4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4009818685685252,1.0703670837657762,0.3997134670487106,0.7364400740790191,1.0,11/34,20.95%,XRN2;PNLDC1;CNOT6;ERI1;CNOT2;EXD2;PNPT1;CNOT8;DIS3L;CNOT6L;PARN
prerank,ribonuclease activity (GO:0004540),0.364832772456106,1.0632227202907285,0.37367021276595747,0.7507506474768567,1.0,14/56,16.35%,ZC3H12D;SAMHD1;ERN1;SND1;CNOT6;RNASE1;KHNYN;RNASE6;INTS11;EXOG;RNASEH2A;RNASEH1;CPSF3;SMG6
prerank,retinoic acid receptor binding (GO:0042974),0.4645252310886385,1.0610022654208238,0.406099518459069,0.7527337374722753,1.0,6/17,15.78%,PPARG;RARG;TACC1;NRIP1;NSD1;MED1
prerank,3'-5' exonuclease activity (GO:0008408),0.3795259215971647,1.0587412920930326,0.39946018893387314,0.7552912369798414,1.0,15/45,20.95%,MRE11;EXD1;XRN2;PNLDC1;WRN;CNOT6;ERI1;EXD2;PNPT1;POLD1;CNOT8;DIS3L;APEX1;CNOT6L;PARN
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4647125952803379,-1.0587350442212249,0.3808353808353808,0.7347278350515464,1.0,5/10,28.03%,CLCN6;CLCN4;CLCN3;CLCN2;CLCN1
prerank,ribonuclease P activity (GO:0004526),-0.45336381712142276,-1.0566674511629404,0.4086294416243655,0.734392216222113,1.0,8/11,34.16%,POP1;RPP30;RPP14;RPP40;POP4;POP5;RPP21;POP7
prerank,proton transmembrane transporter activity (GO:0015078),-0.3207391309310091,-1.0564930555942145,0.3273381294964029,0.7291020645615175,1.0,9/39,19.88%,ATP6V1B2;SLC11A2;CLCN4;CLCN3;COX10;NNT;UQCRC1;UQCR10;COX5B
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.4125549059313501,1.056353812691913,0.3841726618705036,0.7579738667598364,1.0,7/29,13.59%,SLC25A13;SLC25A30;SLC1A5;SLC25A12;SLC1A4;SLC25A18;SLC26A7
prerank,histone methyltransferase activity (GO:0042054),0.4011665055955068,1.0563270906573745,0.39322533136966126,0.7547882037612218,1.0,13/32,20.53%,NSD3;PRMT8;KMT2C;SETD7;DOT1L;SETD2;KMT5B;EZH2;KMT2E;NTMT1;EHMT1;TTLL12;PRDM9
prerank,GTPase activity (GO:0003924),0.3189886594598449,1.0539466649009765,0.38727076591154264,0.7574215749823335,1.0,34/192,15.04%,LRRK2;RND3;GNA14;RAP1A;RAB19;RABL3;RAC2;CDC42;RAB7A;ARHGDIB;RAB6A;GNL1;RHOBTB3;RAC1;GNG10;GNB1;RALB;RHOA;DIRAS1;ATL3;RHEB;GNAI1;DNM1L;ARL8B;GBP5;MMAA;GNAI2;RAB29;GBP2;GNA11;ATL1;GBP3;RHOG;DRG2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.31326654913954455,1.0511288949360904,0.39021852237252863,0.7610864800674099,1.0,31/254,10.42%,HNF4G;KLF4;CREB1;NFKB1;FOSL2;PLSCR1;STAT3;EHF;FOXJ1;ELF4;REL;SCX;ATF6;ATF2;IRF2;ZNF319;RBPJ;KLF5;IRF4;RFX5;KLF10;CDC5L;CREBRF;CLOCK;E2F2;NFYC;ELF1;E4F1;MEF2B;SMAD4;NR3C1
prerank,disordered domain specific binding (GO:0097718),0.4323615689598921,1.0510782170446387,0.40031152647975077,0.7579925805434896,1.0,5/23,11.67%,FYN;HSPA1A;NCOA3;FN1;DFFB
prerank,endopeptidase activator activity (GO:0061133),0.4975540558965468,1.049675928966641,0.3939393939393939,0.7583044859122615,1.0,3/10,10.12%,PSME3;PSME2;NLRC4
prerank,tRNA binding (GO:0000049),-0.3070285024610995,-1.0495150528395574,0.36947791164658633,0.7417029102233678,1.0,19/43,24.73%,ALKBH8;NSUN2;TRNT1;EIF2AK4;PSTK;EEF1A1;DALRD3;ELP5;TYW5;ELP1;PTCD1;SSB;IGHMBP2;KARS1;TRMT10A;NSUN6;TRMT9B;CARS1;NAT10
prerank,water transmembrane transporter activity (GO:0005372),-0.4439771514656958,-1.0485365734731174,0.3976470588235294,0.7388622499267428,1.0,6/11,55.61%,AQP4;PDPN;AQP11;AQP1;SLC5A1;SLC4A11
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.45719478672320035,1.0484261707318319,0.3973941368078176,0.7584303409509728,1.0,3/15,12.71%,PLEKHF1;SESTD1;SNX3
prerank,rRNA binding (GO:0019843),0.386231239289906,1.048262274553563,0.40953716690042075,0.7556367481438345,1.0,11/42,16.41%,RPL5;MRPL18;RPS14;RPF2;ERI1;RPS3;RPLP0;PTCD3;RPL11;MRPS6;MRPS27
prerank,TBP-class protein binding (GO:0017025),0.4320132034926112,1.0469785627331871,0.39228295819935693,0.755480117151962,1.0,4/21,7.94%,TAF13;AHR;THRA;GTF2A1
prerank,potassium channel activity (GO:0005267),-0.26534080873447685,-1.045185923608866,0.33962264150943394,0.7419759450171821,1.0,15/89,10.61%,KCNMA1;KCNK13;KCNQ5;KCND2;KCNQ3;PKD2;GRIK4;GRIK1;KCNN2;KCNMB2;KCNA2;KCNK6;HCN1;HCN2;TMEM38A
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.38885368575565815,-1.0440543384055216,0.3914209115281501,0.7390742635292883,1.0,6/17,13.29%,ABCA1;PITPNC1;ABCB4;ATP8B1;MTTP;ABCA7
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.47721931336447165,1.0432512782961223,0.4181494661921708,0.7614121828707644,1.0,4/11,9.48%,SAMD8;SGMS1;SGMS2;PIGF
prerank,endoribonuclease activity (GO:0004521),0.3927942175436139,1.0426319622437084,0.40226628895184136,0.7598134228443973,1.0,10/32,17.81%,ZC3H12D;ERN1;SND1;KHNYN;INTS11;EXOG;CPSF3;ENDOV;SMG6;NYNRIN
prerank,insulin-like growth factor binding (GO:0005520),-0.40585139819284066,-1.04001498886574,0.40897097625329815,0.7434759970842444,1.0,8/15,30.33%,ITGA6;ITGB3;IGFBP5;IGFBP2;IGFBP4;IGF2R;ITGB4;IGFBP3
prerank,I-SMAD binding (GO:0070411),-0.41542298186611015,-1.0398947724143137,0.39285714285714285,0.7381294731674548,1.0,4/13,9.98%,TGFBR1;CTNNB1;SMAD7;SMAD3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.45133257988145303,-1.0366168213440108,0.41418764302059496,0.7407306252243935,1.0,1/10,0.11%,SLCO2B1
prerank,MAP kinase activity (GO:0004707),0.4620303427057823,1.0353213068335279,0.43029259896729777,0.7747068458684019,1.0,5/14,15.12%,MAPK14;MAPK12;NLK;MAPK8;MAPK1
prerank,protein phosphatase activator activity (GO:0072542),0.47687920033551334,1.0347836472509544,0.44166666666666665,0.7728448665476874,1.0,5/13,18.02%,PPP2R5A;PPP1R15A;PPP2R5C;PPP2R5E;PTPA
prerank,poly(U) RNA binding (GO:0008266),-0.37172278457396934,-1.033378002595815,0.4015748031496063,0.7437399770904926,1.0,6/20,14.33%,ATXN1;RBMS3;HNRNPH1;PATL1;SSB;DIS3L2
prerank,zinc ion binding (GO:0008270),0.30721661497535013,1.0318162389266397,0.4104938271604938,0.7771832685281072,1.0,41/293,11.67%,SAMHD1;GDA;ACE;KLF4;ACER3;LNPEP;PPARG;ACE2;TET2;PLSCR1;KDM7A;MSRB1;UPB1;DHX58;CBLB;SMPDL3B;DPEP1;MBD1;PEX12;SMPDL3A;ARIH1;RC3H1;IFIH1;CRIP1;MYCBP2;PDE2A;ARIH2;CTCF;KAT6A;TNKS;RBAK;NQO2;SLU7;RASSF1;CYLD;PTPN1;RNPEP;DUSP12;TAB3;IKZF5;CAD
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4130901764009559,1.030905300414643,0.41781874039938555,0.7762868123581801,1.0,2/24,2.90%,ITPKC;IP6K3
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.3812506297867106,-1.0308977245111899,0.4111111111111111,0.7439786739438043,1.0,9/17,42.25%,AK3;DTYMK;AK1;CMPK2;AK4;NME2;AK9;NOL9;NME4
prerank,transcription coactivator binding (GO:0001223),-0.3688500079256776,-1.0305025615900998,0.4,0.7395182732585848,1.0,13/20,28.65%,VGLL4;THRB;PGR;SMAD3;MED25;ESR1;ZBTB49;AR;CDK9;ZBTB17;CIT;RORA;PPARD
prerank,single-stranded DNA binding (GO:0003697),0.3326582983229895,1.029595019553885,0.42011834319526625,0.776477098586753,1.0,19/93,15.70%,SAMHD1;MLH1;LONP1;RBBP8;CDC45;FAM111A;MCM6;RBMS1;PURB;MSH3;NABP1;CRY2;RPA3;MCM2;ERCC4;RNF138;WBP11;STN1;MCM9
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.43507833425181897,-1.028919060439122,0.4095238095238095,0.738003635639225,1.0,5/11,20.29%,PPP1R14C;PPP1R8;PPP1R11;PPP1R14A;PPP1R14B
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.47836844358125574,1.0283635284392558,0.4265975820379965,0.7763406407280694,1.0,2/11,3.49%,MARVELD3;STK38
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4668921773245955,1.028223151114861,0.43926788685524126,0.7735417479114374,1.0,4/13,13.34%,KCNQ1;EZR;PRKAR2A;CSK
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.35772882794873034,-1.0258391272373313,0.41964285714285715,0.7349435444280804,1.0,11/21,20.51%,CDK8;CDK11B;CDKL3;CDK5;CCNK;CDK10;CDK4;CDKL1;CDK9;CDK20;CDK7
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.35772882794873034,-1.0258391272373313,0.41964285714285715,0.7349435444280804,1.0,11/21,20.51%,CDK8;CDK11B;CDKL3;CDK5;CCNK;CDK10;CDK4;CDKL1;CDK9;CDK20;CDK7
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.35935937021540554,-1.0222242193580375,0.4131578947368421,0.7388718286173869,1.0,6/19,10.75%,GAS6;ERCC6;NRG3;DGKQ;GRM5;EFNA5
prerank,G protein-coupled receptor binding (GO:0001664),0.3214477751766168,1.0214066349467075,0.43068181818181817,0.7871491756229755,1.0,6/132,2.62%,GRK3;GNA14;FPR1;ACE;HSPA1A;CCDC88C
prerank,microtubule motor activity (GO:0003777),0.3571753279195571,1.0203743178965876,0.42764857881136953,0.7864689255916907,1.0,9/51,10.56%,DNAH2;DNAH8;KIF20A;KIF5B;KIF6;KIF23;KIF24;KIFC3;KIF3B
prerank,sequence-specific DNA binding (GO:0043565),0.2967725381572094,1.0188180149607047,0.43618090452261304,0.7868859314996103,1.0,89/590,17.59%,NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;KLF4;CREB1;PPARG;BCL6;LONP1;PITX3;ELF4;RFX7;FOS;ZBTB20;MYRF;SCX;ZEB2;MBD1;ATF6;ATF2;IRF2;RFX3;RBPJ;HIVEP1;KLF5;IRF4;BBX;RFX5;KLF13;KLF10;AHR;CBFB;CREM;IKZF3;NFE2L2;MECP2;CLOCK;RARG;E2F2;CTCF;ELF1;PKNOX1;IRF7;MEF2B;SMAD4;CSRNP1;NR3C1;UPF2;GMEB2;PBX1;FOXO3;NLRP3;ETS2;MBD2;ATF6B;SMG1;TFAM;TEAD1;JUNB;SREBF2;SLTM;MAFK;SP4;KMT2A;STN1;TAF1;HSF5;BHLHE40;ZNF148;FOXN2;ELF2;SMG6;IRF5;BPTF;HOXC9;PROX1;CREB3L4;CREB3;SMAD5;ELK4;FOXK1;CHCHD2;LRWD1;NR4A1;ERH;NFATC3
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4426380182930364,-1.0171061927957732,0.4528735632183908,0.7454896907216495,1.0,2/10,1.04%,SLC8A1;SLC24A3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3691878687492739,1.0170524945518704,0.4583883751651255,0.788034629823324,1.0,11/49,12.56%,ANXA2;C2CD5;MCTP2;DYSF;ESYT3;ESYT1;ANXA4;CPNE1;ANXA1;CPNE2;ESYT2
prerank,insulin-like growth factor I binding (GO:0031994),-0.41176107308040594,-1.0160951535212313,0.4481012658227848,0.7429865666979069,1.0,7/13,30.33%,ITGA6;ITGB3;IGFBP5;IGFBP2;IGFBP4;ITGB4;IGFBP3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.4176480832225206,-1.015880821238821,0.4388888888888889,0.7384629152348225,1.0,9/12,36.24%,SDHB;FXN;ISCA2;FDX1;ISCU;CIAPIN1;AOX1;ISCA1;CISD3
prerank,3'-5' DNA helicase activity (GO:0043138),-0.37310731763935956,-1.01370415395263,0.4482758620689655,0.7389465576490105,1.0,1/16,0.02%,NAV2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4880515897697648,1.0133140476535811,0.4763572679509632,0.7940561381925325,1.0,4/10,22.60%,B4GALT5;B3GALT2;B4GALT7;B3GALT5
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.37710331197719044,1.011544867594175,0.4563380281690141,0.7951750034523395,1.0,11/33,20.95%,XRN2;PNLDC1;DCP2;CNOT6;ERI1;EXD2;PNPT1;CNOT8;DIS3L;CNOT6L;PARN
prerank,ephrin receptor activity (GO:0005003),-0.3697880011506509,-1.0114483018858504,0.4301369863013699,0.734568225915796,1.0,4/17,11.76%,EPHA6;EPHA5;EFNB3;EPHA7
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.3697880011506509,-1.0114483018858504,0.4301369863013699,0.734568225915796,1.0,4/17,11.76%,EPHA6;EPHA5;EFNB3;EPHA7
prerank,exonuclease activity (GO:0004527),0.3624426332620509,1.009727473882063,0.4605263157894737,0.7965037409481074,1.0,10/46,12.46%,MRE11;FEN1;APEX2;EXD1;XRN2;WRN;CNOT6;ERI1;EXOG;EXD2
prerank,solute:sodium symporter activity (GO:0015370),0.3953227965059541,1.0087954525512435,0.4421364985163205,0.7955518767027073,1.0,3/27,12.21%,SLC4A7;SLC4A8;SLC28A2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3796436240065652,-1.0034655873115539,0.4498567335243553,0.7492778861335563,1.0,7/17,28.95%,BLVRB;DPYD;PECR;TECR;PTGR2;DECR2;PTGR1
prerank,protein kinase inhibitor activity (GO:0004860),0.3714742792646863,1.0032013337604908,0.46238030095759236,0.8062710312509731,1.0,11/42,15.32%,IBTK;GMFG;TAOK3;HEXIM1;PRKRIP1;CIB1;MBIP;GSKIP;SH3BP5;DNAJC3;SPRED1
prerank,transforming growth factor beta binding (GO:0050431),-0.33216385284309674,-1.0019054791415256,0.4528301886792453,0.7480644156922438,1.0,3/23,6.12%,TGFBR2;TGFBR1;ACVR1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.38646234853510153,1.00151001974244,0.44040697674418605,0.8072079955967199,1.0,4/27,7.51%,SLC9A7;SLC23A1;SLC8B1;SLC4A8
prerank,histone deacetylase binding (GO:0042826),0.3201036685144419,0.9965113622159371,0.4837153196622437,0.815788961591788,1.0,20/88,16.30%,PKN1;HSPA1A;NIPBL;SPI1;MTA3;CAMTA2;RBBP4;CCND1;IKZF3;PKN2;HDAC9;MEF2B;NUDT21;MAPK8;CHD4;KAT2B;HDAC3;RELA;MIER1;KPNA2
prerank,E-box binding (GO:0070888),0.378722481725263,0.996376616705499,0.463302752293578,0.8129675241326016,1.0,5/34,7.78%,PPARG;CIART;SCX;AHR;CLOCK
prerank,GABA receptor activity (GO:0016917),-0.3464942797023546,-0.9940319046902855,0.44868035190615835,0.7625996563573884,1.0,8/21,18.60%,GABRG3;GABRG2;GABRB1;GABRA4;GABRB3;GABBR1;GABRA2;GABRA5
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.37043096625681954,0.9938392664235102,0.4892086330935252,0.8159499638908624,1.0,13/34,21.29%,NSD3;SETD7;CAMKMT;DOT1L;SETD2;KMT5B;EZH2;EEF1AKMT1;KMT2E;EHMT1;TTLL12;PRDM9;ATPSCKMT
prerank,cyclic nucleotide binding (GO:0030551),0.40677194160831837,0.9910071275130592,0.4609494640122512,0.819504772129671,1.0,3/21,7.49%,RAPGEF2;KCNH1;PDE2A
prerank,NF-kappaB binding (GO:0051059),0.40245014271663215,0.9894077227343503,0.4678624813153961,0.8201580151223716,1.0,12/24,26.21%,NFKBIA;FAF1;ANXA4;CPNE1;HDAC3;RELA;HDAC1;GSK3B;HIF1AN;PSMA6;SETD6;HDAC2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.3450152573463028,-0.9882450168528099,0.4780058651026393,0.7712620331808562,1.0,8/22,17.60%,RBMS3;CPEB2;CPEB1;ELAVL1;EXOSC9;ELAVL4;CPEB3;ELAVL3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.27429852891603707,-0.9862729803209112,0.4854771784232365,0.7711108473503345,1.0,19/49,22.60%,IKBKE;AGAP3;ZRANB1;MINDY2;RNF169;UBQLN4;OPTN;OTUD7A;MINDY1;OTUD7B;SQSTM1;UBL7;UBQLN2;HDAC6;SPRTN;SHARPIN;WDR81;RAD23A;ZFAND2B
prerank,solute:anion antiporter activity (GO:0140323),-0.3850519332755924,-0.98618954624796,0.4879356568364611,0.7662387979246682,1.0,6/14,29.39%,SLC26A11;SLC26A2;SLC4A2;SLC26A8;SLC26A6;SLC4A3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3622371379313484,0.9836405816648688,0.4842249657064472,0.8306107108029038,1.0,6/38,12.70%,LRRK2;STAP1;AXIN1;SPATA2;DEDD2;RGS14
prerank,telomerase RNA binding (GO:0070034),0.4019580811051677,0.9834316246851103,0.49849397590361444,0.8279434829681079,1.0,9/22,20.95%,TEP1;SNRPB;DCP2;NHP2;WRAP53;TENT4B;SMG6;HNRNPC;PARN
prerank,amino acid:sodium symporter activity (GO:0005283),-0.42049293057822523,-0.9783207972760358,0.475,0.7804960503414111,1.0,2/11,5.54%,SLC1A3;SLC6A15
prerank,metalloexopeptidase activity (GO:0008235),0.3437920166619899,0.9762710435376433,0.5040431266846361,0.8411020100907812,1.0,6/51,7.39%,ACE;LNPEP;ACE2;DPEP1;RNPEPL1;CPQ
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.39400488431048175,0.9729432377817939,0.5023183925811437,0.8462409388230658,1.0,6/23,14.35%,SESTD1;GBF1;HIP1;WIPI2;SNX3;MAPKAP1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3909012082769524,-0.9728124188986842,0.4617283950617284,0.788732956434985,1.0,4/12,8.77%,PDE3B;PDE1B;PDE8B;PDE4A
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4726579602104334,0.9702112397971133,0.511265164644714,0.84938451578308,1.0,2/10,10.64%,PIK3C2A;PIK3CA
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.26851932239422793,-0.9658544133232784,0.5076923076923077,0.8001002290950745,1.0,13/51,18.43%,SLCO2B1;ANKH;CLCN4;SLC25A3;SLC35C2;SLC25A11;SLC7A8;SLC25A14;CLCN3;SLC22A4;SLC35E1;SLC35D2;SLC35E3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4368427539410683,0.9653656905028121,0.5033333333333333,0.8577566862910541,1.0,2/14,6.14%,CAPN13;CAPN2
prerank,sulfotransferase activity (GO:0008146),-0.29709277790605726,-0.9652487628264826,0.4709897610921502,0.7963627508919386,1.0,13/33,26.40%,TPST2;CHST11;CHST9;CHST1;HS6ST1;CHST8;CHST3;GAL3ST4;CHST2;HS3ST2;HS3ST1;SULT1A1;HS3ST3A1
prerank,carboxy-lyase activity (GO:0016831),-0.32954274014231716,-0.9634564683591631,0.5044510385756676,0.7957827656705381,1.0,9/23,22.64%,PPCDC;ECHDC1;PCK2;UMPS;GGCX;MLYCD;ODC1;GAD1;DDC
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.32555057354942457,-0.962893040171698,0.5075075075075075,0.7920702846398238,1.0,4/26,10.66%,SLC16A6;ABCG2;SLC27A1;MPC2
prerank,NAD+ binding (GO:0070403),0.4529809230978117,0.9623535263667072,0.5252854812398042,0.8615658285562934,1.0,6/12,21.20%,ZC3HAV1;PARP9;GLUD1;SIRT1;HPGD;SIRT3
prerank,phosphatase binding (GO:0019902),0.3028044768967582,0.9619334020482886,0.5383720930232558,0.859366492353839,1.0,28/105,18.89%,IQGAP1;MAP3K5;STAT3;CRY1;MAPK14;STX17;MTMR3;SHOC2;TRAF3;CRY2;MTMR4;KCNN4;PXN;SNX3;LGALS3;EIF2AK3;MVP;VCP;ANAPC7;MAPK1;SPRED1;TBK1;ELL;PIK3R2;TRAF2;CTSC;ANAPC4;BAD
prerank,O-methyltransferase activity (GO:0008171),-0.41489920221456666,-0.9611719813472309,0.5246305418719212,0.7915383376288659,1.0,5/10,25.62%,COMT;COQ3;FTSJ3;BCDIN3D;ASMT
prerank,GABA-A receptor activity (GO:0004890),-0.35038522184994114,-0.9589089519945775,0.5121951219512195,0.7922338904185608,1.0,7/18,18.60%,GABRG3;GABRG2;GABRB1;GABRA4;GABRB3;GABRA2;GABRA5
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4504933947183835,0.9570740768465558,0.5183823529411765,0.8675331902725333,1.0,1/11,3.90%,HCN4
prerank,transition metal ion binding (GO:0046914),0.279772924305611,0.9538079003208002,0.6123481781376519,0.8718669717818363,1.0,56/397,12.64%,SAMHD1;GDA;ACE;KLF4;ACER3;LNPEP;PPARG;PIM1;ACE2;TET2;PLSCR1;KDM7A;MSRB1;UPB1;DHX58;CBLB;ETHE1;FEN1;SMPDL3B;DPEP1;MBD1;PEX12;HEPH;SMPDL3A;ARIH1;RC3H1;IFIH1;PRNP;IMPA1;CRIP1;WRN;MYCBP2;PDE2A;ATP7A;GALNT2;ARIH2;CTCF;KAT6A;TNKS;RBAK;NQO2;SLU7;RASSF1;ARG2;ATOX1;CYLD;PTPN1;MTPAP;RNPEP;DUSP12;TAB3;IKZF5;CAD;RCHY1;EXD2;XXYLT1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3151129317717704,-0.9532585962118769,0.5112540192926045,0.8009938059479871,1.0,10/27,27.66%,ANKH;SLC26A11;SLC25A11;SLC25A14;GET3;LRRC8A;SLC26A2;SLC26A8;SLC26A6;SLC25A10
prerank,chloride channel regulator activity (GO:0017081),-0.3709656914100275,-0.9526611561876857,0.5123152709359606,0.7974500874918306,1.0,8/14,17.79%,WNK1;WNK2;SGK1;VTI1B;CHRNA7;STX1A;VAMP8;STX8
prerank,damaged DNA binding (GO:0003684),0.3406728122291714,0.9524095256169607,0.5441176470588235,0.8718579768108664,1.0,16/44,22.08%,RBBP8;FEN1;CRY2;RPS3;TDG;RPA3;ERCC3;ERCC4;CREBBP;POLD1;SMC6;FANCG;APEX1;XPA;POLQ;SDE2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.42407251955948627,0.9515175604764241,0.5281456953642384,0.8707975171431668,1.0,5/14,15.33%,MINDY3;ATXN3;USP15;USP7;USP9X
prerank,ATPase regulator activity (GO:0060590),-0.2869457775820354,-0.950539796228149,0.5302013422818792,0.7975861201910988,1.0,9/38,9.88%,FNIP2;FNIP1;ATP1B3;ATP1B1;PFN1;BAG4;BAG1;DNAJA2;DNAJB2
prerank,RNA stem-loop binding (GO:0035613),-0.3928381190647586,-0.9476369320636928,0.5184210526315789,0.7994736019993752,1.0,5/12,21.35%,RC3H2;DHX9;CPEB3;DDX3X;MYH10
prerank,anion:anion antiporter activity (GO:0015301),-0.34709895521781625,-0.9453537378128222,0.5068493150684932,0.8000533060075353,1.0,8/17,29.39%,SLC26A11;SLC25A11;SLC26A2;SLC4A2;SLC26A8;SLC26A6;SLC25A4;SLC4A3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4263455805687877,0.9439491251249413,0.5320945945945946,0.8848065761517335,1.0,5/13,16.27%,CCDC88A;ARHGDIB;SH3BP4;RGS14;GPSM2
prerank,adenylate cyclase binding (GO:0008179),-0.41286950862378047,-0.943858187794841,0.5314861460957179,0.7988605263699404,1.0,6/10,34.73%,AKAP12;AKAP6;CALM1;AKAP5;ADCY2;CALM2
prerank,peptidase inhibitor activity (GO:0030414),-0.29392473553648396,-0.9438150516085495,0.5512367491166078,0.7942184176075929,1.0,4/33,4.29%,TIMP2;RENBP;PROS1;CST3
prerank,hexosyltransferase activity (GO:0016758),-0.2337332181200065,-0.942749104387937,0.5949367088607594,0.7920830029077452,1.0,20/101,20.22%,HEXB;LARGE1;DPY19L4;B3GALNT1;CHPF2;GYG1;B4GALT4;MGAT4C;PIGB;ALG9;HEXA;MGAT4A;POMT1;PIGV;GCNT1;ALG1;POGLUT2;GBA2;DPY19L3;HYAL1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3766547710263698,0.9397467636592336,0.5326251896813353,0.8913352790503689,1.0,3/24,5.85%,PLEKHF1;GOLPH3L;SESTD1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3683987112015489,0.9383759993179543,0.5355029585798816,0.891320970126674,1.0,4/27,8.97%,POLR3F;POLR3A;POLR2C;TENT2
prerank,glutamate receptor binding (GO:0035254),-0.34527913177089575,-0.938215539678696,0.5331491712707183,0.7979351121892057,1.0,7/17,23.45%,DLG4;SQSTM1;GNAS;IGSF11;CAMK2A;AKAP5;HOMER3
prerank,kinase activator activity (GO:0019209),-0.29894026645844124,-0.9373758634008704,0.5531914893617021,0.7951694097787424,1.0,9/30,13.72%,TREM2;WNK1;RPTOR;FGF13;STRADA;CDK5R1;NCKAP1L;GPRC5B;RPLP1
prerank,SH2 domain binding (GO:0042169),0.3524964400469865,0.9333998947084774,0.5419630156472262,0.8993003337672489,1.0,8/31,11.17%,LILRB1;JAK2;CRK;CCDC88A;DLC1;AFAP1L2;AFAP1;NLK
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3650977571167752,0.9317542790029805,0.5451851851851852,0.8998246819586,1.0,3/27,4.13%,POLR3F;POLR3A;POLR2C
prerank,gated channel activity (GO:0022836),0.4160096326702472,0.9308289643479475,0.5711920529801324,0.8986402579389486,1.0,7/14,24.26%,TMC8;PIEZO1;TMC6;TMC4;PIEZO2;TMEM63A;PACC1
prerank,adrenergic receptor binding (GO:0031690),-0.35531675081603964,-0.9300413203824983,0.5536159600997507,0.8072989091345001,1.0,9/16,23.62%,MAGI2;DLG4;SAV1;ADRB1;UCHL1;GNAS;APLP1;AKAP5;C1QBP
prerank,voltage-gated potassium channel activity (GO:0005249),0.3060507259507163,0.9294029800472299,0.5905224787363305,0.8986404606728955,1.0,6/80,5.68%,KCNE3;KCNG4;KCNA6;KCNQ1;HCN4;KCNH1
prerank,protein tyrosine kinase binding (GO:1990782),0.31218419247328544,0.9276881203398019,0.5917602996254682,0.8991649213415407,1.0,12/71,13.27%,NEDD9;ITGAX;CRK;BMPR2;CBLB;CBL;ELMO2;PITPNM1;PTPN1;MAP3K7;CASS4;LRP4
prerank,anion channel activity (GO:0005253),0.3173743339954748,0.9275345979641773,0.5815950920245399,0.8963282675792538,1.0,6/61,5.20%,LRRC8C;GABRB2;LRRC8D;CLIC4;GABRR2;LRRC8B
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.32451075259866724,-0.9243740235574739,0.5646067415730337,0.8157698190413762,1.0,3/21,9.50%,P2RX7;P2RX4;CHRNA7
prerank,protein heterodimerization activity (GO:0046982),-0.21146561578399178,-0.9236753395608769,0.7464788732394366,0.8128658608839909,1.0,51/178,21.26%,MEF2C;RALGAPA2;NPAS3;BCL2L1;TENM4;UBA3;IRAK2;TENM2;USF2;ATF3;ATP1B1;RALGAPB;HIF1A;RALGAPA1;ATF4;SAE1;ATP1A2;FXR1;NAE1;QTRT1;PDGFA;ALG2;IRAK1;FXR2;HEXA;MIGA2;TLR4;MTTP;ADD2;P4HB;PRMT5;ADRA1B;BHLHE41;ADRB1;BAX;TENM1;RRAGC;BMP6;PAFAH1B2;SMC1A;ZHX2;RAN;ADCY8;TCF4;VAPB;YWHAH;GCA;TCF3;TCOF1;BCL2L2;PPP2R1A
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.38628874133266594,0.9199597025545774,0.5714285714285714,0.909536773996971,1.0,9/21,21.13%,POLI;POLL;POLD4;CHRAC1;POLB;POLD1;PRIMPOL;POLK;POLQ
prerank,alpha-tubulin binding (GO:0043014),0.35338315633017536,0.9190851650841928,0.5716374269005848,0.9083985740124001,1.0,9/31,16.40%,FYN;RACGAP1;SPAST;SETD2;ARL8B;EML4;EFHC2;INO80;TRIM36
prerank,N-acetyltransferase activity (GO:0008080),0.38622975879705546,0.9185836272095969,0.568659127625202,0.9063628154828897,1.0,4/19,13.96%,ATAT1;SMARCE1;NAT2;KAT2B
prerank,general transcription initiation factor binding (GO:0140296),0.3648601335752272,0.9184960291116803,0.5707620528771384,0.9033896290935921,1.0,6/25,15.44%,TAF13;AHR;THRA;GTF2A1;RELA;TAF1
prerank,estrogen receptor binding (GO:0030331),-0.2866539639322812,-0.9161654849307902,0.6127946127946128,0.8254904270986745,1.0,8/32,14.48%,CTNNB1;MMS19;DCAF1;NCOA6;RERG;PPARGC1B;ESR1;PRMT2
prerank,SUMO binding (GO:0032183),-0.3659938021395277,-0.9161099914246663,0.5912596401028277,0.8209270540456108,1.0,7/13,30.49%,HERC2;SIMC1;HABP4;RNF4;UBA2;CBX4;USP25
prerank,N-acyltransferase activity (GO:0016410),0.3502542338473632,0.9130577235245739,0.5888252148997135,0.9122250260266765,1.0,4/32,12.41%,CERS6;CERS1;SMARCE1;NMT2
prerank,adenyl nucleotide binding (GO:0030554),-0.37915192444867224,-0.9125338281211637,0.5915492957746479,0.8199225838835476,1.0,6/11,22.29%,PFN1;BAG4;BAG1;GRPEL1;HSPH1;BAG5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.37915192444867224,-0.9125338281211637,0.5915492957746479,0.8199225838835476,1.0,6/11,22.29%,PFN1;BAG4;BAG1;GRPEL1;HSPH1;BAG5
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.3829906629317995,-0.9120553915532416,0.5875576036866359,0.8162404730365337,1.0,4/11,11.74%,CFLAR;CASP4;PYCARD;CASP3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.42949704950551104,0.9095656684865554,0.5834829443447038,0.916668770586612,1.0,4/12,15.59%,CCDC88A;VEGFC;PGF;ITGA5
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3761235798452072,0.9092376472138274,0.5775075987841946,0.9142688627495038,1.0,5/21,9.90%,WASF2;KCNQ1;EZR;ARFGEF1;GSKIP
prerank,RNA binding (GO:0003723),0.2628451782435301,0.9085136590557517,0.863,0.9126200350337859,1.0,275/1321,16.83%,TENT5A;MBNL1;AHNAK;DNA2;ZC3H12D;ZC3HAV1;SAMHD1;CDK13;RPL5;PTBP3;OAS2;ANXA2;LONP1;MSN;DHX40;FASTKD1;MEX3D;STAT3;VIM;SEPSECS;VIRMA;HSPA1A;TCF20;DHX58;NOA1;IFIT2;RBPMS;EIF4G3;ANKRD17;RCC2;SND1;CORO1A;CTNNA1;NOL6;GTF2E2;RPS10;CRNKL1;RBM27;EIF2AK2;SLPI;FARS2;MYH9;XPO5;STAU1;MBNL3;SUMO1;ZMAT3;LRRFIP1;SNRPD2;RPL37A;PRPF6;DGCR8;RPL6;DIAPH1;S100A4;NUFIP1;RC3H1;EXD1;FLNB;RBMS1;IFIH1;RPS18;HEXIM1;DDX42;HELZ2;PRKRIP1;XRN2;TEP1;UBE2N;SNRPB;DARS2;DBR1;POLR1G;CAST;DEK;KMT2C;HLTF;CDC5L;CLUH;DHX37;GRB2;SETX;LGALS1;PNLDC1;RPS14;FNDC3A;RBM34;FLNA;SRSF10;RPL35A;SAMSN1;BUD13;OASL;PKN2;GIGYF2;NUP98;PURB;DDX41;FNDC3B;HTATSF1;DCP2;MECP2;PUM2;TRIM25;ARF1;RBMS2;FIP1L1;IMMT;RPL22L1;YTHDF3;TUT1;DNAJC21;SAP18;ZBED4;NHP2;EZR;UTP6;RBM10;KHNYN;LSM5;MAGOHB;DDX46;MRPL13;RPL13;TLR3;RPF2;ZFP36L2;ERI1;PRPF3;ASCC3;ACAA2;SF3B6;SEC63;SCAF8;ETF1;NSA2;RBM22;RP9;WRAP53;DDX49;SRSF4;NAA15;DHX34;DHX8;MDH2;RPS3;RTN4;IGF2BP3;NOC4L;RPS21;CELF2;PIN4;SUMO2;ALG13;YTHDC1;PTPN1;FDPS;NUDT21;SPEN;RBM15;YWHAZ;MTPAP;DCP1A;CACTIN;SRRT;SRP72;PRPF38B;SCAF4;FRG1;TUT7;NOL11;EIF4A2;NAP1L1;MAK16;SRP19;MEX3C;DYNC1H1;SLC25A5;ZCCHC7;RPL34;RPLP0;BAZ2A;UTP20;SMG1;PTCD3;NMD3;TFAM;DDX23;SNRPA1;AGFG1;SF3A1;OTUD4;RPL19;LRRC59;LGALS3;MAP3K20;RPL11;EIF4ENIF1;NSRP1;HSPA9;HNRNPLL;IREB2;RPL30;NOP58;METTL3;RRP36;RNASEH1;API5;KTN1;TNRC6B;RBM38;IFIT1;PNPT1;NUFIP2;GPATCH4;SECISBP2;RPS2;TNRC6A;RPL4;RPL7;LARP4B;VCP;CANX;SYNCRIP;AQR;UTP18;TRMT10C;ZCCHC9;SLTM;MRTO4;EIF3E;DDX10;U2SURP;TENT4B;MAZ;FAM133B;ASS1;DRG2;RRP8;RPS15A;CPSF3;WBP11;SLC16A3;NCBP1;TBL3;PHF5A;ENDOV;LRRC47;CELF1;SIDT2;TCP1;RBM39;PTBP2;RPS4X;TFB1M;TPD52L2;PPHLN1;PABPC1;PUM1;TNPO1;KPNB1;TUBA1B;NPM3;PARP12;KPNA2;SMG6;PUS1;MRPS27;PPIB;NCOA5;EIF1AX;EIF1;ACIN1;SYF2;LLPH
prerank,DNA polymerase activity (GO:0034061),0.37919663611404053,0.9040975492213009,0.5927051671732523,0.9189811185450395,1.0,9/22,21.13%,POLI;POLL;POLD4;CHRAC1;POLB;POLD1;PRIMPOL;POLK;POLQ
prerank,fibroblast growth factor binding (GO:0017134),0.37373717813614904,0.9035899287594772,0.5752351097178683,0.9169642639960802,1.0,9/21,20.76%,KL;API5;RPS2;FGFR3;THBS1;GLG1;FGFR1;GPC1;ITGAV
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.3491052604783137,-0.9013541636231183,0.6130653266331658,0.835184230622375,1.0,7/14,42.25%,DTYMK;AK1;CMPK2;AK4;NME2;AK9;NME4
prerank,RNA polymerase II complex binding (GO:0000993),0.3383938154973617,0.9011609133482487,0.5828488372093024,0.9191735520494535,1.0,7/32,11.18%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,ATPase binding (GO:0051117),-0.2366627622287258,-0.9008674269405491,0.7107843137254902,0.8316559397011638,1.0,20/71,15.87%,ABCA1;TCIRG1;ATP1B3;PKD2;ATP1B1;ANK2;PGR;TRPC1;SNTA1;RALA;ATP6V0A1;DERL1;NR1H2;ESR1;SRC;PIH1D1;PTPN3;AR;CLPP;SNU13
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.35239370968563566,-0.9007583594561275,0.6122448979591837,0.827368679430535,1.0,2/14,8.63%,AKR1A1;DHRS3
prerank,R-SMAD binding (GO:0070412),-0.32325015877438196,-0.8980034897067262,0.5962566844919787,0.8291640846525078,1.0,4/18,11.91%,LDLRAD4;DDX5;SMAD3;TRIM33
prerank,ankyrin binding (GO:0030506),0.38628736612056286,0.8953692957115892,0.6133122028526149,0.9281265962880981,1.0,1/19,0.30%,PTPRC
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.368528239395598,0.8904847291501239,0.5834633385335414,0.9350147997942991,1.0,5/20,17.41%,SLC30A4;SLC30A1;SLC39A11;SLC39A13;SLC39A12
prerank,diacylglycerol kinase activity (GO:0004143),0.4195857525251389,0.8819766171667531,0.6327868852459017,0.949369226936601,1.0,1/11,1.04%,DGKG
prerank,RNA polymerase core enzyme binding (GO:0043175),0.333382369075915,0.8813840835415456,0.6280752532561505,0.9473350352813481,1.0,7/33,11.18%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,methylated histone binding (GO:0035064),0.30809419144566563,0.8810490729517338,0.6412903225806451,0.9448986037800103,1.0,24/62,21.83%,KDM7A;MBTD1;PHF19;MSH6;ING3;ING2;TAF7;MSL3;ATRX;MORC3;L3MBTL2;CDYL;KMT2E;RRP8;TAF1;BPTF;LRWD1;PHF13;CBX8;WDR5;TTLL12;RBBP5;GLYR1;KDM5A
prerank,cytokine activity (GO:0005125),0.27682395804142135,0.8793440315693939,0.673055242390079,0.9453573224616509,1.0,8/131,8.62%,IL1B;CXCL10;GDF1;IL33;CKLF;CXCL16;BMP3;IL6
prerank,O-acyltransferase activity (GO:0008374),-0.27943846274606626,-0.8783955876345433,0.6901408450704225,0.8677470865082922,1.0,5/30,9.67%,LPCAT2;PLA2G15;LPCAT1;PLA2G4A;GPAM
prerank,neurexin family protein binding (GO:0042043),-0.3605391106995713,-0.878151937361995,0.6187214611872146,0.8635998885483421,1.0,4/10,23.23%,NLGN1;NLGN2;NLGN3;CPE
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.43032685388580905,0.8774437754663594,0.6082474226804123,0.9460226561557379,1.0,2/10,11.67%,DPEP1;CAD
prerank,deubiquitinase activity (GO:0101005),0.28718947579843834,0.874255817146202,0.6755126658624849,0.9495497940735671,1.0,26/88,18.07%,MINDY3;USP3;EIF3F;OTUD1;USP49;USP45;JOSD1;ATXN3;USP32;USP48;USP31;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47;EIF3H;USP14;USP38
prerank,lipid phosphatase activity (GO:0042577),-0.34265216726739156,-0.8730512424378069,0.6220472440944882,0.8696509071425932,1.0,5/14,19.90%,PLPP3;PLPP1;PLPPR1;PLPP7;PLPPR4
prerank,endopeptidase regulator activity (GO:0061135),0.31550836732331644,0.871781162937842,0.6497948016415869,0.9513564528126036,1.0,5/40,10.12%,PSME3;SLPI;PSME2;CAST;NLRC4
prerank,"DNA binding, bending (GO:0008301)",-0.34477827643004155,-0.8717574698351127,0.6183574879227053,0.8679985114945696,1.0,7/14,33.92%,HMGB1;HMGB2;TERF1;HMGA2;HHEX;LEF1;HMGB3
prerank,poly(A) binding (GO:0008143),-0.30683167183546256,-0.87099043741975,0.6609195402298851,0.8648904182203699,1.0,8/21,18.25%,RBMS3;ZC3H14;HNRNPDL;TIA1;ELAVL4;KHDRBS2;PPIE;DDX3X
prerank,chemoattractant activity (GO:0042056),0.3444325366331158,0.8702208085917533,0.6421207658321061,0.9513573089408881,1.0,6/26,12.84%,CXCL10;GDNF;VEGFC;HGF;PGF;LGALS3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.252113288691699,-0.868233994986765,0.7066115702479339,0.8660521100383644,1.0,9/48,13.66%,TRPV2;TRPM3;ATP6V1B2;PKD2;UNC80;TRPC1;MCOLN1;TRPM2;TRPV4
prerank,endopeptidase inhibitor activity (GO:0004866),0.29016033082580545,0.8681614999256706,0.7008652657601978,0.9523988975804863,1.0,10/82,12.09%,NGF;ANXA2;BIRC6;SLPI;CAST;PRNP;SERPINB9;CARD16;UBE2Z;APP
prerank,protein kinase activator activity (GO:0030295),0.29452984908739693,0.8679380326558613,0.6447876447876448,0.9497860523313502,1.0,7/60,7.56%,IQGAP1;PRKAG2;GPRC5C;ABI1;STK4;PAK2;AFAP1L2
prerank,cation transmembrane transporter activity (GO:0008324),-0.2503255134229444,-0.8674706531981634,0.7137254901960784,0.8631104177970699,1.0,9/48,12.68%,SLC38A6;MFSD12;SLC7A1;SLC36A4;SLC36A1;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.34820420099033456,-0.8658058157138397,0.6370558375634517,0.8619829618034941,1.0,5/12,26.10%,SLC25A25;LRRC8A;SLC17A9;SLC35B2;SLC25A42
prerank,metalloendopeptidase activity (GO:0004222),-0.22261522104883671,-0.8652611999786775,0.7845303867403315,0.8584648840206186,1.0,17/76,18.62%,ADAM33;MMP16;MMP14;AFG3L2;IDE;ADAMTSL1;ADAMTS16;SPG7;ADAMTSL4;ZMPSTE24;MBTPS2;ADAMTS5;NLN;SPRTN;NRDC;ADAMTS2;ADAMTS1
prerank,Hsp70 protein binding (GO:0030544),0.33032368448235033,0.8651306513019796,0.6131805157593123,0.9524367786989104,1.0,7/31,10.81%,ERN1;RNF207;SPN;DNAJC8;RPS3;HIKESHI;DNAJB12
prerank,telomeric DNA binding (GO:0042162),-0.267974178492986,-0.8624824133291624,0.7191780821917808,0.8596936595267346,1.0,10/32,19.07%,CTC1;BLM;UPF1;TERF2IP;XRCC5;TEN1;SMG7;TERF1;ZBTB48;HNRNPA2B1
prerank,NADPH binding (GO:0070402),-0.32940066218530045,-0.8612331128806471,0.6384615384615384,0.8575937931767457,1.0,3/13,13.10%,QDPR;DUS2;CBR4
prerank,AMP binding (GO:0016208),0.4093106984964448,0.8608569548216376,0.6649029982363316,0.9579573463554625,1.0,4/11,19.94%,PRKAG2;PRKAG1;PYGL;ACSS2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.284405636032355,0.8601797509671567,0.6913730255164034,0.956309052360996,1.0,22/83,16.04%,MINDY3;USP3;OTUD1;USP49;USP45;JOSD1;ATXN3;USP32;USP48;USP31;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47
prerank,death receptor activity (GO:0005035),0.40618402570882245,0.859725072046323,0.6328671328671329,0.9541456816660033,1.0,3/11,15.21%,NGFR;TNFRSF1B;TNFRSF4
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.22807189393944322,-0.8577519443725311,0.7342995169082126,0.860418098510882,1.0,3/70,2.75%,HEXB;LARGE1;B3GALNT1
prerank,pre-mRNA binding (GO:0036002),0.3352281102412631,0.8568021189324526,0.6481751824817519,0.9568726342191777,1.0,9/28,22.54%,RNPC3;ERI1;RBM22;SLU7;CELF2;CELF1;RBM41;SLBP;TARBP2
prerank,receptor tyrosine kinase binding (GO:0030971),0.29727352390192685,0.8563368648474934,0.6743589743589744,0.9547243055755776,1.0,12/56,17.09%,STAP1;ITGAX;CBLB;CBL;ELMO2;PITPNM1;PTPN1;MAP3K7;LRP4;FRS2;RNF41;PIK3R2
prerank,methylation-dependent protein binding (GO:0140034),0.30247158175498545,0.8553167384927731,0.6696891191709845,0.9535978639157279,1.0,21/57,21.83%,KDM7A;MBTD1;PHF19;MSH6;ING3;ING2;MSL3;ATRX;MORC3;L3MBTL2;CDYL;KMT2E;RRP8;BPTF;LRWD1;PHF13;CBX8;WDR5;RBBP5;GLYR1;KDM5A
prerank,myosin binding (GO:0017022),0.29312438846474165,0.8518578243798421,0.6815286624203821,0.957323587361047,1.0,17/55,22.76%,LMTK2;RAB3D;CORO1A;SPATA6;RAB6A;RHOA;ARFGEF1;USH2A;TRIOBP;SHROOM1;RAB10;RAB3B;TRAK1;LLGL2;TRAK2;RAB8A;RAB11B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3442378308881737,0.851168366185768,0.6578947368421053,0.9495611512871504,1.0,3/22,9.66%,HTR1D;HTR4;HRH1
prerank,serotonin receptor activity (GO:0099589),0.3442378308881737,0.851168366185768,0.6578947368421053,0.9495611512871504,1.0,3/22,9.66%,HTR1D;HTR4;HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3442378308881737,0.851168366185768,0.6578947368421053,0.9495611512871504,1.0,3/22,9.66%,HTR1D;HTR4;HRH1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.40957439528323425,0.849022124031341,0.6793103448275862,0.9507051556802902,1.0,1/10,0.77%,CD47
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.40959423273348383,0.8483506625270436,0.657243816254417,0.9490483462455305,1.0,3/10,12.76%,ATXN3;CYLD;OTUD4
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.3817780141869413,0.8467201965359017,0.6366782006920415,0.949121116594076,1.0,4/13,15.59%,ERN1;PDGFD;PTPRJ;ITGA5
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.40879646330781494,0.8465485121935984,0.6597582037996546,0.9464846232839407,1.0,3/10,10.49%,SETDB2;SETD5;ASH1L
prerank,phospholipase A2 activity (GO:0004623),-0.2768481142388722,-0.8451410181860651,0.7160493827160493,0.8808664702994599,1.0,4/26,10.36%,PLA2G15;PNPLA8;PLA2G4A;ABHD3
prerank,potassium:proton antiporter activity (GO:0015386),0.40864211788652643,0.8418814963203727,0.6619469026548672,0.9522085642487345,1.0,1/10,2.03%,SLC9A7
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.31700015128178993,0.8416193715233014,0.6720351390922401,0.9497275668312617,1.0,7/33,11.18%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,GABA receptor binding (GO:0050811),-0.35073050334250105,-0.8387647488477057,0.6701030927835051,0.8888446979608213,1.0,5/11,22.31%,JAKMIP1;ARFGEF2;LHFPL4;GABARAP;AKAP5
prerank,phospholipase binding (GO:0043274),0.390190519795406,0.8384662896875593,0.6814449917898193,0.9527806520059202,1.0,4/13,7.27%,FYN;SYK;PDPK1;PAFAH1B1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.37300177545649915,0.8383864041013316,0.6601941747572816,0.9499710644218786,1.0,1/14,1.01%,NGF
prerank,protein phosphatase 2A binding (GO:0051721),-0.29262004546698756,-0.8353334299534234,0.71900826446281,0.8909832864729772,1.0,8/23,22.59%,CTTNBP2NL;ENSA;MFHAS1;DAB2IP;SMG7;ADCY8;IGBP1;BOD1
prerank,mRNA 3'-UTR binding (GO:0003730),0.2800930357184036,0.8351836276115768,0.7375455650060754,0.9530162913160365,1.0,20/79,17.96%,RPL5;MEX3D;RNF20;RC3H1;RBMS1;PUM2;RBMS2;TUT1;ZFP36L2;IGF2BP3;CELF2;NUDT21;SECISBP2;LARP4B;CELF1;PABPC1;PUM1;BOLL;YBX3;AUH
prerank,channel activity (GO:0015267),0.2968888440599379,0.8350035601755313,0.6899441340782123,0.9504219132200687,1.0,2/41,2.86%,SLC14A1;MCUB
prerank,sequence-specific mRNA binding (GO:1990825),-0.35290482610413554,-0.8348791414662793,0.6896551724137931,0.8872187397468441,1.0,3/10,14.03%,SHFL;SSB;DHX9
prerank,kinase inhibitor activity (GO:0019210),0.32119707293515837,0.8338974119933742,0.6883852691218131,0.9495954388145846,1.0,8/33,13.93%,GMFG;TAOK3;HEXIM1;PRKRIP1;MBIP;GSKIP;SH3BP5;DNAJC3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4027662979159278,0.831257885286518,0.6605839416058394,0.9517578905004412,1.0,4/10,19.99%,FEN1;EXD2;POLD1;APEX1
prerank,omega peptidase activity (GO:0008242),0.27169119424790567,0.8310893118002426,0.7523696682464455,0.94921652315399,1.0,22/89,16.04%,MINDY3;USP3;OTUD1;USP49;USP45;JOSD1;ATXN3;USP32;USP48;USP31;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.32361648713553826,-0.8310456132272712,0.6804123711340206,0.89009235395189,1.0,7/14,27.66%,SLC26A11;SLC25A11;SLC25A14;SLC26A2;SLC26A8;SLC26A6;SLC25A10
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.35779094122256805,-0.8305630826535998,0.6771084337349398,0.8865141645723273,1.0,2/10,2.73%,NAA50;NAA40
prerank,phosphatase inhibitor activity (GO:0019212),0.3534656855709079,0.8293328707093746,0.6816,0.9494713914401005,1.0,4/20,12.84%,LMTK2;PPP1R9B;PPP1R2;LGALS3
prerank,phosphatidic acid binding (GO:0070300),0.34612525559960483,0.8276348484168338,0.6782477341389728,0.9496197287019695,1.0,5/19,14.35%,RAPGEF2;SESTD1;PITPNM1;PACSIN2;MAPKAP1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.29144482814707606,-0.8238835930276421,0.7205128205128205,0.8939683916845292,1.0,2/19,5.46%,PRKN;DERL2
prerank,ribosomal small subunit binding (GO:0043024),-0.3031756108117603,-0.8202548621051642,0.7096774193548387,0.8963316574407936,1.0,6/17,18.25%,LARP1;CPEB2;DHX29;NPM1;EIF4H;DDX3X
prerank,glutathione transferase activity (GO:0004364),-0.28309585168733853,-0.8177956961975743,0.7259475218658892,0.8962081396132336,1.0,2/23,5.81%,HPGDS;LTC4S
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3279086608685834,0.817567675167051,0.701062215477997,0.9649381468630932,1.0,4/24,9.01%,ZDHHC7;ZDHHC6;ZDHHC23;ZDHHC17
prerank,miRNA binding (GO:0035198),0.31633770857541643,0.8159773670301456,0.7101024890190337,0.9648504285993836,1.0,7/30,16.02%,RC3H1;PUM2;RBM10;TRIM71;TUT7;PNPT1;PUM1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.31240398567296646,0.8140308524666195,0.7285921625544267,0.9653566715720854,1.0,5/31,11.21%,KCNK7;SLC12A7;TMEM38B;SLC12A6;SLC12A9
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.32698164019696274,-0.8133274351459331,0.7279236276849642,0.8999484536082475,1.0,3/12,10.54%,BLNK;IRS1;PIK3R1
prerank,ferrous iron binding (GO:0008198),0.3389999524060714,0.8131082154990479,0.7245696400625978,0.9640736590169466,1.0,3/21,4.94%,TET2;HEPH;HAAO
prerank,potassium ion antiporter activity (GO:0022821),-0.3044268299508205,-0.8119261449675701,0.7091836734693877,0.8979544089680713,1.0,3/15,7.09%,SLC24A3;SLC9A9;SLC9A6
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.36330091144592436,0.8095109973965411,0.6978653530377669,0.9676462691063407,1.0,3/14,11.49%,SLC25A13;SLC25A12;SLC25A18
prerank,NADP binding (GO:0050661),-0.2475980480341036,-0.8094589672344746,0.7792207792207793,0.897851818649667,1.0,7/32,17.07%,ME3;QDPR;DPYD;DUS2;CBR4;PGD;NNT
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3021106290671268,0.8086639943208244,0.7296918767507002,0.966313894845016,1.0,9/34,20.84%,IQGAP1;STK4;CCNT2;CCNT1;CDK5R2;STK3;MAP2K1;CAB39L;RICTOR
prerank,mRNA binding (GO:0003729),0.24202949274614066,0.807882726807024,0.8618899273104881,0.9648337105998539,1.0,66/249,20.52%,ZAR1;ZC3H12D;RPL5;PTBP3;RBPMS;EIF4G3;SLPI;XPO5;RNF20;RC3H1;RBMS1;CLUH;RPS14;NUP98;PURB;PUM2;RBMS2;YTHDF3;TUT1;KHNYN;MRPL13;SF3B6;SCAF8;ETF1;SRSF4;RPS3;IGF2BP3;CELF2;YTHDC1;NUDT21;RBM15;DCP1A;EIF4ENIF1;NSRP1;HNRNPLL;IREB2;METTL3;SECISBP2;RPS2;RPL7;LARP4B;SYNCRIP;AQR;MARF1;NCBP1;CELF1;PTBP2;PABPC1;PUM1;BOLL;DDX6;NYNRIN;YBX3;AUH;SHMT1;CSTF3;PUM3;SF3B1;RPS13;UPF3B;N4BP1;PARK7;HNRNPC;LUC7L3;EDC3;LUC7L
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.295970274897259,0.8061375355718113,0.739972337482711,0.9649723147781512,1.0,7/38,12.71%,PLEKHF1;DENND1A;SESTD1;SNX20;HIP1;WIPI2;SNX3
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3017155167605379,-0.8054478024373676,0.7351351351351352,0.9004564003436426,1.0,5/16,14.59%,SLC25A26;SLC22A5;SLC7A8;SLC5A7;SLC22A4
prerank,sodium:proton antiporter activity (GO:0015385),0.3855429471392449,0.8044274107657479,0.7057793345008757,0.9651073452403357,1.0,1/11,2.03%,SLC9A7
prerank,acetyltransferase activity (GO:0016407),0.31091609796094855,0.8030322868972894,0.7308823529411764,0.9645748518570183,1.0,7/31,15.26%,NAA16;KAT6A;NAA15;SMARCE1;ACAT1;KAT2B;CREBBP
prerank,leak channel activity (GO:0022840),-0.2844329225777809,-0.8025999980767408,0.7435158501440923,0.9011123168746609,1.0,7/18,28.37%,KCNK13;KCNK6;KCNK2;PANX1;KCNK1;KCNK9;KCNK12
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3028022004141544,0.8020426468796074,0.7340720221606648,0.9634136212624586,1.0,5/35,5.58%,PLD4;SMPDL3B;APEX2;SMPDL3A;GPCPD1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.30523832147015845,0.7992437350948627,0.7535612535612536,0.9652447826827265,1.0,7/33,11.52%,ANKIB1;ARIH1;DCUN1D1;RNF217;ARIH2;RPS3;DCUN1D3
prerank,myosin II binding (GO:0045159),0.3774308104704278,0.7975656456820615,0.7092819614711033,0.965350152407067,1.0,4/10,21.09%,MYL4;TRIOBP;SHROOM1;LLGL2
prerank,Notch binding (GO:0005112),0.3226729959619778,0.795644332262484,0.7405159332321699,0.9657653767472991,1.0,3/22,11.97%,CUL3;ADAM17;MEGF10
prerank,cAMP binding (GO:0030552),0.37287803714903683,0.795134719880839,0.7093023255813954,0.9638157083555957,1.0,2/11,7.49%,RAPGEF2;PDE2A
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.25583024447973307,-0.7948265078600059,0.8135593220338984,0.9093618065783015,1.0,13/29,31.08%,GALC;NEU1;GAA;ABHD10;HEXD;GANAB;GLA;GBA2;ACER2;ENGASE;MOGS;OVGP1;PGGHG
prerank,outward rectifier potassium channel activity (GO:0015271),-0.33433165747733384,-0.7941732811716634,0.6905940594059405,0.905967736681813,1.0,6/11,29.18%,KCND2;PKD2;KCNT2;KCNK2;KCND1;KCNT1
prerank,RNA polymerase binding (GO:0070063),0.3343557770705078,0.7925582402331183,0.7397476340694006,0.9653214628451215,1.0,6/18,12.14%,PKN2;SCAF8;STOM;CCNT2;PHRF1;CCNT1
prerank,nuclear localization sequence binding (GO:0008139),0.34092405672039705,0.7923056827850112,0.7465224111282844,0.9629387025370337,1.0,6/18,16.30%,NFKBIA;KPNA4;NUP153;TNPO1;KPNB1;KPNA2
prerank,syntaxin binding (GO:0019905),0.2673034310255061,0.788603676936029,0.7917205692108668,0.9662153037004049,1.0,7/61,10.04%,LRRK2;DAPK1;CACNA1A;STX6;TMED10;SYP;STX7
prerank,chloride transmembrane transporter activity (GO:0015108),-0.2943315117211134,-0.7884342870141504,0.7889182058047494,0.9115087855799779,1.0,6/16,26.63%,CLCN6;CLCN7;SLC26A2;SLC1A1;SLC26A8;SLC26A6
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2646652830471018,0.7882374438789604,0.815914489311164,0.9641120091172236,1.0,14/74,16.97%,DGKG;NADK;PIK3C2A;PANK1;PANK4;PAPSS1;PAPSS2;PIK3CA;PGM2L1;NT5C3A;GNE;IPMK;MVK;GK
prerank,gap junction channel activity (GO:0005243),0.3193181872704073,0.78741470948796,0.7262658227848101,0.9627809165581773,1.0,1/22,2.90%,GJA5
prerank,gamma-tubulin binding (GO:0043015),0.33312554315268494,0.78660780717005,0.7449768160741885,0.9613292083565412,1.0,2/21,2.18%,PAK1;RACGAP1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2623038693688816,0.7861740011503046,0.8027812895069533,0.959385226735862,1.0,12/75,13.12%,ME2;HIBADH;HSD17B7;MDH2;LDHD;DHRS4;BDH1;NSDHL;ABCC4;DHRS9;HSD17B11;RDH5
prerank,nuclear import signal receptor activity (GO:0061608),0.34263511443335487,0.785901688110943,0.7210031347962382,0.9571442441797063,1.0,5/15,16.30%,KPNA4;HIKESHI;TNPO1;KPNB1;KPNA2
prerank,antiporter activity (GO:0015297),0.33090223682958225,0.7853447027781721,0.7339593114241002,0.9553234643082501,1.0,2/20,5.59%,SLC25A16;SLC25A30
prerank,manganese ion binding (GO:0030145),0.2777037101157403,0.7845321144903143,0.7764390896921017,0.9539325642296391,1.0,12/48,17.10%,PIM1;FEN1;IMPA1;WRN;GALNT2;ARG2;MTPAP;EXD2;XXYLT1;PAPOLA;DYRK2;ABL2
prerank,glucuronosyltransferase activity (GO:0015020),0.3369040905162754,0.7845223428031096,0.7577639751552795,0.9512885320528722,1.0,1/19,0.85%,EXT1
prerank,hormone receptor binding (GO:0051427),0.34977417564964364,0.782104619599555,0.7363344051446945,0.9525625744934445,1.0,1/14,2.34%,JAK2
prerank,peptide hormone receptor binding (GO:0051428),0.36532546607243743,0.7819082579093858,0.7186963979416809,0.9502511139526251,1.0,11/11,63.49%,ADCYAP1;GPHA2;UCN3;GPHB5;UCN2;PSMC5;GHRH;VIP;GNRH1;PTHLH;CCK
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.33118122569120423,-0.781455112964685,0.7469287469287469,0.9183138925189164,1.0,2/11,2.73%,NAA50;NAA40
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.29034926250130744,0.7812921094928835,0.7608391608391608,0.9485189033436091,1.0,3/38,6.79%,ANXA2;SLPI;SERPINB9
prerank,lysine-acetylated histone binding (GO:0070577),0.33024397691961543,0.7795532555677679,0.7341772151898734,0.9459787105453716,1.0,8/20,20.89%,PSME4;BAZ2A;KMT2A;TAF1;BRD7;BRD2;BRD4;PHIP
prerank,acetylation-dependent protein binding (GO:0140033),0.33024397691961543,0.7795532555677679,0.7341772151898734,0.9459787105453716,1.0,8/20,20.89%,PSME4;BAZ2A;KMT2A;TAF1;BRD7;BRD2;BRD4;PHIP
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.37703991965854877,0.7794308508944804,0.7340241796200345,0.9435708104653522,1.0,10/10,62.32%,SLC6A11;SLC6A1;SLC10A5;SLC10A4;SLC10A2;SLC6A13;SLC6A12;SLC10A3;SLC10A6;SLC10A1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.31356876390559785,-0.7786007580111227,0.7602040816326531,0.9184378713427755,1.0,1/12,1.08%,LARP1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3662153376844128,0.7781922186464735,0.7408695652173913,0.9428362777143526,1.0,2/12,11.09%,SLC9A7;LETM1
prerank,metalloaminopeptidase activity (GO:0070006),0.33437055651337133,0.778161474126282,0.7471451876019576,0.9402955658625279,1.0,3/16,11.34%,LNPEP;RNPEPL1;RNPEP
prerank,iron ion binding (GO:0005506),0.2782056710423972,0.7771229679271345,0.7676508344030809,0.9392195493007796,1.0,5/48,4.94%,TET2;KDM7A;ETHE1;HEPH;HAAO
prerank,potassium ion leak channel activity (GO:0022841),-0.2932525008058514,-0.7748744682581363,0.7932011331444759,0.919708702948933,1.0,6/15,28.37%,KCNK13;KCNK6;KCNK2;KCNK1;KCNK9;KCNK12
prerank,wide pore channel activity (GO:0022829),0.30930383175421694,0.7725885964471098,0.7570093457943925,0.9435043792801286,1.0,1/23,2.90%,GJA5
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.36170506585857876,0.7715664965139389,0.7715289982425307,0.942555763664226,1.0,2/12,7.20%,KDM7A;KDM3B
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.297403706464347,-0.770714528613804,0.7706666666666667,0.9217485204276441,1.0,6/15,44.93%,PLA2G4A;PLA2G3;PLA2G4C;PLA2G5;PLA2G4F;PLA2G2D
prerank,myosin V binding (GO:0031489),0.3425662719177437,0.7695836139562777,0.7722772277227723,0.9428425482231033,1.0,2/15,6.12%,RAB3D;RAB6A
prerank,snRNA binding (GO:0017069),0.2809873734665956,0.7689206443754008,0.7751004016064257,0.9413038343869978,1.0,8/42,12.45%,RNPC3;HEXIM1;TUT1;COIL;RBM22;CCNT2;CCNT1;SNRPA1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3341215670627352,-0.767854674098938,0.7561576354679803,0.9215873279807434,1.0,4/10,11.67%,KDM2A;KDM2B;KDM4A;PHF8
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3751481013416653,0.7668710946140965,0.7631133671742809,0.9418204543078723,1.0,2/10,9.24%,NAA16;NAA15
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.30095194621608007,0.7662262842555592,0.7812041116005873,0.9402497470978858,1.0,6/27,11.52%,ANKIB1;ARIH1;DCUN1D1;RNF217;ARIH2;DCUN1D3
prerank,copper ion binding (GO:0005507),0.275808032685208,0.7660362818905586,0.7894736842105263,0.9380044951472841,1.0,7/42,14.33%,HEPH;PRNP;ATP7A;ATOX1;SUMF1;COX17;CUTC
prerank,metallopeptidase activity (GO:0008237),0.24515079539116974,0.765896943777698,0.8689492325855962,0.9357133800189109,1.0,19/113,18.02%,ACE;ADAM21;LNPEP;ACE2;MMP1;DPEP1;ADAM17;ADAMTS6;ADAM11;ADAM19;RNPEP;THSD4;ADAMTS12;ADAM9;MIPEP;ADAMTS19;EIF3H;ANPEP;MMP8
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.2663799786762995,-0.7636478265162627,0.7943661971830986,0.9234358743970491,1.0,8/20,23.98%,LPCAT2;PLA2G15;LPCAT1;GPAT4;LPGAT1;AGPAT3;AGPAT2;DGAT1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.3355645369808308,0.7601375676710126,0.7877758913412564,0.9414406213571886,1.0,4/14,18.89%,ATP2A3;APAF1;MAL;BAD
prerank,LRR domain binding (GO:0030275),-0.29188099644490867,-0.7588867928590687,0.7846153846153846,0.9257418129893769,1.0,5/14,22.04%,ROBO1;ATF4;ERC1;PMF1;POLR2J
prerank,signal sequence binding (GO:0005048),0.28691565052836365,0.7561392191655287,0.7991689750692521,0.9443825523852768,1.0,9/35,16.30%,NFKBIA;KPNA4;AP2B1;KDELR1;NUP153;PEX5L;TNPO1;KPNB1;KPNA2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.3571631530041278,0.7543169212574976,0.7486818980667839,0.9443567607588413,1.0,2/10,10.37%,LAPTM5;DAXX
prerank,alkali metal ion binding (GO:0031420),0.34619215979944223,0.7538269038332157,0.7689655172413793,0.9425679290598368,1.0,3/13,11.96%,IMPA1;TDG;ACAT1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.32996053890730986,0.75149463142516,0.7620528771384136,0.9434424317341739,1.0,7/15,21.35%,KMT2C;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,metal ion:proton antiporter activity (GO:0051139),-0.2978822410146032,-0.7505709812244074,0.7819905213270142,0.9325246016869728,1.0,3/13,7.09%,SLC11A1;SLC9A9;SLC9A6
prerank,mannose binding (GO:0005537),0.3490190017807384,0.7480250151212572,0.7668393782383419,0.9457595456356759,1.0,2/12,10.22%,LMAN2L;MBL2
prerank,fatty acid synthase activity (GO:0004312),0.35315120822608387,0.7477204020445835,0.7658862876254181,0.9437392608294185,1.0,2/10,8.29%,ELOVL5;ELOVL6
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.34678361235480293,0.7462075593669409,0.7722602739726028,0.9434349326366422,1.0,2/11,9.96%,APEX2;RPS3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.2936917572432953,0.7460985708878771,0.8129713423831071,0.941139089073705,1.0,5/26,13.14%,LMTK2;PPP1R9B;PPP1R2;LGALS3;PABIR1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.362241774114855,0.7459027410695572,0.775438596491228,0.9389653097648059,1.0,5/10,18.66%,RPE;GNE;GALM;GLCE;DSEL
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.32957724662880056,0.7458013874663587,0.7779632721202003,0.9366928804395889,1.0,5/14,23.46%,RSAD1;IREB2;NFU1;ACO1;ETFDH
prerank,translation initiation factor activity (GO:0003743),-0.22765038986605296,-0.743472704756908,0.9102990033222591,0.9382251869820093,1.0,11/36,20.64%,EIF4A1;EIF2S2;EIF3M;EIF5;EIF2B5;EIF2B4;EIF3L;EIF4G1;EIF3K;EIF3B;EIF2D
prerank,neuropeptide hormone activity (GO:0005184),-0.25335370981853855,-0.7416424777026117,0.8706624605678234,0.93640367171295,1.0,16/22,57.38%,PENK;CCK;PNOC;GRP;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;CORT;NPPA;GHRH;CALCB;PPY
prerank,leucine zipper domain binding (GO:0043522),0.36402958847767086,0.7409640559653948,0.7666666666666667,0.9407719627300191,1.0,3/10,16.38%,PAWR;MRTFA;DAPK3
prerank,active ion transmembrane transporter activity (GO:0022853),-0.22814728466674541,-0.7396279575758375,0.9114754098360656,0.9347487402339236,1.0,1/37,0.11%,SLCO2B1
prerank,Hsp90 protein binding (GO:0051879),0.2765783802654407,0.7373244628564769,0.8191933240611962,0.9431198368902699,1.0,5/33,10.42%,ERN1;AHR;CSNK2A1;RPS3;NR3C1
prerank,glycine binding (GO:0016594),-0.31114608078280553,-0.7362087629788401,0.8190255220417634,0.9347938144329897,1.0,2/11,8.20%,GLRA3;GLRA2
prerank,triglyceride lipase activity (GO:0004806),-0.25682264881407857,-0.7354064984153434,0.8463611859838275,0.9317311951126384,1.0,3/20,17.30%,PLA2G15;DDHD2;LIPH
prerank,store-operated calcium channel activity (GO:0015279),0.3524557848454232,0.7335923888372199,0.7737226277372263,0.9454677860875715,1.0,4/10,17.53%,STIM2;ORAI3;ORAI1;TRPC5
prerank,Tat protein binding (GO:0030957),-0.31708109183786093,-0.7329711516800907,0.7981651376146789,0.93063779156403,1.0,3/10,18.23%,SMARCB1;NPM1;TRIM32
prerank,histone deacetylase activity (GO:0004407),0.3063141662188829,0.7321720683801347,0.838006230529595,0.9448986279488735,1.0,8/19,24.12%,HDAC9;HDAC3;MIER1;SIRT1;HDAC1;SIRT3;HDAC5;SIRT2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2803001082579042,0.7288651497041655,0.8298192771084337,0.9468347018698506,1.0,7/30,17.41%,SLC30A4;ATP7A;SLC30A1;SLC39A11;SLC31A1;SLC39A13;SLC39A12
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.31853613303363376,-0.7273913797684848,0.7952380952380952,0.9333374964046203,1.0,3/10,11.74%,CFLAR;CASP4;CASP3
prerank,mRNA 5'-UTR binding (GO:0048027),0.29340725114717925,0.7269024600424533,0.8372781065088757,0.9469791242885349,1.0,6/24,19.18%,RPL5;RPS14;IGF2BP3;SYNCRIP;SHMT1;RPS13
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2755138819043341,-0.7259644780144374,0.8597883597883598,0.9311836830047626,1.0,7/15,25.91%,LPCAT2;LPCAT1;ABHD4;GPAT4;AGPAT3;AGPAT2;ABHD8
prerank,pyridoxal phosphate binding (GO:0030170),-0.25381517567926903,-0.7243956529507847,0.8684931506849315,0.9287950749561068,1.0,12/20,44.76%,PYGB;PSAT1;ACCS;OAT;SHMT2;PNPO;PDXK;CBS;PYGM;THNSL2;CTH;GLDC
prerank,histone acetyltransferase binding (GO:0035035),-0.25573884521421475,-0.724199087565165,0.8544474393530997,0.9249607799193187,1.0,5/21,13.36%,KANSL1L;ECD;HIF1A;GLI3;PCNA
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2520315922490328,0.7209338178694924,0.8673602080624188,0.9521116595691718,1.0,9/57,14.09%,CYB561A3;NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9
prerank,ribosome binding (GO:0043022),0.26227171840889973,0.720419883430938,0.8561643835616438,0.9503830875902812,1.0,13/46,18.75%,NAA16;MAIP1;YTHDF3;ERI1;ETF1;NAA15;SRP72;SRP19;MRPS27;EFL1;NCLN;MTIF3;RPSA
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2750496390076129,0.7195866504826707,0.8390313390313391,0.9466283393113943,1.0,9/34,16.21%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2750496390076129,0.7195866504826707,0.8390313390313391,0.9466283393113943,1.0,9/34,16.21%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,snoRNA binding (GO:0030515),0.2718860495260017,0.715712643963621,0.8547008547008547,0.9488775394082621,1.0,6/30,15.49%,NUFIP1;DHX37;NHP2;UTP6;NOP58;TBL3
prerank,methyl-CpG binding (GO:0008327),-0.24280166487095106,-0.7035098034518572,0.9011976047904192,0.9436028175718897,1.0,6/22,13.29%,CXXC5;ZCWPW1;TET1;TET3;ZBTB21;PRMT5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.23889957959989105,0.6973929151999432,0.9114249037227214,0.9678294578605546,1.0,10/54,18.05%,ACER3;UPB1;NAAA;HDAC9;SIRT4;HDAC3;FAAH;MIER1;SIRT1;HDAC1
prerank,death domain binding (GO:0070513),0.3161535559843015,0.6911791174130454,0.8157894736842105,0.9723131278733186,1.0,2/11,10.65%,MCL1;RIPK1
prerank,methyltransferase activity (GO:0008168),-0.20275625873821154,-0.6907643469921838,0.9538461538461539,0.9523984624955564,1.0,16/46,26.25%,COMT;MGMT;NSUN2;COQ3;NSUN3;AS3MT;PRMT5;FTSJ3;SUV39H1;LCMT1;NDUFAF7;COQ5;N6AMT1;BCDIN3D;ASMT;BUD23
prerank,bHLH transcription factor binding (GO:0043425),-0.24717563237749937,-0.6902020005238386,0.9008498583569405,0.9489052844269428,1.0,6/19,20.36%,LMO2;USF2;SMAD3;BHLHE41;SP1;TCF3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.31056512842567957,0.688954592323608,0.8456260720411664,0.9722026026369459,1.0,2/12,10.80%,ATP2A3;APAF1
prerank,mRNA methyltransferase activity (GO:0008174),0.3196771490753713,0.6868737251636085,0.8529411764705882,0.9721513960929221,1.0,5/12,20.57%,CMTR1;METTL3;TRMT10C;TRMT61B;PCIF1
prerank,galactosyltransferase activity (GO:0008378),0.3260567690649492,0.6867898993256172,0.8433931484502447,0.9698375963687971,1.0,3/11,20.32%,B4GALT5;B4GALT3;B4GALT7
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.31343201314606517,0.6863060523996253,0.8177257525083612,0.9679516136101947,1.0,5/12,19.92%,CDK13;CDK12;MAPK1;BRD4;CDK19
prerank,ubiquitin-dependent protein binding (GO:0140036),0.32682560273269035,0.6817409835319005,0.8250460405156538,0.97053628973772,1.0,2/10,9.34%,LAPTM5;USP15
prerank,Wnt-activated receptor activity (GO:0042813),-0.2599926972255522,-0.6816629284569958,0.8854748603351955,0.9529352806414663,1.0,8/15,37.64%,RYK;ROR1;LRP5;FZD4;FZD6;FZD2;TSPAN12;FZD5
prerank,organic anion transmembrane transporter activity (GO:0008514),0.21317842668336923,0.6799439436150143,0.9521094640820981,0.970054432113563,1.0,28/134,19.15%,SLC23A2;SLC23A1;CD36;SLC25A13;SLCO1B1;ABCC1;SLC4A8;SLC15A4;SLC1A5;SLC25A12;SLC1A4;SLC25A18;ABCC4;SLC38A1;SLCO1C1;SLC26A7;SLC35A1;SLC66A1;SLC6A9;SLC35A3;SLCO4C1;SLC52A1;SLCO3A1;SLC25A2;SLC16A7;CTNS;SLC25A1;SLC38A2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.2715046404877378,-0.6781338288551689,0.8787878787878788,0.9522355048621773,1.0,8/13,42.78%,PYCARD;SRC;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,GDP binding (GO:0019003),0.23200369615175076,0.673229277498189,0.9448717948717948,0.9747364673467177,1.0,17/63,22.76%,RAP1A;RAB7A;RALB;DIRAS1;RHEB;GNAI1;ARL8B;RAB29;RAB35;RAB9B;RAB2A;RAB10;RAB3B;RAB21;RAB8A;RAP1B;RAB11B
prerank,regulatory RNA binding (GO:0061980),0.24977082770347192,0.6728356212236241,0.9115168539325843,0.9728175924720305,1.0,7/38,16.02%,RC3H1;PUM2;RBM10;TRIM71;TUT7;PNPT1;PUM1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.29375067249426046,0.6696941448887064,0.8673139158576052,0.9735305406990759,1.0,3/16,10.69%,SMUG1;RPS3;TDG
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2604241158056952,0.6669623399746305,0.9002976190476191,0.9737283268201318,1.0,9/28,20.36%,FEN1;DBR1;RNASEH2A;RNASEH1;ENDOV;PRORP;RPP38;APEX1;EDC3
prerank,U6 snRNA binding (GO:0017070),-0.26189862134259134,-0.6657293000744983,0.8901098901098901,0.9589194187197857,1.0,5/14,25.08%,DDX39B;PRPF4;EIF5A;LSM3;LSM2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.22938258584294524,0.659348738101638,0.9463087248322147,0.9782960747003795,1.0,4/55,6.93%,SLC23A2;SLC23A1;SLC38A10;ABCC1
prerank,BMP receptor binding (GO:0070700),-0.27153148197600074,-0.6563448276018169,0.8976982097186701,0.9627948874099208,1.0,8/12,42.78%,PYCARD;SRC;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.24263115971712934,-0.6557468925161191,0.9234828496042217,0.9593126425828064,1.0,5/18,22.05%,WDR91;PIK3R1;SOCS2;PIK3R3;WDR81
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.24239408935884488,0.655224897394858,0.9266666666666666,0.9796029509736015,1.0,4/37,6.02%,FARS2;VARS1;VARS2;DARS2
prerank,symporter activity (GO:0015293),0.3093773537534521,0.6528413542518777,0.8505338078291815,0.9794207826764166,1.0,10/10,69.08%,SLC28A2;SLC28A3;SLC5A8;SLC4A4;SLC5A12;SLC5A5;SLC28A1;MFSD2A;SLC46A2;SLC5A6
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3065116597987855,0.6518928386341226,0.8540268456375839,0.9778653602706564,1.0,2/11,11.98%,TAF9;MBD2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2698482529293978,0.6447586149951223,0.9035222052067381,0.9816003397208791,1.0,6/20,17.21%,OTULINL;EIF3F;USP7;USP9X;USP47;EIF3H
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.2857215026492481,0.6374719980577578,0.9074675324675324,0.9850265925224954,1.0,2/15,13.59%,SLC4A8;SLC26A7
prerank,metallocarboxypeptidase activity (GO:0004181),0.24844274047385964,0.63521515983909,0.9086826347305389,0.9844025886050908,1.0,1/26,2.21%,ACE2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.26034640678469345,-0.6332475066994261,0.9047619047619048,0.9713597607442235,1.0,1/12,2.75%,B3GALNT1
prerank,phosphate ion binding (GO:0042301),0.3020124005501033,0.6257425209554327,0.8953687821612349,0.9890356036912087,1.0,2/10,15.28%,PDE2A;RELA
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.2763148116736619,0.6170034281001198,0.9138513513513513,0.993055595628553,1.0,2/13,13.62%,IDI1;SREBF2
prerank,NAD binding (GO:0051287),0.24905121528732296,0.6156566418591395,0.9281437125748503,0.9916564301525139,1.0,9/26,24.12%,ZC3HAV1;PARP9;GLUD1;SIRT1;HPGD;SORD;SIRT3;ALDH2;SIRT2
prerank,dynactin binding (GO:0034452),-0.2519070642164971,-0.6146462910185453,0.9238845144356955,0.9789461626575029,1.0,2/12,9.58%,SNX5;SNX6
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.28804050790089636,0.6118403526756075,0.8747795414462081,0.9918015047726361,1.0,3/12,18.15%,NQO2;DHRS4;AIFM2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.20324929340910902,-0.6085180081463841,0.9650793650793651,0.9781327087878399,1.0,14/26,42.30%,B3GALNT1;CHPF2;GBGT1;CHSY1;B3GALT1;B3GNT7;B4GALNT3;EXTL2;B4GALNT4;B3GNT8;CHPF;B3GNT6;CSGALNACT2;B3GALT4
prerank,neuropeptide receptor binding (GO:0071855),0.2714716223003515,0.6084631112291873,0.9158878504672897,0.991775701801884,1.0,14/14,72.88%,AGRP;NMU;QRFP;UCN3;UCN2;APELA;PPY;GHRH;NPPA;GAL;APLN;SHANK1;NPY;NTS
prerank,ATPase activator activity (GO:0001671),0.2517678146536107,0.6082637670466756,0.9392,0.9895539510658826,1.0,6/20,21.28%,DNAJC1;DNAJC19;TOR1AIP1;ATP1B2;DNAJC10;DNAJB4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.2578475384744661,0.607049240364816,0.9310344827586207,0.9879667385766009,1.0,2/18,9.47%,HSD17B12;FAR1
prerank,platelet-derived growth factor binding (GO:0048407),-0.24986651065526808,-0.6019377250552747,0.9268867924528302,0.9774228934139899,1.0,1/11,8.54%,PDGFA
prerank,pseudouridine synthase activity (GO:0009982),0.27425232749364714,0.5983609831626601,0.9303904923599321,0.9909185605112129,1.0,4/13,21.47%,PUS3;PUS1;PUS7L;TRUB2
prerank,semaphorin receptor binding (GO:0030215),-0.20465113849524869,-0.5975287002571146,0.9873817034700315,0.9755928895676892,1.0,13/23,35.96%,SEMA3D;SEMA3E;SEMA6D;RIT2;SEMA7A;SEMA5B;SEMA4C;SEMA4G;PLXNB1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,acid-thiol ligase activity (GO:0016878),0.27424874380284564,0.597445626353396,0.9163822525597269,0.9891470395675603,1.0,3/13,20.16%,AASDH;ACSS2;ACSL1
prerank,RNA methyltransferase activity (GO:0008173),0.248649994381142,0.5941621336300219,0.9363354037267081,0.9887537378811702,1.0,5/19,17.91%,TRDMT1;METTL4;METTL3;TYW3;TRMT13
prerank,receptor antagonist activity (GO:0048019),-0.22416106068119013,-0.593842269029389,0.9534246575342465,0.9733979775787279,1.0,3/17,22.87%,DKK2;DKK3;IL18BP
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2786535808401698,0.5897513461773057,0.9273049645390071,0.9888281514804801,1.0,2/11,14.37%,PRMT8;PRMT3
prerank,frizzled binding (GO:0005109),0.2197639723370422,0.5894174599591833,0.9556786703601108,0.986679589778517,1.0,6/34,18.67%,CCDC88C;DVL3;DVL2;WNT7A;WNT5B;FZD7
prerank,phospholipid transfer activity (GO:0120014),0.23837550762187212,0.5839569928703664,0.9502332814930016,0.9874441571400853,1.0,6/21,19.75%,ABCA3;PITPNB;PITPNM1;PRELID1;PITPNA;PRELID3A
prerank,carboxylic acid binding (GO:0031406),0.21098739844191366,0.5670120023378772,0.972183588317107,0.9934235201952544,1.0,7/38,15.59%,PSAP;UBR2;GLUD1;CAD;CASTOR2;GRIN3A;SRR
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.2488512975511013,0.5636745764645602,0.9604810996563574,0.9925436200503244,1.0,4/15,19.83%,PIK3R6;PIK3R2;PIK3R5;SOCS5
prerank,DNA polymerase binding (GO:0070182),0.23475169251126043,0.5599717406635019,0.9641255605381166,0.9918358330623289,1.0,4/18,16.35%,LONP1;FANCI;POLG2;SMG6
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.2596305929826622,0.5545332656765177,0.9222972972972973,0.991773648211255,1.0,1/11,6.03%,UBR5
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.2528118132793055,0.5540596788483995,0.9286898839137645,0.9896827093008919,1.0,1/13,2.41%,AGPAT4
prerank,5'-nucleotidase activity (GO:0008253),-0.22079287112620788,-0.5535006579467927,0.9730337078651685,0.9853660845781611,1.0,3/13,20.17%,NT5M;NT5DC3;NT5DC1
prerank,amino acid binding (GO:0016597),0.20680401978347213,0.5480802770526515,0.9854227405247813,0.9897839709633731,1.0,7/31,18.37%,CAD;CASTOR2;GRIN3A;ASS1;SRR;DDAH1;SHMT1
prerank,CoA-ligase activity (GO:0016405),0.2512556504269211,0.5478107046848216,0.9546218487394958,0.9876120056060761,1.0,14/14,74.90%,ACSS2;ACSL1;ACSM2A;ACSM2B;ACSM1;AACS;ACSS3;ACSBG2;SLC27A5;ACSM3;ACSF3;SLC27A2;ACSBG1;ACSS1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.2050605889370252,-0.5373823477439237,0.9851485148514851,0.986009485094851,1.0,15/15,79.52%,COX10;COX5B;COX6A1;CYB5A;COX15;COX6A2;COX8A;COX4I2;COX7A1;NDUFA4L2;COX6B1;COX4I1;NDUFA4;COX7A2L;COX5A
prerank,neuropeptide receptor activity (GO:0008188),0.19978599270001673,0.5224162245893409,0.9854014598540146,0.993680973295485,1.0,2/29,9.06%,TACR1;OPRM1
prerank,hormone activity (GO:0005179),0.17968543532677878,0.5101795565404611,0.9974554707379135,0.9946657748462424,1.0,1/54,1.96%,METRNL
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.23162583521532493,0.4994541661497641,0.9797297297297297,0.9948900979830658,1.0,1/11,7.35%,DCP2
prerank,nucleotidase activity (GO:0008252),-0.18624849656650863,-0.4835773049913064,0.9881516587677726,0.9928965454874299,1.0,3/15,20.17%,NT5M;NT5DC3;NT5DC1
prerank,steroid hydroxylase activity (GO:0008395),0.20720179140993325,0.4813734496403394,0.9761526232114467,0.996379835775618,1.0,1/16,7.75%,CYP27A1
prerank,peptidoglycan binding (GO:0042834),0.23384142207786615,0.4789838592498122,0.986013986013986,0.9945147014522321,1.0,2/10,12.51%,NLRP3;TLR2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.21959502284638904,0.4738907475286728,0.9882352941176471,0.9931144899622906,1.0,1/12,10.96%,GPR88
prerank,lysine N-methyltransferase activity (GO:0016278),0.1902412256959252,0.45887073633461345,0.9838969404186796,0.9930742380384812,1.0,6/20,23.06%,SETD7;SETD2;EEF1AKMT1;EHMT1;ATPSCKMT;ANTKMT
